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Introduction
The healthcare marketplace is continually evolving in terms of technological innovation, payment
models, delivery of care, and in addressing population health. These trends have implications for
the healthcare workforce with regards to the demand for various types of services and the capacity
of the workforce to meet this demand. Some challenges faced by the healthcare system are longstanding, such as shortages of providers in certain geographic regions and locales and improving
quality of care, while others, such as the opioid epidemic are more recent. The nation continues to
look for innovative ways to address both types of challenges, including mechanisms that enable the
efficient dissemination of clinical knowledge throughout the healthcare system.
The primary means of training healthcare providers is through medical education which prepares
trainees for certification and/or licensure in their healthcare professions. Such training provides
practitioners with a broad knowledge base that is ideally current upon entering the workforce, and
addresses conditions they are likely to treat. However, the current pace and breadth of innovation is
remarkably fast moving, especially in primary care where providers are tasked with diagnosing,
triaging, and treating patients presenting with a wide array of conditions. Moreover, the needs of
local populations vary and in remote locations where access to specialists is limited, primary care
practitioners may need to address conditions or problems that are within their scope of practice, but
for which they would benefit from consultation with more knowledgeable health care professionals.
Addressing this perceived need for a continuing learning network is the primary motivation behind
the relatively recent development of technology-enabled collaborative learning and capacity-building
models that Congress asked the Department to examine. Such models connect primary care
providers, often located in remote areas, with specialist teams that help mentor these providers in
treating real patients with a given condition. Mentoring sessions typically involve the anonymous
presentation of cases, discussion around options to treat or triage (when it becomes evident a patient
requires the care of the specialist) such cases, and a didactic webinar similar to a continuing medical
education session. Such models have the potential (and in certain circumstances have been shown)
to help address important gaps in care for underserved populations. The ECHO Act (see
Attachment A) speaks to other potential benefits of such models including improving provider
retention, quality of care, and public health, and alleviating wait times, which Congress asked the
Department to examine.
In this report, we share what we have learned about: (1) how such models are being used to address
healthcare workforce capacity-building and quality improvement objectives; (2) what the existing
evidence base tells us about the effectiveness of these models in achieving these objectives; and (3)
where there are gaps in the evidence base that warrant further evaluation. The report, “Evaluation
of Technology-Enabled Collaborative Learning and Capacity Building Models,” prepared by the
RAND Corporation and found at Attachment B, addresses these topics.
Congressional Charge
On December 14, 2016, the President signed into law the Expanding Capacity for Health Outcomes
(ECHO) Act, Public Law 114-270, a freestanding piece of legislation that requires the Secretary to
submit a report to Congress that examines “technology-enabled collaborative learning and capacity
building models” and their impact on addressing a range of health conditions, health workforce
issues, implementation of public health programs, and the delivery of health services to rural and
other underserved populations. The Act also called for the Department to provide
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recommendations on opportunities for increased adoption of such models and the role of such
models in continuing medical education. The materials here respond to these requests.
Preparation of the Report
Given the cross-cutting nature of technology-enabled collaborative learning and capacity building
models funded across the Department, the Office of the Assistant Secretary for Planning and
Evaluation (ASPE) prepared this report in consultation with agencies across the Department.
ASPE contracted with the RAND Corporation to assist the Department in meeting this
Congressional requirement, and working closely with the Department, prepared the report,
“Evaluation of Technology-Enabled Collaborative Learning and Capacity Building Models,” (see
Attachment B below) which is summarized below along with the Department’s assessment of
potential future work that could contribute to further developing the evidence base for such models.
In short, this report provides a brief history of such models, describes examples of implementations
of the model (and one additional model that is similar in nature), reviews the current status of the
evidence base for such models as of December 2018, and reports on input provided by a panel of
technical experts on potential evaluation options.
The report that RAND prepared, along with the Department’s related work, responds to the
legislative requirements in the ECHO Act (see pg. 11 for greater detail on how the requirements in
the ECHO Act were addressed).
Key Findings of the RAND Report (Attachment B)
·

While the use of technology-enabled collaborative learning and capacity building models is
widespread across the Department, the existing empirical evidence for their impact on
patient and provider outcomes remains modest, though the evidence consistently shows
positive effects in the areas that have been measured.

·

An absence of standardized information collection, both in terms of the characteristics of
individual implementations of the intervention as well as measurement of health outcomes,
around these models hampers research on their effectiveness. This gap can be addressed as
new efforts are put in place.

·

To date, funders’ efforts addressing technology-enabled collaborative learning and capacity
building models have focused on their implementation, although some funders have devoted
additional resources to evaluation in recent years. Given the modest evidence available on
the effectiveness of this type of intervention, the Department believes that strengthening the
evidence base on the effectiveness of such models would be helpful to determine how best
to encourage expanded use of such models.

Summary of the RAND Report
Brief Overview of ECHO and ECHO-Like Models (EELM):
The ECHO Act defines a ‘‘technology-enabled collaborative learning and capacity building model’’
as a “distance health education model that connects specialists with multiple other health care
professionals through simultaneous interactive videoconferencing for the purpose of facilitating
case-based learning, disseminating best practices, and evaluating outcomes.”
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By providing links to specialists and a forum for case-based learning, such models are designed to
equip generalist providers, many of whom are practicing in remote locations, with the confidence to
treat patients in their practice who present with complex or unfamiliar conditions that are still within
the scope of primary care. The original model of this type, Project ECHO (Project Extension for
Community Healthcare Outcomes) originated in 2003 at the University of New Mexico through the
work of Dr. Sanjeev Arora as a way of expanding access to care for hepatitis C (HCV) in rural New
Mexico. Project ECHO established the key components of technology-enabled collaborative
learning and capacity building model: a hub and spoke organization with a specialist or other clinical
content expert who tele-mentors generalists in the care of a specific condition through a
teleconferencing link, on a regular and recurring basis combining a didactic component with case
study presentations by participants. Implementation of the Project ECHO model (and close
variants) has since been expanded to address a wide variety of disease conditions across the US and
internationally. Many of the replications are under the aegis of the ECHO Institute at the University
of New Mexico which provides training in its model and maintains a data base on its participants.
However, there are other examples of technology enabled learning models that share similar
characteristics but may not be tracked through the ECHO Institute. Hence, throughout this
document (as well as in RAND’s report) we refer to technology-enabled collaborative learning and
capacity building models as “ECHO and ECHO-like models” (EELM).
The use of technology-enabled collaborative learning and capacity building models is widespread
across the Department. For purposes of this report, an intervention is considered to be an EELM if
it provides interactive mentorship for participants who are often in remote areas through
videoconferencing technology. EELM use a hub-and spoke model with an interdisciplinary mentor
team at the hub site. EELM sessions are built on a case-based approach where participants present
and discuss cases. An EELM project consists of multiple sessions at regular time intervals, usually
bi-weekly for a fixed time period. Some EELM are time-limited to a set number of sessions.
Others continue indefinitely. While recently the EELM approach has been applied to a growing
number of disciplines, this report is limited to the use of EELM whose goals are health-related.
RAND’s report includes an inventory of EELM implementations funded by the Department and a
variety of other sources, arranged by the site of the EELM hub. These programs vary by content
area; target mentees; number, frequency and duration of sessions; whether an intervention ends after
a fixed number of sessions or is open ended; whether an intervention is geographically targeted; and
how it is funded. This variation raises many interesting questions as to where EELM are most
effective as an intervention and how EELM should be structured for best results, but also poses
challenges in terms of evaluating such models. Given the diversity of EELM no single study or
targeted suite of studies will answer all the questions raised by Congress in the ECHO Act.
The RAND report consists of these major parts:
·
·

Nine case studies which illustrate some of the diversity across EELM programs in topical
area, organizational placement, geographic focus and funding sources. (Appendix E of
RAND report)
An inventory of current and recent EELM projects supported by the Department and other
funders in the United States, as well as examples of EELM programs in other Englishspeaking countries. (Appendix F of RAND report)
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·
·

A systematic review of the evidence of the effectiveness of EELM in affecting both
provider- and patient-relevant outcomes.
The results of a Technical Expert Panel held April 2018 that considered gaps in the
evidence of the effectiveness of EELM and evaluation options for addressing these gaps.

Inventory:
The inventory describes the current landscape of EELM. RAND identified 585 ongoing and recent
EELM for improving access to care and enhancing the quality of health care across the United
States and in several international locations. Of these, 469 were based in the United States and 116
were international.
·

·

·

·

As of 2018, Project ECHO had 165 affiliated hubs in 35 states and 24 countries; 101 of
these hubs are located in the United States. Project ECHO also coined the term “superhub”
to describe a site which has developed the capacity to train and mentor new hubs in the
ECHO model. As of January 2018, there were nine superhub sites in addition to UNM listed
worldwide on the Project ECHO website.
A number of other EELM exist. For example, the Veterans Health Administration and the
Department of Defense support their own EELMs (VA SCAN-ECHO and various DoD
programs, respectively) covering a wide variety of conditions, with the largest offerings in
the areas of HCV, pain management, and opioid use disorder.
Within the United States, the average number of identified EELM was 9 programs per state,
ranging from a low of 1 in states such as Mississippi and Louisiana to a high of 50 in
Colorado. Numbers of EELM have been climbing rapidly in recent years, with 76 new
programs identified in 2017 alone.
The ten most common health content areas covered by EELM in our inventory were mental
health, opioid use and other substance use disorders, chronic pain management, hepatitis C,
autism spectrum disorders, cancer care, palliative care, HIV/AIDS, and diabetes. Together
these accounted for almost half of all programs identified. Many of these topics correspond
closely to conditions that are common and impactful for patients, and that many clinicians
feel under-equipped to address.

The total amount of funding being devoted to EELM is difficult to discern. Most websites featuring
EELM highlight a program name, topical area, training dates, location, and general objective.
However, the funder was reported in only about half of all cases and the total dollar amounts from
funding sources such as grants devoted specifically to EELM were seldom available. An EELM
model is often part of a larger effort being funded.
Case Studies:
Appendix E of the RAND report contains nine case studies of EELM that collectively provide a
snapshot of the diversity of such programs across target conditions, organizational locus, funding
sources, geographic reach and other key aspects. Cases studies include: Project ECHO, the
University of Washington; ECHO-Chicago; ECHO efforts based at the University of Rochester; VA
SCAN-ECHO; Vermont Hub-and-Spoke; Oregon ECHO; Show-Me ECHO; ECHO Colorado,
and the Weitzman Institute. The case study reports contain much more detail than what is
summarized below.
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·

·

·

·

Many EELM exist alongside other telehealth-related mechanisms, including direct-care
telehealth, e-consults, and other mechanisms. This suggests that EELM can be implemented
as part of a suite of strategies for telehealth delivery frequently used alongside and
complementing these other strategies.
Human connections are important in making EELM “work” for generalist mentees, both in
terms recruiting and retaining participants. Key informants frequently commented on how
different subject areas require different designs, different implementations, perhaps different
frequencies and durations of sessions, and even different approaches to evaluation.
An important source of variation is the geographic spread of these programs. Some
programs use EELM as a way to recruit specialist mentors from far away or to deliver
content across state lines. Others limit their offerings to a particular state due to funding.
One program explicitly mentioned the importance of local knowledge by ECHO specialist
mentors as being important for generalist mentees to absorb not only how to practice, but
also how best to access locally available resources and feel part of a practice community.
The case studies also illustrate challenges and opportunities for evaluation within these
programs, in part, due to the interests and requirements of their funders.

Evidence Review:
The evidence review was designed to identify and evaluate the current state of published evidence
on the effectiveness of EELM, as of December 2018, including evidence of impact on providers, on
the care provided, and on the outcomes patients experience from care. The evidence review
examined academic and gray literature, targeting peer-reviewed publications that evaluated EELM.
Studies included in the evidence base are found in Appendix C of the RAND report.
·
·

·

·

The empirical evidence for the impact of EELM on patient and provider outcomes remains
modest, though the evidence consistently shows positive effects in the areas that have been
measured.
The great majority of the 52 articles found with empirical results on the effects of EELM
addressed only provider outcomes, such as provider satisfaction, changes in provider
knowledge, changes in provider confidence or self-efficacy, and changes in self-reported
provider behavior. Of these 43 articles, 34 provided no between-subjects comparison group,
raising questions as to what the observed outcomes would be in the absence of intervention,
or what the outcomes would be after participation in an alternative intervention, such as
online self-guided coursework. Several other limitations were apparent in these studies,
including the possibility of the lack of baseline data and publication bias. No studies
evaluated whether change in care provision continues after the conclusion of training
through EELM.
Fifteen studies examined patient-related outcomes associated with EELM implementation,
such as sustained viral response for hepatitis C, but none of these studies were randomized.
Although these studies had limitations they provide evidence that EELM can improve
outcomes, at least in some cases.
More evidence is required before conclusions can be drawn about the efficacy of EELM
interventions. The quality of evidence for the effectiveness of EELM is generally rated as
“low” or “very low,” according to a standardized system for grading evidence. However, in
the field of health services research (of which the evaluation of EELM is an example),
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·

·

implementation complexities and constraints can contribute to adoption of less rigorous
evaluation study designs. This, in turn, may contribute to low quality of evidence scores.
Only a small number of studies to date have included measurements of cost, including the
cost of implementing EELM and the costs of patient care delivered under these programs,
as well as comparison costs in the absence of EELM. Such information would be especially
useful to funders as they consider potential expansions of EELM.
Published evaluations frequently do not include details of how EELMs are implemented
(e.g., frequency and duration of sessions), which would be helpful in identifying under what
conditions EELMs may be successful.

Technical Expert Panel:
On April 9, 2018, RAND and ASPE hosted a technical expert panel (TEP) meeting in Washington,
DC to examine the evidence base for EELM, identify gaps and explore a potential research agenda
to expand that evidence base. Participants included representatives from EELM hubs, researchers
who had studied EELM, evaluation methodologists, and Federal personnel familiar with EELM.
·

·

·

The TEP identified seven categories of research gaps: implementation and dissemination;
impacts on health (and other) outcomes for patients; impacts on provider/workforce
outcomes; effects on population health and health equity; health system impacts, such as
cost, efficiency, and access; policy and funding considerations; and optimal study designs.
The TEP also identified key themes to consider in developing an EELM evaluation portfolio
including:
‒ EELM programs have different goals/purposes requiring unique metrics.
‒ Heterogeneity in implementation, with varying degrees of fidelity to a “model”
implementation.
‒ Limited methodological rigor in studies conducted to date.
‒ Barriers to high quality evaluation of EELM include: lack of resources, the perceived
urgency to implement rather than evaluate, limited evaluation capacity or expertise,
challenges with collecting or obtaining high-quality data, and challenges with defining
and collecting meaningful measures of impact.
‒ It is important to balance enthusiasm for the promise of EELM, which led to significant
demand for this model, with the need for a strong evidence base.
The TEP identified potential short and longer term strategies for addressing these themes
through future work and studies.
‒ Building consensus around EELM’s various intended purposes and better
understanding the different ways it is implemented.
‒ Developing a ready-to-use (but customizable) “evaluation kit” for sites to use.
‒ Carrying out qualitative evaluations that use existing programs as the unit of study, to
answer questions such as “What makes a hub successful?”
‒ Conducting pre-post studies with a control group, with specific attention to choosing
comparators and patient outcomes that are clinically meaningful.
‒ Building evaluation components into grant funding, both public and private.
‒ Building capacity related to evaluation of EELM through annual seminars/conferences
or the creation of a resource center.
‒ Conducting studies of the persistence of EELM’s impacts on various outcomes.
‒ Performing stepped-wedge trials rolling out the intervention over time.
‒ Establishing policies to support more consistent funding for evaluation.
7

Recommendations
The proposals in this section were developed within the Department and were considered in light of
the findings in the RAND report. RAND’s report highlights the need for additional evidence on the
situations in which EELM may be effective at achieving goals such as building new capacity
amongst primary care providers practicing in underserved areas to treat various conditions and
improving quality of care for treatment of conditions that are already frequently addressed by such
providers. Although the existing evidence base shows some promising signs of this type of
intervention’s effectiveness, more evidence is needed to better understand the extent of this type of
intervention’s effectiveness in addressing various conditions and purposes. Hence, the
recommendations that follow focus on expanding what is known about the effectiveness of EELM.
Building this evidence base will help illuminate where and under what circumstances EELM are
effective interventions, which could inform any future considerations regarding further adoption of
such models. The recommendations that follow are based on these principles:
·
·
·
·

Consider approaches that make use of existing government resources and other mechanisms
that facilitate and harness creative thinking of private individuals and organizations.
Tie the quality of evidence generation to available funding.
Focus on a priority set of conditions where expanded provider knowledge is particularly
pertinent and whose evaluation may be generalizable to varying extents to other similar types
of conditions.
Give attention to EELM’s role in both capacity building and quality improvement.a

The intent of such a research portfolio would be to identify how EELM may improve both access to
care and the quality of care by better understanding under what circumstances and for what
purposes EELM “works” and when it does not including consideration of its potential to build
capacity and improve quality; to identify attributes of successful EELMs, the duration of the EELM
effect, and whether detectable positive effects of EELM extend beyond participants to other
providers in their practices.
Activities that could be helpful in strengthening the EELM evidence base include:
·

Enhancing the capacity to perform evaluations –
This activity could take multiple forms. One finding of the RAND report is that evaluations
that have been performed have often not reported on key details related to how a particular
implementation of the model has been designed (e.g., frequency and duration of trainings,
number of attendees, costs of the program, and funding sources). Use of a standardized
EELM data set would facilitate comparisons across EELM programs. TEP participants also
thought it would be helpful to assemble a list of evaluation outcomes and define best
practices for their measurement, which could help improve the consistency and rigor with
which they are analyzed. Hence, development of an EELM “evaluation toolkit,” which
could be customized for use in specific circumstances given the varied contexts within which
such models are implemented, could help facilitate future evaluations. Another option to
enhance evaluation capacity would be to directly fund organizations implementing EELMs

The RAND report indicates that EELM may be used to either expand existing capacity to treat various conditions or
improve the quality of care for conditions that are already widely treated in primary care. These represent distinct use
cases of EELM to be evaluated.
a
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to develop in-house expertise in evaluation and provide technical assistance in evaluation
through a training center.
·

Directly supporting evaluations –
As noted above, in the past, funders have focused most of their resources on supporting
implementation of EELMs, and with rare exceptions such as the Center for Medicare &
Medicaid Innovation funded effort, discussed in the full report, have generally devoted little
or no funding to evaluation. Through our various consultations with stakeholders, some
funders expressed to us that their organizations were focused on identifying “disruptive
innovations” that could potentially result in dramatic improvements in care delivery. They
saw EELM as a potential game changer and wanted to rapidly expand its availability. At the
same time, now that the model has spread geographically and addresses a relatively wide
variety of conditions, some funders have taken a greater interest in evaluating its impact.
To maximize existing resources, an evaluation could be built on top of one or more existing
or planned implementations of EELMs. Generally, evaluation is more effective when
planned in advance of implementation for reasons discussed in greater detail in RAND’s
report. In the case of federally-supported EELMs, they are often supported as one
intervention among others that may serve as substitutes or complements. This makes
distinguishing the unique contribution of EELM to observed outcomes challenging in an
evaluation, unless site level data have been collected and it is possible to identify sites that
only implemented EELM. Even when such information is available, it is possible that there
may be something unique about sites that elect to implement EELM, which causes the sites
to be more or less successful in addressing a healthcare priority (regardless of whether they
had chosen to implement EELM). Hence, without randomization around which sites
implement the intervention, drawing firm conclusions on causality is not possible.
Regardless, evaluations of many interventions in healthcare involve various methodological
limitations for similar reasons, and there is still value in retrospective evaluation in building
the evidence base.
More broadly, future research could specify the types of evidence that funders are interested
in generating on EELM. Funding could be made available for implementation and/or
evaluation. A portfolio of methodologically rigorous proposals could be solicited from
academic institutions and other appropriate parties.

·

Conditions to evaluate –
Future evaluation efforts could focus on EELM applications that improve the ability of
primary care providers to address conditions with which they may lack familiarity or
confidence in treating (e.g., substance use disorders, pain management), as this was a key
originating intent of EELM, but attention could also be given to evaluating the ability of
EELM to improve quality of care for conditions regularly treated in primary care, as this
potentially applies to a wider set of conditions. For example, priority areas could include
substance use disorders, behavioral health, pain management, diabetes, HIV/AIDS, or
palliative care, which would help fill gaps in evidence on EELM identified in the RAND
report. Depending on the level of funding available, secondary evaluations could be pursued
in areas that have not received as much attention to date or are using study designs that are
more robust. For example, the effectiveness of EELM in addressing children with medical
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complexity could be evaluated, in particular children affected by Zika who are expected to
have extensive long-term healthcare needs. Another option would be to compare
knowledge gained and/or treatment competency improvements resulting from use of
traditional models of CME versus EELM case-based and didactic learning sessions.
How This Report Addresses Requirements in the ECHO Act
Section 3 of the ECHO Act sets out its requirements for examination of ECHO and ECHO-like
models (EELM), consultation with stakeholders, and submission of a report with prescribed
contents. RAND’s report, “Evaluation of Technology-Enabled Collaborative Learning and
Capacity Building Models,” including its accompanying evidence review, inventory of EELM
activities, case studies, and the recommendations contained in the Department’s summary statement
address various elements of these three requirements. The below sections describe in greater detail
how requirements around examination, inventorying, and consultation were addressed. Following
this discussion is a table that maps where specific elements are addressed in the RAND report.
Examination:
The Act called for examining the impact of EELM on addressing “mental and substance use
disorders, chronic diseases and conditions, prenatal and maternal health, pediatric care, pain
management, and palliative care; addressing health care workforce issues, such as specialty care
shortages and primary care workforce recruitment, retention, and support for lifelong learning; the
implementation of public health programs, including those related to disease prevention, infectious
disease outbreaks, and public health surveillance; and the delivery of health care services in rural
areas, frontier areas, health professional shortage areas, and medically underserved areas, and to
medically underserved populations and Native Americans.”
The Department’s consultation efforts combined with research performed by RAND have touched
upon many of these topics. The Department focused its examination efforts on the following tasks:
(1) understanding the breadth and diversity of EELM interventions and (2) reviewing the existing
evidence base on the impact of EELM on provider and patient outcomes.
EELM Activity Funded by the Federal Government and Other Sources:
In addition to assessing the evidence for EELM, the Act also called on the Department to analyze
“efﬁcient and effective practices used by States and communities that have adopted such models,
including potential cost-effectiveness of such models” and provide a “list of such models that have
been funded by the Secretary in the 5 years immediately preceding” publication of this report,
including “Federal programs that have provided funding for such models.” The inventory of
EELM activities (including federally funded and EELMs receiving funding through other sources)
and case studies of local implementations of EELMs, which include discussion of ongoing
evaluation work (where applicable), some of which includes potential cost savings, are intended to
address these requirements.
Consultation:
In performing the above examinations, the Act required the Department to consult with “public and
private stakeholders with expertise in using technology-enabled collaborative learning and capacity
building models in health care settings.” These consultations took many forms. In September 2017,
Department staff attended the 2017 Meta-ECHO conference in Albuquerque, New Mexico. This
meeting convened approximately 650 people with interests or involvement in EELM. During this
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conference, staff met individually with an array of attendees from state governments; academic
institutions, including many EELM “hubs;” the health care sector, including safety net providers;
foundation funders; insurance companies; and the ECHO Institute staff. Contacts made through
attendance at this meeting helped refine how best to proceed with this report.
Following Meta-ECHO, Department staff attended two ECHO sessions, one on care for HIV and
one on HCV, to better understand the dynamics of an EELM intervention. Staff also met with
representatives of several EELM projects.
In April 2018, the Department convened a Technical Expert Panel (TEP) meeting, facilitated by
RAND, to explore existing evidence on the effectiveness of EELM programs, evidence gaps, and
how they might be addressed. Attending the TEP were representatives of EELM programs, health
services researchers, evaluation methodologists, foundation representatives, and Department staff
involved in EELM. Advice from the TEP helped shape the Department’s research
recommendations.
On November 16, 2017, the Health Resources and Services Administration focused part of its 2017
Rural Health Day on ECHO activities, with several grantees participating. This was also an
opportunity to share thoughts on the report to Congress. Moreover, throughout the year, input on
examination activities and preparation of the report, including its recommendations, was sought
from staff across the Department.
Table Mapping Requirements to Contractor Report:
The below table identifies specific examples illustrating how elements of the Act’s requirements for
the report to Congress are addressed in the RAND report. The examples are not exhaustive. Given
the numerous requirements contained in the Act, the Department pursued work thought to be most
informative, given available time. Recommendations required in the Act are discussed above.
Report Requirement
Analysis
Sec. 3(b)(2)(A)(i):
Use and integration of
models by health care
providers

Where Addressed

Comments

Addressed throughout the RAND
report. Chapter 2, “EELM in
Context” (pps. 3-20) gives an
overview of EELM, how defined,
their history, recent trends, and
strengths and weaknesses
Sec3(b)(2)(A)(ii)
Addressed in a separate report
Impact on provider
prepared by The Lewin Group,
retention including in “Impact of Participation in
Health Professional
Technology-Enabled Collaborative
Shortage Areas
Learning and Capacity Building
(ECHO) Models on Provider
Retention,” to be posted on the
ASPE website
Sec. 3(b)(2)(A)(iii):
Quality of Care:
Impact of models on
The RAND report cites studies
the quality of
examining the impact of EELM on
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The case studies found in Appendix
E, beginning on Page 118 illustrate
the ways EELM models have been
used to address various conditions
in different settings

The case studies describe
experiences addressing quality of
care: see, for example, ECHO

and access to care

the quality of care for patients with
HCV (p. 9) and care for dementia/
gerontology (p.40). The HCV study
found quality of care to be similar at
hubs and spokes.

Chicago’s work with HCV on page
126, and the Vermont hub and
spoke program on pages 142-143.

Reports on EELM’s ability to
increase access to specialty care are
Access to Care:
found in the case studies of ECHO
EELM’s potential to increase access Chicago (p 125-127) and the
to care is discussed throughout the Veterans Health Administration (p.
report. Specific examples
134-136). Expanding access to
addressing HCV are found on pps. opioid use disorder care is
6-9 and pain management on pps.
discussed in the Vermont hub and
39-43. Studies citing impact on
spoke example on p. 144. The
access to care and for a range of
Weitzman Institute has expanded
conditions are listed in Table C.1.
access to many types of specialty
that begins on page 79.
care, including HCV, HIV, MAT,
complex care management, and
LGBT health (p. 161). Similarly,
the University of Washington also
provides access to a wide range of
specialists (p. 122). Both of these
programs serve large geographic
areas.
Sec. 3(b)(2)(A)(iv):
Barriers to adoption of models are
Barriers faced by health discussed throughout the report
care providers, States,
and summarized on pps. 17-19. A
and communities in
discussion of barriers to high quality
adopting such models
evaluation of EELM is found
beginning on p. 50.
EELM’s ability to expand the
The ECHO Chicago case study is a
Sec. 3(b)(2)(A)(v):
capacity of individual providers to
good example of the reported
Impact of models on
practice to the full extent of their
effect of EELM on wait times (p.
the ability of local
health care providers
education, training and licensure is
126): The prevalence of diagnosed
presented as one of the two major
ADHD was only approximately 1
and specialists to
“poles” upon which EELM are
percent among the pediatric
practice to the full
extent of their
organized (p.46).
populations of the FQHC partners,
education, training, and
epidemiological data suggested an
actual prevalence of ADHD closer
licensure, including
to 7–9 percent. Providers explained
the effects on patient
wait times for specialty
that they were not screening or
care
diagnosing given that wait times
were more than a year for referrals
to specialists. Three years into the
ECHO-Chicago Pediatric ADHD
program, data showed that 4–6
percent of pediatric populations in
the spoke clinics were being
12

diagnosed with ADHD, which is
closer to the estimated prevalence.
Examples of state support for
EELM can be found in the case
studies, including the University of
Washington ECHO which receives
support from the state health
department (p. 124), the Oregon
ECHO network (p. 146) and Show
Me ECHO in Missouri (p. 152).

Sec. 3(b)(2)(A)(v):
Efficient and effective
practices used by States
and communities,
including potential
cost-effectiveness
Inventory
A list of models that
have been funded by
the Secretary in the 5
years immediately
preceding such
report

Executive Summary, p. ix
Methods, pps. 21-22
Findings, pps. 28-34
Appendix F is a listing arranged by
State of EELM activity supported
by the Department and others.
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Attachment A
Public Law 114-270,
the ECHO Act

SECTION 1. SHORT TITLE.
This Act may be cited as the “Expanding Capacity for Health Outcomes Act” or the “ECHO
Act”.
SEC. 2. DEFINITIONS.
In this Act:
(1) Health professional shortage area.--The term “health professional shortage area” means a
health professional shortage area designated under section 332 of the Public Health
Service Act (42 U.S.C. 254e).
(2) Indian tribe.--The term “Indian tribe” has the meaning given the term in section 4 of the
Indian Self-Determination and Education Assistance Act (25 U.S.C. 5304).
(3) Medically underserved area.--The term “medically underserved area” has the meaning
given the term “medically underserved community” in section 799B of the Public Health Service
Act (42 U.S.C. 295p).
(4) Medically underserved population.--The term “medically underserved population” has the
meaning given the term in section 330(b) of the Public Health Service Act (42 U.S.C. 254b(b)).
(5) Native Americans.--The term “Native Americans” has the meaning given the term in
section 736 of the Public Health Service Act (42 U.S.C. 293) and includes Indian tribes and tribal
organizations.
(6) Secretary.--The term “Secretary” means the Secretary of Health and Human Services.
(7) Technology-enabled collaborative learning and capacity building model.--The term
“technology-enabled collaborative learning and capacity building model” means a distance health
education model that connects specialists with multiple other health care professionals through
simultaneous interactive videoconferencing for the purpose of facilitating case-based learning,
disseminating best practices, and evaluating outcomes.
(8) Tribal organization.--The term “tribal organization” has the meaning given the term in
section 4 of the Indian Self-Determination and Education Assistance Act (25 U.S.C. 5304).
SEC. 3. EXAMINATION AND REPORT ON TECHNOLOGY-ENABLED
COLLABORATIVE LEARNING AND CAPACITY BUILDING MODELS.
(a) Examination.-(1) In general.--The Secretary shall examine technology-enabled collaborative learning and
capacity building models and their impact on-(A) addressing mental and substance use disorders, chronic diseases and conditions,
prenatal and maternal health, pediatric care, pain management, and palliative care;
(B) addressing health care workforce issues, such as specialty care shortages and primary
care workforce recruitment, retention, and support for lifelong learning;
(C) the implementation of public health programs, including those related to disease
prevention, infectious disease outbreaks, and public health surveillance;
(D) the delivery of health care services in rural areas, frontier areas, health professional
shortage areas, and medically underserved areas, and to medically underserved populations
and Native Americans; and
(E) addressing other issues the Secretary determines appropriate.
2

(2) Consultation.--In the examination required under paragraph (1), the Secretary shall consult
public and private stakeholders with expertise in using technology-enabled collaborative learning
and capacity building models in health care settings.
(b) Report.-(1) In general.--Not later than 2 years after the date of enactment of this Act, the Secretary shall
submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the
Committee on Energy and Commerce of the House of Representatives, and post on the appropriate
website of the Department of Health and Human Services, a report based on the examination under
subsection (a).
(2) Contents.--The report required under paragraph (1) shall include findings from the
examination under subsection (a) and each of the following:
(A) An analysis of-(i) the use and integration of technology-enabled collaborative learning and capacity
building models by health care providers;
(ii) the impact of such models on health care provider retention, including in health
professional shortage areas in the States and communities in which such models have been
adopted;
(iii) the impact of such models on the quality of, and access to, care for patients in
the States and communities in which such models have been adopted;
(iv) the barriers faced by health care providers, States, and communities in adopting
such models;
(v) the impact of such models on the ability of local health care providers and
specialists to practice to the full extent of their education, training, and licensure, including
the effects on patient wait times for specialty care; and
(vi) efficient and effective practices used by States and communities that have
adopted such models, including potential cost-effectiveness of such models.
(B) A list of such models that have been funded the Secretary in the 5 years immediately
preceding such report, including the Federal programs that have provided funding for such
models.
(C) Recommendations. Recommendations to reduce barriers for using and integrating such
models, and opportunities to improve adoption of, and support for, such models as
appropriate.
(D) Opportunities for increased adoption of such models into programs of the Department
of Health and Human Services that are in existence as of the report.
(E) Recommendations regarding the role of such models in continuing medical education
and lifelong learning, including the role of academic medical centers, provider organizations,
and community providers in such education and lifelong learning.
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Preface

Technology-enabled collaborative learning and capacity-building models, such as Project
ECHO (Extension for Community Healthcare Outcomes), have spread rapidly over the past 15
years across the United States, as well as into other countries. However, little is known about the
optimal conditions under which these models improve care and achieve other objectives, such as
improving workforce retention in medically underserved areas. This report is the culmination of
the project “Expanding Capacity for Health Outcomes (ECHO) Act Report to Congress: A Study
of Technology-Enabled Collaborative Learning and Capacity Building Models.” The Office of
the Assistant Secretary for Planning and Evaluation (ASPE) engaged the RAND Corporation to
assist in developing a report to Congress that responds to the ECHO Act.
This research was funded by ASPE and carried out within the Payment, Cost, and Coverage
program in RAND Health Care.
RAND Health Care, a division of the RAND Corporation, promotes healthier societies by
improving health care systems in the United States and other countries. We do this by providing
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evidence to support their most complex decisions. For more information, see
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Summary

Across the United States and internationally, multiple health care sites have embraced
technology-enabled collaborative learning and capacity-building models. Such models connect
generalist providers, often located in remote areas, with specialist teams that help train these
providers to deliver care for patients with conditions that they might not feel adequately prepared
to handle but are nevertheless within their scope of practice. The first implementation of this
model, Project ECHO (Extension for Community Healthcare Outcomes), launched in 2003 in
New Mexico. Project ECHO began with a focus on supporting the management of patients with
the hepatitis C virus (HCV) in rural regions of the state. This model has since been adapted to
many different sites within the United States and other countries, and these programs now
address a wide range of medical conditions and other issues that providers face. We refer to such
adaptations as ECHO and ECHO-like models (EELM).1
Although the publication of a landmark journal article (Arora, Thornton, et al., 2011) describing
the impact of Project ECHO generated much enthusiasm within the medical and health care policy
communities, the evidence base to date for whether or how EELM work remains modest. Many
efforts have focused on rapidly diffusing the original model or closely related adaptations, with much
less attention to conducting systematic evaluations of its effect on key outcomes.
This report is the culmination of efforts by our team of researchers at the RAND Corporation
on behalf of the Office of the Assistant Secretary for Planning and Evaluation to collect and
analyze information on what is currently known about EELM, what knowledge gaps remain, and
how to address those gaps.

What We Did
To document what is known about EELM, we first gathered an inventory of active EELM
across the United States and in select international countries, as well as the most frequently
addressed topic areas and funding sources. Secondly, based on an extensive literature search, we
summarized the findings of 52 peer-reviewed articles presenting empirical evidence for the
effectiveness of EELM. We also conducted discussions with key informants to gain a more
detailed understanding of nine specific implementations of EELM, presented as case studies in
Appendix E.
In addition, RAND convened a day-long Technical Expert Panel (TEP) meeting to gain
insight on research and evaluation options that would help fill the information gaps on EELM
and inform potential future evaluations. We also gathered data on a set of recently completed

1

All references to ECHO that do not refer explicitly to the ECHO Act refer to those programs based on Project
ECHO.
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evaluations to illustrate a range of possible methodological choices for future EELM evaluations
of varying complexity.

Inventory Findings
In total, we identified 585 ongoing and recent EELM for improving access to care and
enhancing the quality of health care across the United States and in several international
locations. Numbers of EELM have been climbing rapidly in recent years; we identified 88 new
programs in 2017 alone. The ten most common health content areas covered by EELM in our
inventory were mental health, opioid use disorder and other substance use disorders, chronic pain
management, HCV, autism spectrum disorders, cancer care, palliative care, human
immunodeficiency virus/acquired immune deficiency syndrome, and diabetes. Together, these
accounted for almost half of all programs identified.

Evidence Review Findings
RAND reviewed the evidence for the effectiveness of EELM to impact both providerrelevant outcomes and patient-relevant ones. We found that the empirical evidence for the impact
of EELM on patient and provider outcomes remains modest, though the evidence consistently
shows positive effects in the areas that have been measured.
The great majority of the 52 articles we found with empirical results on the effects of EELM
addressed only provider outcomes, such as provider satisfaction, changes in provider knowledge,
changes in provider confidence or self-efficacy, and changes in self-reported provider behavior.
Of the 43 articles that addressed provider outcomes, 34 provided no between-subjects
comparison group, raising questions about what the observed outcomes would be in the absence
of intervention or what the outcomes would be after participation in an alternative intervention,
such as online self-guided coursework. Several other limitations were apparent in these studies,
including the possibility of publication bias and the lack of baseline data. It is unclear whether
EELM are truly building generalists’ capacity to operate independently, and at least one study
suggested that generalists remained dependent on specialist advice to deliver advanced care
(Beste et al., 2016). No studies evaluated whether change in care provision continues after the
conclusion of training through EELM.
A smaller subset—15 studies—examined patient-related outcomes associated with
implementation of EELM, including both processes and outcomes of care. Conditions studied
included HCV, chronic liver disease, dementia care, chronic pain management, opioid addiction, and
diabetes. Examples of process measures studied included frequency of opioid prescriptions among
patients managed for chronic pain and frequency of initiating treatment for HCV. Examples of
outcome measures included sustained viral response for HCV and decreased average blood glucose
levels (hemoglobin A1c) for diabetes. Notably, none of the 15 studies used randomization. This lack
of randomization means that it is more likely that the findings could be because of study bias and
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might not be attributable to true findings. Nevertheless, these studies support the general notion that
EELM can improve processes or outcomes of care, at least in some cases.
Overall, we found that significantly more evidence is required before conclusions can be drawn
about the efficacy of such interventions. The quality of evidence for the effectiveness of EELM is
generally rated as “low” or “very low,” according to a standardized system for grading evidence. The
problem of low scores for evidence quality is by no means limited to EELM; in the field of health
services research (of which the evaluation of EELM is an example), implementation complexities
and constraints could contribute to adoption of less-rigorous evaluation study designs. This, in turn,
could contribute to low quality of evidence scores. Nevertheless, it is important for those evaluating
EELM to strive to generate higher-quality evidence, despite challenges in producing such evidence.
Similarly, in order to generate a more robust evidence base, it is important that entities funding
implementation of EELM incorporate dedicated funding to support evaluation.

TEP Findings
In examining the evidence base, TEP members identified many gaps, which we organized
into seven categories: implementation and dissemination; impacts on health (and other)
outcomes for patients; impacts on provider/workforce outcomes; effects on population health and
health equity; health system impacts, such as cost, efficiency, and access; policy and funding
considerations; and optimal study designs.
After discussing these gaps, the panel confirmed stakeholder enthusiasm for EELM and
observed that the primary purposes of EELM vary among programs, as does implementation.
The panel noted that existing evaluations do not provide a sufficiently robust evidence base;
structural barriers impede progress in collecting high-quality evaluations, and rigorous
evaluation methods have been used infrequently.
A relatively weak evidence base in the academic literature does not necessarily imply that
EELM are ineffective. More data are needed to assess the impact of EELM and, despite the
significant challenges of studying this model of care delivery, the panel was supportive of the
potential for more-rigorous evaluation. The panel also observed that the primary purposes of
EELM vary among programs, as does implementation.
From these discussions, RAND developed 16 potential strategies to strengthen the evidence
base for EELM, organized by stakeholder and possible time frame. Here, these are summarized
as four main points about advancing the evidence base on the impact of EELM:
1. Developing a clear understanding of EELM is critical. Building the evidence base
requires a recognition of the diversity of EELM and how they vary in their fidelity to the
original ECHO model. Evaluations should account for this diversity and attempt to
identify the core components of EELM.
2. An expanded focus on rigorous reporting of program characteristics of EELM
would help evaluators assess how the model is put into practice and what “ingredients”
might lead to better outcomes and are worth replicating.
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3. Building capacity to evaluate EELM is a third critical opportunity and is two-pronged.
Building such capacity could help implementers design EELM to facilitate improved
evaluations, and it could help researchers more effectively choose populations for study,
outcomes, comparators, and study designs.
4. Implementers and evaluators can engage with policymakers, funders, and others to
explore mutually beneficial mechanisms for supporting rigorous evaluation. Such
mechanisms would ideally address care delivery imperatives in the near term and enable
rigorous evaluations that would expand the evidence base to support longer-term
investments in EELM.

Examples of Evaluation Design
Evaluations of EELM are likely to differ in terms of resources and context, and some might
be more rigorous than others. Nevertheless, a key finding of the TEP was that even relatively
simple evaluations could be more rigorous than they have been historically. RAND examined
three possible types of evaluations that varied in complexity, rigor, and likely cost to conduct.
Key program features that would affect evaluation complexity include the length of the
intervention, the scope of the population from which the sampling frame is drawn, the content
area of study, the type of site leading the implementation, funding sources, and the degree of
difficulty in collecting data.

Lessons Learned from Case Studies
RAND conducted case studies of ten EELM. These case studies provided important insights
into the origins of EELM in different settings, the unique and the common features across
programs, the challenges that programs have faced and the approaches taken to address these
challenges, and the ways that programs have approached the evaluation of their work. Key
lessons learned, which could be useful for policymakers and implementers alike, included the
challenges of financial sustainability; the importance of champions, institutional support, and
creation of demand among generalist participants to receive educational offerings from EELM;
and the need for and challenge of conducting rigorous evaluations of program impact.

Looking Ahead
This work makes clear that stakeholder enthusiasm for EELM should be balanced with the
need for rigorous evaluations of their impact on key outcomes. Future evaluations will need to
consider the four overarching aims for advancing the evidence base, as already described. Welldesigned evaluations can help policymakers, researchers, and clinicians understand how and
under what circumstances EELM can be effective, thereby identifying their appropriate role in
expanding and enhancing health care delivery.
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1. Introduction

To achieve healthy lives and wellbeing for all, the right knowledge must get to the right
place at the right time for those who need it most.
—Struminger et al., 2017

Expanding access to care, particularly in areas where there are shortages of providers, has
been a long-standing goal of policymakers. One tool for expanding access is the use of
technology, such as videoconferencing, to allow specialists to reach patients and providers in
areas that lack specialty care, either directly or through their generalist providers. In December
2016, the Expanding Capacity for Health Outcomes Act (ECHO Act) was signed into law. This
act mandated an evaluation of the evidence base for technology-enabled collaborative models of
care (Public Law 114-270, 2016). Quoting the ECHO Act:
The term “technology-enabled collaborative learning and capacity-building
model” means a distance health education model that connects specialists with
multiple other health care professionals through simultaneous interactive
videoconferencing for the purpose of facilitating case-based learning,
disseminating best practices, and evaluating outcomes. (Public Law 114-270,
2016, Sec. 2)

The original such program, Project Extension for Community Healthcare Outcomes (Project
ECHO), launched in 2003 at the University of New Mexico (UNM) as a way to expand access to
hepatitis C virus (HCV) treatment for people in rural settings in that state (UNM, undated-a).
Several health care providers have also deployed Project ECHO, using technology to facilitate
medical education and care management collaboration, with the intent to increase the capacity of
the medical workforce to deliver high-quality care and reduce health disparities. Other providers
have created programs using the ECHO structure but are not directly affiliated with Project
ECHO. Here, we will refer to such programs as ECHO and ECHO-like models (EELM).2 In
Project ECHO and other EELM, front-line clinicians, typically located in underserved areas, are
paired with specialist mentors at academic medical centers or hubs to help manage a particular
condition. EELM have now expanded across the United States and the world, encompassing
numerous areas of expertise. The general model also has expanded its remote mentoring via
technology, or “telementoring,” to include nonmedical uses in education, policing, and other
non-health applications (Agency for Healthcare Research and Quality [AHRQ], 2017). This
report focuses on medical applications of the model.
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All references to ECHO that do not refer explicitly to the ECHO Act refer to those programs based on Project
ECHO.
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The ECHO Act called for an examination of “the use of, and opportunities to use,
technology-enabled collaborative learning and capacity building models to improve programs of
the Department of Health and Human Services, and for other purposes” (Public Law 114-270,
2016). As a result of this law, the U.S. Department of Health and Human Services (HHS), Office
of the Assistant Secretary for Planning and Evaluation (ASPE), engaged our research team at the
RAND Corporation to provide the following material:
•
•
•
•

•

•

a conceptual overview and brief history of EELM, focusing especially on major
issues likely to be relevant to the evaluation of EELM (Chapter 2)
a description of the methods used to gather the information for this report (Chapter 3)
an inventory of ongoing EELM, focusing especially on federally funded programs as
of June 2018 (Chapter 4 and Appendix F)
a review of the evidence base for the effectiveness of EELM, as of December 2018,
focusing on the extent of their proven ability to improve processes and outcomes of
care, and identifying key gaps in the evidence base (Chapter 5)
findings from a Technical Expert Panel (TEP), which was conducted in April 2018
(TEP members focused on assessing the state of the evidence for the effectiveness of
EELM and considering options to help expand that evidence base through evaluation.)
(Chapter 6)
examples of three potential rigorous study designs for evaluating EELM, varying in
complexity and resource requirements (Chapter 7).

As part of this evaluation, we were also asked to deliver brief, illustrative case studies of
representative EELM. With input from ASPE, we selected EELM that are noteworthy in terms of
program scope, organization, funding, ability to meet local needs, and potential for lessons
learned. These case studies are presented in Appendix E. Selected quotations from key
informants appear in boxes throughout the text where relevant.
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2. EELM in Context: History, Promise, and Challenges

Before considering the evidence base for the effectiveness of EELM, and what can be done
to expand that evidence base, it is necessary to understand what EELM are and how they came to
be. In this chapter, we briefly describe the history and development of EELM, their potential
advantages and disadvantages, the barriers and facilitators to more widespread adoption of these
models, and funding sources that have supported EELM to date.

EELM in Health Care
Although EELM have been applied to non–health care needs, such as policing and education
(AHRQ, 2017), this report focuses on their application to health and related concepts of wellbeing, such as child development. Health-oriented EELM combine features of several related
models, such as remote provider-to-patient direct care delivery, e-consults, and continuing
medical education (Arora et al., 2014). EELM typically involve a specialist or other clinical
content expert who telementors generalists in the care of a specific condition via
teleconferencing link, on a regular and recurring basis (Arora et al., 2007). The instructional
aspect of EELM features both case presentations, submitted and presented by the mentees, and a
didactic component. The aim is to increase the capacity of the mentees to treat a given condition
themselves, to the top of their scope of practice. Hence, EELM have the potential to expand
access to care for specific conditions without requiring patients to travel to a specialist. This also
helps free up the specialist’s time to address patients with conditions that cannot be treated by a
generalist (Arora, Kalishman, et al., 2011). In addition, by generating opportunities for
generalists in remote areas to connect with other members of the medical community, EELM
might have beneficial effects on job satisfaction and reduce burnout among the health
professionals who participate (Struminger et al., 2017).
Although their spread has been rapid, EELM face certain challenges to future growth and
perpetuation. EELM might not work equally well for all conditions, and greater adoption of such
models could be constrained by current funding limitations. Existing models have largely been
supported through grant funding, partly because of the current lack of a reimbursement
mechanism in most instances, especially under fee-for-service (FFS) payment modalities. It is
worth noting, however, that some Medicaid programs are providing funding to support EELM,
either through capitated or lump-sum payments. The extent to which EELM could be
incorporated into alternative payment models is still uncertain, although doing so might be a way
to expand adoption, as can be seen in the Rochester ECHO case study (see Appendix E). Within
HHS, most EELM to date have been funded by grants from AHRQ, the Substance Abuse and
Mental Health Services Administration (SAMHSA), the Centers for Disease Control and
Prevention (CDC), and the Health Resources and Services Administration (HRSA). Agencies
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such as the U.S. Veterans Health Administration (VHA, colloquially referred to as “the VA”)
and the Department of Defense (DoD) have developed their own EELM.
EELM Criteria
We defined EELM as programs that feature collaboration between one or more specialists
who share specialized knowledge with two or more generalists who receive telementoring via
videoconferencing. The mentorship is interactive (not simply unidirectional lectures), and it is
largely based on discussion sessions that feature cases submitted by the generalist mentees,
although sessions typically incorporate a didactic component as well. Mentors are located at one
or more “hub” sites, where a collection of expertise exists, whereas mentees are located at one or
more “spoke” sites, where access to some types of medical care might be less available. EELM
span multiple sessions that occur on a regular and recurrent basis, and they focus on a defined
topic, most often a specific disease state. The goal of the mentoring is to enable the generalist
mentees to build capacity to independently manage most patients with the focus condition,
referring only complex or unusual cases to a specialist.
In consultation with ASPE, we developed the following defining characteristics of EELM:
1. Specialist-generalist framework: The intention of the program is to capture translation
of knowledge from someone with specialized skills to someone with less specialized
skills. Although the usual case is for the mentees to be generalist physicians, there could
also be other types of health professionals providing generalist care, who receive
mentorship from a mentor with specific expertise. For example, a nutritionist with
specific expertise in the care of patients with cystic fibrosis might telementor nutritionists
who lack such expertise. The generalist must be a fully trained professional who is in
charge of some aspect of care delivery for a particular condition; this expression of the
model is not meant to incorporate trainees who are fulfilling orders from an attending
physician. A real-life example of this type of model would be mentorship of generalist
psychologists by a psychologist who specializes in managing talk therapy for survivors of
childhood trauma or abuse (Wonderlich et al., 2011).
2. Interactive mentorship: The program incorporates interactive consultations between
specialists and generalists, in which the generalists are delivering care—with guidance.
The specialists (mentors) are not billing the patients’ insurance for this time and are not
the providers of record (the specialists are generally paid directly through the program).
Although we are not aware of any legal test cases, it would seem that the specialists
would not be liable for care provided because they are primarily providing general advice
about care management principles and only secondarily discussing how to manage a
particular patient. Traditionally, generalist mentees are not charged a fee to attend EELM,
and we have not found any counterexamples to date.
3. Case-based method: The model of learning includes a case-based component, meaning
that it features theoretical examples and knowledge but also addresses real-world
anonymous cases, including active cases introduced by generalist mentees.
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4. Use of videoconferencing technology: Although some generalist mentees might lack
video capability, the program should provide videoconferencing to those who can use it.
5. Hub-spoke model: EELM typically involve a hub site, which houses a multidisciplinary
mentor team with specialized knowledge, and various spoke sites, which sign up to
participate as mentees. For the purposes of our review, to be considered among EELM, at
least two or more mentees should be involved simultaneously, to be distinguished from a
1:1 mentorship model. In practice, most EELM involve many trainees at many sites.
6. Multiple sessions: Sessions occur multiple times over an extended time horizon.
Operationally, we defined this as eight or more sessions each lasting at least 60 minutes
and occurring at least monthly.
7. Health-focused: In this evaluation, we considered EELM that have a goal of promoting
health, defined broadly to include social well-being. EELM might also be used in
nonhealth areas (education, criminal justice), but such models are beyond the scope of
this study.
For the purposes of this report, we considered an ECHO-like model to be one that meets all
of our criteria but is not formally affiliated with the ECHO Institute in Albuquerque, New
Mexico, and therefore does not use the label.

History and Development of EELM
Some populations in the United States are relatively isolated from specialty care by
geography or other issues of access, and these populations might rely on generalist providers to
deliver most or all of their medical care. Access to specialty care has long been unevenly
distributed, with rural or low-income patients especially likely to have difficulties accessing care.
Generalists in isolated areas might handle a somewhat wider spectrum of conditions (still within
the scope of generalist practice) than their colleagues in areas with many specialty physicians,
but these generalists still might consider themselves underqualified to address some conditions
that they feel are beyond the scope of their personal training. Underserved communities within
urban areas might be in close geographic proximity to specialist care but still have trouble
accessing care for various reasons, such as insurance coverage, ability to pay, and transportation.
Over the past 20 years, emerging technologies have been used to address such challenges. In
particular, videoconferencing technology has been used to support telemedicine (Ekeland,
Bowes, and Flottorp, 2010), where a provider located at one site is able to deliver care to a
patient located elsewhere. Another innovation is the e-consult (Vimalananda et al., 2015), in
which a generalist provider and a specialist communicate electronically, perhaps in conjunction
with review of the patient’s medical chart or history, so that the patient does not need to actually
travel to see a specialist. Similar to these other modalities, EELM rely on videoconferencing
technology, but also add elements similar to continuing medical education (CME), which aims to
“maintain, develop, or increase the knowledge, skills, and professional performance and
relationships” of a physician or other health care provider after completing residency or similar
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professional training (Barash, 2015). Hence, EELM combine elements of telemedicine, econsults, and CME, as well as several new elements that none of the aforementioned modalities
fully embodies (Table 2.1).
Table 2.1. Comparison of EELM with Other Modalities
Features

EELM

Telemedicine

e-Consult

CME

Didactic presentations

✓

✓

Case-based presentations

✓

+/–

Direct care delivery

✓

Ability to bill for services

✓

Hub-and-spoke model

✓

Videoconferencing

✓

✓

Rural/underserved populations

✓

✓

CME credit

✓

Increases access to care

✓

Aimed at building capacity

✓

+/–

+/–
✓
✓

✓

✓

NOTE: means present; +/– means present to some extent.

EELM do not involve the specialist delivering care directly (as in telemedicine) or acting as a
consultant for a single case (as in e-consults). Rather, EELM are focused on building capacity
and self-efficacy over time through a series of both didactic and case-based interactive
presentations.3 Time spent on the training activity is not billable—in general, specialists are paid
by the EELM; generalists do not pay to participate but have to find the hours to do so. The
generalist continues to provide direct care; the specialist does not have contact with the patient
and as a result cannot bill for patient care. This stands in contrast to traditional telemedicine, in
which the consulting provider gives direct care to the patient and bills for the services provided.
In e-consults, both the specialist and the generalist are considered to be providing direct care and
therefore both can bill for the care of the patient. Both telemedicine and e-consults can help
increase access to care, but EELM have the additional potential to create new capacity to address
a specific clinical area, whereas direct-care telemedicine can allow existing capacity only to
reach geographically isolated patients.
The first known EELM, Project ECHO (UNM, undated-e), was created by Sanjeev Arora, a
gastroenterologist at UNM who was concerned about access to care for patients with HCV. At
the time, in 2003, treatment for HCV lasted an entire year and was associated with considerable
3

Self-efficacy is commonly defined as the belief in one’s capacity to execute behaviors necessary to achieve a goal
or an outcome (Bandura, 1977).
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side effects, so it required expert monitoring and ongoing management. At the time of Project
ECHO’s founding, an estimated 34,000 New Mexicans were infected with HCV, but fewer than
1,600 were receiving treatment for their diseases (Arora et al., 2014). The gastroenterology
department at UNM had a months-long wait to be seen for HCV, and some patients needed to
drive five hours or more—each way—to be seen. Arora envisioned Project ECHO as a way to
help community-based providers treat HCV themselves, which ideally would shorten patient
wait times, obviate the need for patient travel, and reduce burden on specialists.
Project ECHO established a hub-and-spoke system to connect specialists and generalists at
different medical sites, with mentoring based at the UNM campus and delivered by experts not
only in gastroenterology but also other fields relevant to treating HCV. Initially, spoke sites were
all located in New Mexico and consisted of prisons, Indian Health Service (IHS) facilities,
federally qualified health centers (FQHCs), and other health care providers (Arora et al., 2007).
Educational sessions lasting two hours were delivered weekly, including a brief didactic
presentation followed by case-based learning involving real (but deidentified) patient cases that
had been submitted by the spoke sites. By 2009, more than 1,000 health care professionals had
participated in HCV ECHO sessions. In that year, Project ECHO’s HCV focus discussed 1,582
cases, each submitted by a clinician from a spoke site (Arora, Kalishman, et al., 2011).
Over time, the focus of Project ECHO expanded from HCV to encompass other areas of
expertise. By 2011, ECHO networks had been developed in New Mexico for asthma, chronic
pain, diabetes and cardiovascular risk reduction, high-risk pregnancy, human immunodeficiency
virus (HIV) and acquired immune deficiency syndrome (AIDS), pediatric obesity, rheumatology,
substance use disorders (SUDs), and mental illness. Each of these networks had an expert team
at UNM, and more spoke sites were added as the areas of focus expanded.
Based on enthusiasm about Project ECHO’s early results (Arora, Thornton, et al., 2011),
other localities began setting up hubs outside New Mexico, often with help from the team at
UNM (Figure 2.1).
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Figure 2.1. Establishment of New ECHO-Affiliated Hubs, 2004–2017

SOURCE: Based on data from Arora, 2018.
NOTE: This figure does not reflect EELM established independently from the ECHO Institute.

Hubs would often start with one area of expertise and then set up additional networks to meet
community needs. The most common conditions addressed by ECHO include mental health
conditions, opioid use disorder (OUD) and other SUDs, chronic pain, HCV, autism spectrum
disorders, cancer, palliative care, HIV/AIDS, and
diabetes. (For more detail, see Table 4.2.)
As of 2018, Project ECHO had 165 affiliated
Project ECHO is exactly what we needed.
hubs in 35 states and 24 countries; 101 of these hubs
Daren Anderson,
are located in the United States (Arora, 2018).
director of the Weitzman Institute (2018)
Project ECHO also coined the term ECHO superhub
to describe a site that has developed the capacity to
train and mentor new hubs in the ECHO model. As of January 2018, there were nine superhub
sites in addition to UNM listed worldwide on the Project ECHO website (UNM, undated-b).
As Project ECHO expanded, other EELM sprouted up (Figure 2.2).
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Figure 2.2 Time Line of Key Events in Development of EELM

NOTE: CU = University of Colorado; IAP = Integrated Addiction and Psychiatry; MAT = medication-assisted
treatment; NEJM = New England Journal of Medicine; NMAETC = New Mexico AIDS Education and Training Center;
RWJF = Robert Wood Johnson Foundation; SCAN-ECHO = Specialty Care Access Network–Extension for
Community Healthcare Outcomes; UNC = University of North Carolina; UW = University of Washington.

Some EELM were set up in “closed” health care systems, such as SCAN-ECHO in VA.
From 2011 to 2014, the specialties with the greatest number of visits, patients, and providers
within VA SCAN-ECHO were HCV, diabetes, and pain management (Clancy, 2017). EELM
were also set up within the military health system, with specific approaches to implementation of
EELM and specific areas of expertise being emphasized by different service branches.
In 2011, the NEJM published a landmark study and evaluation of Project ECHO (Arora,
Thornton, et al., 2011). This nonrandomized study documented outcomes for patients who began
treatment for HCV between 2004 and 2008, comparing outcomes for patients who were treated
at the spoke sites with those treated at the hub site. The spoke sites treated more patients than the
hub over this period (261 vs. 146), suggesting a significant expansion in the overall capacity to
treat HCV in New Mexico. There was no difference in sustained virologic response between
patients treated at hub sites and at spoke sites (50 percent vs. 46 percent, p = 0.57). This indicates
that the outcomes for patients were similar at hub sites and at spoke sites—a reassuring finding
regarding quality of care at spoke sites. The rate of serious adverse events was lower at the spoke
sites than the hub (7 percent vs. 14 percent, p = 0.02). This might be attributable to the younger
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age and lower complexity of patients treated at spoke sites, but it is also a reassuring signal
regarding the quality of care delivered at spoke sites. The NEJM article (Arora, Thornton, et al.,
2011), which had been cited 512 times as of the end of 2018, appears to have spurred great
interest in more widespread adoption of EELM and might have contributed to many sites seeking
to become hubs or spokes in ECHO networks.
Over the next several years (2012–2016), EELM expanded rapidly, developing new hubs and
spoke sites, new areas of expertise, and new funding sources—many from within HHS. These
years were also characterized by a rapid increase in the number of publications related to EELM
(Figure 2.3), likely reflecting interest generated by the 2011 NEJM publication.
Figure 2.3. Empirical Publications Evaluating Impacts of EELM Through 2018
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NOTE: Empirical publications present empirical data, as opposed to merely describing a program or a conceptual
model. There were no relevant publications identified in 2013. Data for 2018 includes articles published only through
December 1.

Within this environment of building enthusiasm and a sense that EELM could have the
potential to help address unmet health care needs, Congress passed the ECHO Act and the
President signed it in December 2016.

EELM Strengths, Weaknesses, Opportunities, and Barriers
We evaluated EELM for their potential strengths, weaknesses, opportunities for spread, and
barriers (or threats) to their success—also referred to as a SWOT analysis. This process was
informed by knowledge of the program, a literature review, and conversations with experts.
Here, we present the results of this analysis. In many cases, we identified these ideas ourselves;
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in some cases, we provide citations for ideas that were raised by others in the published
literature. It should be noted that the following is a conceptual review, not a synthesis of the
evidence base. (In contrast, we present our summary of the evidence base for EELM, including
what research evidence has been demonstrated and what evidence gaps remain, in Chapter 5.)
Potential Strengths of EELM
There are several potential strengths of EELM, which are distinct for particular categories of
stakeholders. We considered the effects on patients, generalist mentees, and specialist mentors,
as well as the effects on quality of care.
Patients

Patients might benefit from reduced travel to see specialists and reduced wait times for care.
Although it is recognized that exceptional or complex cases might still require referral for inperson evaluation by a specialist, the aim of EELM is to help generalists develop the expertise
and self-efficacy to handle a preponderance of cases themselves. To the extent that this is
achieved, many patients will not need to travel to access specialty care. In addition, wait times
could theoretically be reduced in two ways. First, the majority of patients, who now can be cared
for by a generalist, will no longer need to wait to see a specialist. EELM have the potential to
increase the capacity of a clinic to handle more than one complex condition: If all the providers
in a health center or clinic join EELM that focus on different clinical topics, the group practice
might collectively be able to handle a range of problems without resorting to external referrals
and rely instead on internal referrals within the practice. Second, the subset of patients who still
need to be referred could encounter reduced wait times if EELM have reduced a specialist’s
caseload. This sort of effect would require a certain penetration of EELM in the region.
Patients might also receive more patient-centered care from their generalists (who ostensibly
already know them and are familiar with their context and circumstances) than they would from
a specialist (who might lack such familiarity). This could be especially important for patients
who require services in another language or who are members of underserved communities and
might experience mistrust or have culturally sensitive needs, such as Native American tribes.
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Generalist Mentees

Generalist mentees might gain not only knowledge
but also self-efficacy and professional satisfaction.
Taking the time to do a site
EELM can enable generalists to help new groups of
visit to a potential spoke
patients while expanding the capacity of the generalists’
before the program begins
practice groups to handle a wider range of issues. Thus,
goes a long way toward
EELM have the potential to contribute to professional
obtaining support.
accomplishment and to provide generalists with a sense
Brian Wood, director of
of self-efficacy and pride in their work. Job-related
Project ECHO UW (2018)
burnout is usually defined as emotional exhaustion,
depersonalization, and reduced feelings of work-related
personal accomplishment (Maslach and Jackson, 1981).
Because they might lead to increased self-efficacy and pride in accomplishment, EELM could
help reduce burnout. Reduced burnout could, in turn, theoretically lead to increased retention,
which is an issue of particular importance in remote and underserved areas. However, EELM
also might increase burnout by increasing demands to deliver care for new conditions and by
requiring clinicians who attend case discussion sessions to later make up for the time not spent
on patient care. The impact of EELM on burnout and retention has not yet been empirically
addressed in the literature.
In addition, connecting with other generalists (at spoke sites) and with specialist-telementors
(at hub sites) could reduce feelings of professional isolation and expand participants’
professional networks. Generalists gaining new expertise might also be recognized for their
professional growth, which could provide opportunities for further professional accomplishment.
Finally, to the extent that patients receive more of their care from generalists (as opposed to
being referred out to other providers), EELM might increase revenue among participating
generalists.
Specialist Mentors

Specialists might find professional satisfaction in telementoring generalists and helping to
expand capacity and serve patients through EELM. Some specialists might feel burdened by a
backlog of patients awaiting appointments, as was the case for Dr. Arora when he developed the
idea for the first Project ECHO model. To the extent that EELM reduce this backlog, it could
also reduce specialist burnout. Specialists might also appreciate changes in the types of cases
referred to them. Shifting away from routine, uncomplicated cases and toward more-complicated
cases could allow specialists to practice to the full extent of their training, potentially making
their practices more professionally rewarding. By mentoring generalists from the surrounding
community, specialist mentors could become a favored destination for referrals, which could be
beneficial from a business standpoint. Although mentors located at academic medical centers
might have many opportunities to teach (medical students, residents, and fellows), communitybased specialist mentors might enjoy having an opportunity and a forum to share their
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knowledge—especially with fully credentialed providers, who might be particularly gratifying to
teach. Finally, specialist mentors might also learn important skills, including not only greater
awareness of the realities of practicing in rural or underserved communities but also deeper
expertise developed by sharing their knowledge with others. At the same time, these programs
could siphon off easier cases, which could pose a problem for specialists. Compensation for time
participating might also be less than their payment rate for clinical work.
Technical Quality of Care

The effects of EELM on quality of care could depend on the area of expertise. For some
conditions, such as diabetes, generalists already deliver care for this condition, but EELM could
improve the quality of care as measured through changes in processes of care or clinical
outcomes. For other conditions, such as HCV, generalists have not historically delivered such
care, so at first glance EELM might appear to play a larger role in expanding access than
improving quality. However, one important aspect of quality of care is the proportion of patients
who receive treatment. There are millions of patients in the United States who are candidates for
HCV treatment and not nearly enough specialists to treat them all. The proportion of such
patients who are offered treatment can be viewed as a quality measure in its own right; by
expanding the number of providers able to offer such treatment, EELM can improve quality from
this standpoint and thus improve outcomes for these patients.
Overall Cost of Care

EELM have the potential for cost savings at the societal level for several reasons. Generalist
care costs less than specialist care, and treating conditions sooner might achieve better outcomes
at lower cost. To the extent that EELM reduce wait times, overall cost savings could accrue as
patients are treated earlier in the course of disease. It is possible, on the other hand, that EELM
could increase the cost of care by providing treatment to more patients than before. Although
additional treatment might be cost-effective as measured in cost per quality-adjusted life year
gained, the overall total cost might still be higher. In terms of the cost savings or costeffectiveness of EELM, the bottom line could vary according to both the context of treatment
and the condition being treated.
Our analysis so far has focused on the cost to the health system; it might be important to also
consider costs from the societal perspective. For example, the time and money that patients and
caregivers save by not traveling to see a specialist should also be considered part of the cost
savings, from a societal perspective.
Potential Weaknesses of EELM
It is important to understand the potential challenges and limitations of EELM, because these
would also be logical topics for measurement and evaluation. Here, we consider financial
challenges, generalizability, and implementation issues as a few key potential weaknesses. We
do not consider the limited evidence base for the effectiveness of EELM as a weakness here; our
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review of the evidence base is found in Chapter 5. Here, we consider the likely inherent
weaknesses of EELM and tasks that EELM might be ill-suited to address, even if the evidence
base were to be augmented.
Payment for EELM

The lack of separate payment for EELM has the potential to negatively affect income among
different stakeholders through several mechanisms—especially under FFS models of payment
that reward volume of care. To date, a relatively large proportion of participants in EELM are
from community health centers, academic centers, or other similar practice configurations in
which providers are salaried or otherwise more insulated from immediate financial pressures.
Salaried providers, such as those in health centers, are subject to volume pressures through
productivity measures, making it harder to take on obligations that require significant time. To
the extent that providers are expected to make up this time later, it could occur after hours,
potentially contributing to burnout. A major theme from our case studies (see Appendix E) was
that finding ways to cover provider time was one of the greatest barriers to participation in
EELM. The potential for EELM to reach such providers might depend on changes in financial
incentives over time. With their emphasis on proactive population health management and
quality metrics, the incentive to participate in EELM might be higher under alternative payment
models.
Another potential issue for generalists is perverse financial incentives, which might operate
unevenly by condition. Some conditions are challenging to manage and might require longer
visits than usual or more care coordination, sometimes with no additional payment. Attracting
such patients to one’s practice by becoming an expert could be perceived as a money-losing
proposition for some providers under FFS. HCV is not a condition typically subject to these sorts
of perverse incentives (Langston, 2017). Although generalists had not historically delivered
HCV care, it is not a major departure from other forms of medication therapy management that
they deliver, it does not require more effort than other conditions, and its services can be billed.
It remains an open question, therefore, whether EELM will translate to other conditions with the
same degree of success—and, if so, which ones.
For telementors—specialists—the financial risks might be even more acute. Although they
share the issue of unreimbursed time, they might also find it undesirable to unload their easier
cases. EELM typically have a stated goal for generalists to handle the majority of uncomplicated
cases, sending only the most complex patients to specialists. Although this is clearly efficient for
the patient and for society, specialists in an FFS framework are often paid almost as much to
manage straightforward cases as complex cases—with much less effort. Retaining the easier
cases might be particularly desirable for specialists whose schedules are not as full as they would
like. In contrast, specialists located at academic medical centers, who usually receive a fixed
salary, might be more eager to shed extra patients if they are paid the same amount regardless of
the number of patients seen.
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Limited Generalizability to Other Conditions

One potential concern about the use of EELM is that this approach might work better for
some conditions than for others. The paradigmatic example of HCV has certain advantages. Prior
to Project ECHO’s launch in New Mexico, generalists already understood the basic idea of
medication therapy management; they did not usually treat HCV, likely because they sensed they
were not adequately trained to do so but could be trained to do so; reimbursement for HCV
treatment was relatively straightforward to obtain; and there were far too many HCV patients for
specialists to treat.
However, EELM are increasingly being applied to conditions for which at least one of these
factors does not apply. For instance, as already mentioned, EELM are now used for conditions
that generalists already treat (such as diabetes or depression), in which case the goal of EELM
might be to improve the quality of care and not to expand capacity. Generalists might be less
enthusiastic about using EELM in this context because (1) they might feel that they already
deliver high-quality care, and (2) participating in EELM for such conditions might be less
exciting than learning what is perceived to be a new skill. Langston (2017) raises the possibility
that suboptimal outcomes for chronic disease management might be more symptomatic of
failures in the organization of and payment for primary care and chronic disease management
and less symptomatic of a lack of knowledge and self-efficacy that can be remediated through
EELM.
Although the management of such diseases as diabetes and depression is generally thought of
as a basic function of generalists, new treatments continue to be developed for both conditions.
For example, diabetes can now be treated with DPP-4 inhibitors, GLP-1 agonists, and SGLT-2
inhibitors, none of which existed a decade ago. The skillful and fluent use of newer treatment
options might elude many generalists, in which case EELM could help clinicians stay abreast of
new treatments.
As EELM continue to expand the list of conditions under their purview (see Table 4.2), it
will be necessary to continue to evaluate the conditions and contexts in which EELM work best.
Limited Generalizability to Other Patients

At least one objective of EELM is to expand clinical capacity. For this to come to fruition,
clinicians (i.e., generalist mentees) must be able transfer their newly acquired skills to other
patients who were not discussed directly with the telementor specialist. It remains to be seen,
however, whether generalist mentees participating in EELM alter the management only of
patients directly discussed during sessions or whether generalists indeed extend these new skills
to patients not discussed. EELM that change the management only of patients directly discussed
might be functioning more as e-consult mechanisms than as capacity-building tools. This is an
important topic for future evaluations.
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Loss of Interest over Time

One feature of the original Project ECHO was the ability to sustain an ongoing program. In
other EELM, some mentee participants might have “drifted away” from attendance over time. In
some cases, this might be because mentees have a sense of having mastered the skills they had
been seeking. In other cases, however, it could have to do with a waning of novelty over time.
This sustained participation factor, coupled with limitations of funding or other resources, has
led some EELM to design their programs as cohorts, with predefined 12- or 18-week durations.
Thus, although the program might be ongoing, the participation of any individual is limited.
However, this means that the ongoing mentorship portion of the program is time-limited, so it
might also be necessary to address attrition if it is threatening the viability of a project, consider
the ideal length of affiliation for those that are ongoing, formalize what it means to complete a
program, and find ways to maintain connections between mentors and mentees over time.
Opportunities for Implementation of EELM
Contextual factors, such as alignment with other efforts and needs in primary care, are likely
to affect further implementation of EELM. Here we discuss how such factors might be
opportunities to support EELM.
Alignment with Primary Care

Primary care has been changing rapidly in recent years, and the pace of change seems to be
accelerating. One major trend is a shift toward the patient-centered medical home (PCMH);
according to AHRQ, PCMHs aim to transform primary care and make it more comprehensive,
patient-centered, coordinated, accessible, and of higher quality (AHRQ, undated). Another trend
is an increasing emphasis on proactive population health management and preventive health, as
opposed to waiting to treat patients when they present with complaints. Health care payers,
especially the Centers for Medicare and Medicaid Services (CMS), are working to incorporate
incentives consistent with these trends through pilot programs, payment changes to encourage
certain behaviors, and testing alternative payment models. EELM appear to be highly compatible
with these approaches to payment policy, which could represent one possible facilitating factor
for further adoption of EELM.
One major example of this approach is the Accountable Care Organization (ACO). For
ACOs receiving shared savings, a portion of such savings could be shared with one or more
specialists, partially defraying the costs of the time spent participating in an EELM.
Implementation Support

EELM employ a hub-and-spoke model that is collaborative by design, and—at least for
Project ECHO—there is an existing community of people who are actively engaged in its
implementation. For those interested in exploring EELM before making the investment in
videoconferencing technology, the public availability of informational materials simplifies the
process of collecting necessary information. The ECHO Institute hosts regular interactive
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orientation programs online, and facilitates a biennial conference, community phone calls,
collaborative peer groups, and a biweekly newsletter about Project ECHO (UNM, undated-c;
UNM, undated-d).
Clearly Defined Need

EELM generally respond to a clearly defined need. The original Project ECHO program for
HCV and the other New Mexico–based programs have all responded to the clear needs of the
geographically isolated regions of New Mexico, for which a trip to a referral hospital could
require considerable time and effort. In other cases, the need might not be geographically based
but oriented around a high-need condition. For example, providers trained to deliver MAT to
treat OUD, a major public health crisis, are in short supply throughout the United States (Dick et
al., 2015; Rosenblatt et al., 2015). Therefore, increasing generalist capacity to provide MAT is
needed in many areas of the country. In general, a review of the EELM we found (Chapter 4)
highlights an emphasis on addressing topic areas of mental health and SUD; this could be a
particularly useful area of focus for future EELM. Establishing EELM that are based on a clearly
defined need might be more likely to generate enthusiasm and persistence by participants.
Technology

A major enabling factor for implementing this kind of intervention is the increasing access to
and decreasing cost of the relevant technology, particularly videoconferencing, and has been
adopted by many EELM. Increasing access to broadband across the country means that, even in
remote locations, internet speeds are high enough to enable seamless video connections.
Familiarity with videoconferencing is rising with its increasing ubiquity, now often free and
available on handheld devices through a variety of applications. This familiarity paves the way
for use of videoconferencing in the clinical context.
For providers without technical expertise, partnership with Project ECHO includes support
for technology rollout and maintenance. Having this resource of experts available for
implementation or to answer questions when problems arise can ease what might be a hurdle for
some practices to engage with EELM.
Threats to the Implementation of EELM
As the final component of our SWOT analysis, we consider threats or barriers to the
continued implementation of EELM. The status quo plays a large part here, both in terms of
payment mechanisms and current medical culture.
FFS Dominance

As detailed previously, several of the most prominent challenges to EELM are related to
billing and loss of income. These challenges might lessen to the extent that FFS is replaced by
other payment modalities, or if payers begin to allow sessions to be billed or otherwise devote
funds to support EELM. A recent study, which did not focus on EELM but rather on nonvisit
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care in general, might be instructive. Basu et al. (2017) conducted a simulation-based study
showing that, under 100 percent FFS, a shift to proactive team-based and nonvisit care would
result in a loss of $42,000 per physician full-time equivalent. This loss became progressively
smaller as the proportion of patients under an alternative payment model (APM) increased. The
tipping point was 63 percent penetration of APM; above that level, adoption of team-based and
nonvisit care would produce a cost benefit to the practice in 95 percent of simulations. By
analogy, this could also be the tipping point for making the adoption of EELM financially
attractive. It seems that truly widespread adoption might require a shift in financial incentives for
large numbers of providers, where the specialists and generalists share the incentive structure. It
is worth noting that, to date, four states have received waivers to use Medicaid funds to support
EELM (see the section in this chapter on Funding). Such waivers could help push providers to
adopt EELM within a state despite the prevalence of FFS payment models.
Leadership and Cultural Support

Adoption of any innovation in care delivery will need to be supported by leaders, including
midlevel leaders (immediate supervisors), as well as department chairs and other upper-level
leaders. This support can take the form of protected time—during which clinician implementers
are explicitly released from patient care responsibilities so they can implement EELM, or
clinicians from spoke sites are given release time to attend sessions—or other logistical support
(such as access to teleconferencing software). It is also important that leaders generally show
support for the implementation effort through statements and actions—or at least not undercut it
by demonstrating that it is not a priority.
Beyond the contribution of leaders, any health care delivery organization will have its own
culture, which might be more or less supportive of EELM adoption. Depending on how EELM
are perceived in a specific location, generalists might want to gain expertise in a commonly
treated disease or to distinguish themselves by gaining expertise in an arena their colleagues do
not treat. If the culture values this kind of expertise, investment in EELM is more likely. Both the
hub sites, which contribute effort by specialists, and the spoke sites, which contribute time and
energy from generalists, will need to be invested in EELM for any ongoing project to be
successful.
Availability of Funding

Some EELM will be supported by internal funding, which is intimately tied to leadership
support, as previously mentioned. However, internal funding might not always be available—and
where it is available, it might be limited in scope in terms of what can be addressed. The
availability of external funding might sometimes be critical to support ambitious implementation
of EELM, especially when reimbursement is not available from payers. External funding could
come from federal, state, or local government; foundations; health care payers; or other sources.
Funding is needed for implementation of the model—to pay for staff time to organize and
facilitate sessions and particularly to cover the time spent away from direct patient care. There
are some sources of funding for physician education that could support the generalist’s time, but
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this would not cover the specialist’s time. Lastly, finding funding for evaluation can be a
challenge. External funding is critical to support evaluation, which is rarely funded internally and
might not be adequately supported by implementation-focused grants.

Funding Sources
Availability of funding can be a key facilitator for implementation of EELM (when
available) or a key challenge (when absent), meaning that funding fits into our SWOT analysis
both as an opportunity and as a challenge. Funding for EELM varies program to program, with
different institutions supporting their implementation in different ways, and often cobbling
together multiple funding sources. Of note, funding generally has not replaced revenue that
would come from billing clinical services, but rather has been directed at supporting program
implementation and, in some cases, program evaluation. Of the programs identified in our mid2017 inventory of EELM, the majority were located in the United States and supported by HHS.
There are also various EELM that are funded through other sources, such as state-based grants,
institutional funding, and private foundations.
HHS is the biggest grant funder of EELM in terms of the number of programs funded,4 with
HRSA funding the largest number of programs. Many of the grants are relatively small in size or
not entirely focused on supporting EELM, making it hard to compare funding amounts among
agencies. The CDC also funds several EELM, many of which support treatment for HIV
internationally, particularly in low- and middle-income countries. Other funding agencies include
AHRQ, SAMHSA, CMS, IHS, and the National Institutes of Health (NIH). The largest single
federal grant was the CMS Health Care Innovation Awards grant to the University of New
Mexico, for $8.5 million over three years, beginning in 2013 (Ahn et al., 2017; Miller, 2014).
This grant funded not only implementation but also evaluation of an ECHO project targeting
high-risk adult Medicaid beneficiaries. Foundations have also been among the important funders
of EELM, especially early in development.
Two closed health care systems (VA and DoD) support their own EELM (VA SCAN-ECHO
and various DoD programs, respectively; see the case report on VA SCAN-ECHO in Appendix
E). SCAN-ECHO and DoD programs address a wide variety of conditions, with the largest
offerings in the areas of HCV, pain management, and OUD. These programs are internally
funded rather than from a defined grant source; therefore, they can be measured only in terms of
the number of programs and not the dollar amounts that have been obligated.
In some states, funding has come directly through yearly appropriations in the state budget
(see the case report on Missouri in Appendix E). Others have obtained waivers to use Medicaid
funds to support EELM. Waivers are necessary because, under typical Medicaid rules, providers
might be paid only for direct health care delivery. The waivers for California, Colorado, New
4
Throughout the report, we quantify the number of EELM rather than attempting to quantify the total funding
devoted to them. In part, this choice was made because some programs devote all of their funding to activities of
EELM, while others devote only a small percentage—a percentage that in many cases cannot be known precisely.
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Mexico, and Oregon are for EELM that focus on pain management in rural areas, run through
Medicaid managed care organizations.
Increased uptake of APMs could therefore help facilitate uptake of EELM. More details on
payment for EELM are provided in an in-depth brief from the Center for Health Care Strategies
(Howe, Hamblin, and Moran, 2017).

Summary
EELM share characteristics with several related activities (telemedicine, e-consults, and
CME) and are facilitated by the contemporaneous availability of specific technology, especially
videoconferencing hardware, software, and broadband internet. Project ECHO has spread since
its start in 2003, with EELM adopted across the United States and internationally. The use of
EELM has expanded from HCV treatment to encompass a range of other conditions. The model
poses various potential benefits for patients, physician specialists, and physician generalists, as
well as for quality and overall cost of care. However, there are also potential limitations, such as
perverse business incentives for some providers and challenges regarding evaluation.
Funding sources also have expanded and now include federal sources (mostly HHS) as well
as state-based and private funders. Whether such funding sources will remain a viable source of
sustainability for EELM in the future is uncertain. To the extent that existing funding sources,
such as grants, become less available or less generous, EELM might need to identify other
mechanisms to continue their operations.
This brief overview of the conceptual underpinnings and history of EELM sets the stage for
the upcoming chapters looking at the evidence base for these models, key gaps in the evidence,
and options for addressing those gaps.
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3. Methods

This chapter describes the methods used in this report to support the findings in the following
chapters. We compiled an inventory of existing EELM, conducted an evidence review to
compile what is known in the published literature about EELM, convened a TEP, and estimated
the cost to fully evaluate EELM.

Inventory
The inventory was intended to identify all active EELM in the United States and selected
other countries. A summary of findings based on this inventory can be found in Chapter 4, and
the full state-by-state and country-by-country inventory of these initiatives can be found in
Appendix F.
Methodology
To find relevant EELM, we executed the following steps:
1. We compiled key terms pertaining to technology-based collaborative learning and
capacity-building models, through the end of May 2018.
2. We compiled a list of state government agencies functioning as funders and implementers
of collaborative learning models in the health sector (n = 417).
3. We compiled a list of medical schools, including schools of osteopathy, in each state
(n = 172)
4. We compiled a list of the five largest and five top-ranked medical institutions in each
state, including Washington, D.C., and Puerto Rico (n = 520);5 where there was overlap,
we listed additional top-ranked medical institutions such that a list of ten institutions was
catalogued for each state.
5. We entered terms from (1) through (4), state by state (Appendix A), into an online search
engine using Boolean operators. Each return was reviewed against inclusion criteria to
the extent that it was available. Returns deemed to include EELM were added to the
inventory.
We supplemented information obtained through internet searches through key informant
discussions with investigators and project leaders (for example, administrators of Project ECHO
at UNM), key funders, and host organizations (such as DoD).
As part of preliminary work in August and September 2017, ASPE issued a call on behalf of
RAND for information about funded ECHO projects. The recipients of this request were AHRQ,
5

We derived this data based on searches run on the websites for U.S. News and World Report
(https://www.usnews.com/) and Only In Your State (https://www.onlyinyourstate.com).
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Office of the Assistant Secretary for Preparedness and Response, Office of the Assistant
Secretary for Health, CDC, CMS, IHS, HRSA, SAMHSA, NIH, and ASPE. To maximize the
likelihood of response, we asked for minimal information about each project—such as name,
contact person, amount of funding, and dates of funding. At the time, we extracted the relevant
information from these lists and then filled in remaining fields, where possible, using other
sources, such as web searches, government websites, information from publications, and direct
contact with researchers. For the current update of this inventory (2018), we improved upon this
earlier effort by filling in as many cells as possible, using additional search terms.
Criteria for EELM
In consultation with ASPE, we developed criteria to define EELM. They are detailed in
Chapter 4; briefly, the review included only projects with (1) specialist-generalist training,
(2) interactive mentorship, (3) case-based presentations, (4) technology-enabling platforms, (5) a
hub-spoke framework, (6) multiple sessions over extended time, and (7) a health-focused
objective. Where full information was not available, we used our best judgment to determine
fitness for inclusion.
Inventory Structure
The inventory is organized alphabetically by state and then by country. Where available, we
provided the following specifications: (1) state of implementation, (2) name of the implementing
organization(s), (3) topic area of initiative, (4) starting date, (5) funders, (6) brief description of
the initiative, (7) web address from which data were extracted, and (8) contact information for
inquiries.
Limitations
Online searches for this inventory were conducted between December 2017 and March 2018
and updated in December 2018. This search focused only on hub locations and not on the
necessarily much higher number of spoke sites involved with each hub, sometimes located in a
different state (or country). Returns were limited to extant websites and relevant online
information available during this time period, identified based on the search criteria outlined
previously. In the event that search terms were missing from a web page or the initiative was not
listed online, it is possible that some initiatives were not captured. Additionally, many initiatives
contained minimal information online, making it difficult to determine whether they met the
inclusion criteria. This is reflected in the frequency of “unknown” entries in the following pages.
Many projects also use different names in different settings, creating risk of duplicate entries.
Individuals can refer to URLs and contact information to follow up directly with specific
initiatives and inquire about additional content.
The full search approach can be found in Appendix A.
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Evidence Review
The purpose of the evidence review was to evaluate the current state of published evidence
for the effectiveness of EELM that have been measured in any way. This broadly consists of
evidence of any impact on providers, on the care provided, and on the outcomes that patients
experience from care. Findings from this work can be found in Chapter 5.
Search Strategy
We conducted a systematic review of academic and gray literature, in accordance with
Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines (undated),
targeting peer-reviewed publications that evaluate EELM. In consultation with public health
experts in the field of telehealth, we operationally defined EELM according to a set of six
inclusion criteria as previously described.
Based on these inclusion criteria, we implemented a Boolean search procedure based on key
words defined under one or more of three domains: (1) a technology-enabling component,
(2) involvement of health personnel, and (3) key terms connoting resource or geographic
barriers, which EELM are typically implemented to address (Table 3.1). Each search query was
conducted by combining all terms within each column using “or” statements, and then linked
across columns 1–3 using “and” statements. As a complementary, independent strategy, we
searched for ECHO-specific terminology, linked by “or” statements (Domain 4). Sample search
terms can be found in Table 3.1; the full search is detailed in Appendix B.
Table 3.1. Search Term Categories
Domain 1
Technology Component

Domain 2
Health Personnel

Domain 3
Resource Barriers

Domain 4
Echo-Specific Terms

Tele-mentor*

Primary care provider*

Rural

ECHO

Video-conferenc*

Internist*

Remote

TeleECHO

Tele-educat*

General practitioner*

Underserved

SCAN-ECHO

Tele-conferenc*

Nurse or nurse
practitioner*

Low-resource

Specialty care access
network

Tele-train*

Psychiatr* or psycholog*

Resource-constrained

Extension of community
healthcare outcomes

Collaborative learn*

Mental or behavioral
health

Community-based

Learning collab*

NOTE: * denotes truncation search terms (all terms that begin with a given string of text). For example, “tele-mentor*”
could return “tele-mentor,” “tele-mentors,” tele-mentoring,” “tele-mentored,” etc.

For academic literature, we searched Google Scholar in addition to three academic databases:
PubMed, Embase, and PsychInfo. Google Scholar was limited to the first 100 returns. In
addition, we searched trial registration websites, such as ClinicalTrials.gov, the Cochrane Central
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Register (CENTRAL), and Scopus. Using seminal articles identified through this process,
including a 2016 review by Zhou and colleagues (2016), we also examined bibliographies.
For gray literature, we compiled an inventory of all U.S. medical schools and the 250 largest
and top-ranked teaching hospitals in the United States, which represent the principal hub
locations of EELM. We then queried all associated hospital-related and medical school–related
websites based on this inventory. As a second step, we identified a list of countries implementing
EELM and repeated this query. Lastly, we sought direct inputs from key authors, practitioners,
and telehealth experts through phone-based and in-person interviews, featuring interviews with
experts from VA, which operates SCAN-ECHO (U.S. Department of Veterans Affairs, Office of
Public and Intergovernmental Affairs, 2012), IHS, Kaiser Permanente, HRSA, other departments
within HHS, and Project ECHO. These interviews alerted us to recent articles and ensured we
had not missed any evidence considered relevant by experts in the field.
Document Review

We limited results to peer-reviewed articles published in English between January 2007 and
December 2017, and we updated the search results as of December 1, 2018. After identification
of articles and reports based on the search procedures already described, we inspected titles,
abstracts, and report summaries to determine whether the source addressed topic areas and
didactic approaches consistent with EELM. Returns were screened independently by two
research team members. In the event that a discrepancy arose, remaining members of the
research team were consulted.
A screening form was used to assess each record for agreement with the six inclusion criteria.
As a further requirement, articles also needed to report outcomes—whether these were provider
outcomes, such as self-reported improvement in self-efficacy, or patient outcomes, such as
decreased systolic blood pressure or changes in processes of care. Where one or more criteria
were not met, or where results were not reported, articles were excluded (n = 2,622). For
situations in which agreement with inclusion criteria was unclear from the title and abstract
alone, the full text was obtained and reviewed so that missing information could be completed
and so that a determination could be made about eligibility for full data abstraction. For every
record that was excluded (2,622 excluded based on title and abstract + 159 excluded after full
text review = 2,781 excluded total), the reason for exclusion was documented in the screening
form. Records that reported results and were scored as meeting all inclusion criteria were flagged
for full data abstraction. Articles that did not meet all inclusion criteria or failed to report
outcomes were excluded (see Figure 3.1).
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Figure 3.1. Flowchart of Systematic Review

Data Abstraction

For each article that met inclusion criteria, we abstracted the following content: author(s),
journal, year, title, health topic, hub name and geographic location, number of spokes, number of
trainees, implementation and analytic period, number of training sessions, training session
frequency and duration, evaluation design, primary provider outcome measure, primary provider
outcome results reported, primary patient outcome measure, and primary patient outcome results
reported. We also noted cases where more than one article was published from a single research
project.
For both provider-related outcomes and patient-related outcomes, a primary coder assigned a
Grading of Recommendations Assessment, Development and Evaluation (GRADE) score for
quality of evidence on each article (Ryan and Hill, 2016). In accordance with Cochrane
Collaboration conventions, GRADE scores reflect the merit of evidence for each outcome based
on six characteristics: study design, risk of bias, inconsistency, indirectness, imprecision, and
publication bias. Quality of evidence is assigned an ordinal GRADE score from + (very low) to
++++ (high). An overview of all abstracted data can be found in Appendix C in Tables C.1–C.3.
The research team then collectively deliberated the weight of evidence across articles for each
patient- and provider-related outcome, rendering a final grade score for these.
Limitations

A few study limitations should be noted. First, although we tried to be comprehensive in our
search, it is possible that we missed some articles, particularly if they did not use any of the key
words outlined in our search criteria (see Table 3.1). Second, study outcomes presented in Tables
D.1 and E.1 are those identified by the authors as primary research findings and do not reflect an
exhaustive list of outcomes. For an exhaustive list, we recommend that readers refer to the
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bibliography to examine the primary source. Third, we were unable to include works in progress
in this review, though there are many underway. Likewise, there were several studies that
included five of six inclusion criteria and reported relevant findings, but we were unable to
discuss these within the scope of this review. The most common reason for exclusion was that
training sessions did not involve a case-based model of pedagogy. This was necessarily the case
for many remote surgery training programs, which required real-time coaching.

Evaluation Options: Convening of a Technical Expert Panel
We convened a TEP for the purpose of assessing the state of the evidence for the
effectiveness of EELM and discussing the potential options to strengthen the evidence base. In
consultation with ASPE, we invited ten individuals to participate in the TEP, representing a
range of expertise and backgrounds in implementation science, statistical methods, program
evaluation, telehealth policy, clinical research, and leadership and implementation of EELM.
The TEP meeting covered three broad areas: what is currently known about EELM
(reviewing and evaluating the existing evidence base), what is not yet known about EELM
(identifying key research gaps), and approaches to address those gaps, including potential study
designs that could answer the key research questions about EELM and fill the gaps in
knowledge. The Populations, Interventions, Comparators, Outcomes, Timing, Settings, and
Study design (PICOTSS) framework, which is often used for the identification and evaluation of
research questions, was used to guide discussions throughout the day (Davies, 2011).
Our team moderated four discussion sessions, which were audio-recorded with participants’
consent. Both high-level and detailed notes were taken, and these were reviewed to extract key
themes. Federal observers and representatives of foundations that have funded the
implementation, and in some cases evaluation of EELM, attended the TEP meeting to provide
additional context as needed.
Findings from this work are detailed in Chapter 6.

Examples of Evaluations of EELM That Vary in Complexity and Rigor
As a companion to the evaluation report, we created examples of evaluations of EELM that
varied in complexity and scientific rigor. The findings of this effort are presented in Appendix D
as an aid to policymakers considering an investment in such evaluation.
We selected the PICOTSS framework, a common variation on the Population, Intervention,
Comparison, and Outcome framework, as already described.
Data Collection
As inputs for our analysis, we identified 41 implementation research studies registered on the
U.S. National Library of Medicine’s (USNLM’s) ClinicalTrials.gov website or on its webpage
listing Health Services Research Projects in Progress (2018q) that examined the effects of health
interventions on provider- and patient-related outcomes—limited to topic areas overlapping with
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the scenarios previously described—specifically, pediatric asthma, OUD, MAT, and dementia
care (see Table D.1). Evaluation costs from studies featured both costs associated with
implementation and indirect costs.
In addition to topic area, research studies were selected based on proximity to each of the
PICOTSS dimensions previously outlined. In other words, we attempted to identify research
studies that contained features as similar as possible to those that would be reflected in potential
studies of EELM, in terms of content and design. We also limited studies selected to funding
mechanisms oriented toward implementation and evaluation of health services, such as R-series
grants (large or medium-sized project grants by NIH or AHRQ). We did not consider career
development grants, such as K awards, which exist for the purpose of funding development of an
investigator more than any particular project.
Study features of the 41 studies are outlined in Appendix D. The appendix also provides
source citations for reviewing the original study and funding information.
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4. Findings: Inventory

Although EELM have expanded in recent years, there have been limited efforts to
systematically document their scope and scale. Given the extent of human and financial capital
invested to-date—thousands of trainers and trainees and millions of dollars of grant funding—an
overview of scope and scale of EELM in the United States is warranted.
In order to describe the landscape of EELM, we conducted a systematic and wide-ranging
search for existing EELM across the United States. (Methods are described in detail in Chapter
3.) For each program identified, we gathered information regarding topic, date of initiation,
topics covered, contact person, website, and funding source and amount (where that information
was available). Of note, programs were counted based on hubs because spokes frequently enter
and leave EELM and are exceedingly difficult to count. The findings are presented here, with
further details on individual programs located in Appendix F.

Overview
In total, we identified 585 ongoing and recent EELM for improving access and enhancing
quality of community health (see Figure 4.1 for state-by-state numbers). Of these,
469 (80 percent) were U.S.-based; 116 (20 percent) were international (Canada, United
Kingdom, India, Australia, and the Caribbean). Within the United States, the average number of
identified EELM was nine programs per state, ranging from none in Mississippi and one in such
states as Delaware and Louisiana to a high of 49 in Colorado. Internationally, of the countries we
searched, the country with the most instances of EELM implemented was India (with 40),
followed by Northern Ireland (with 39).
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Figure 4.1. Count of EELM Implemented, by State
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Trends in Implementation
Time trends. There has been a steady growth in the number of EELM implemented over the
past several years: Between 2012 and 2017, there has been an average of 41 new EELM
introduced each year—with 76 new programs generated in 2017 alone. The international trend is
more modest, but it follows a similar pattern (see Figure 4.2), with an apparent dip between 2016
and 2017 that might simply be due to random variation in the context of low numbers.
Figure 4.2. Number of New EELM Introduced, by Year, 2008–2017
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Topic areas. We identified a wide range of topic areas targeted by EELM. In total, we
identified EELM covering more than 100 health topics ranging from chronic pain management
to control of Zika virus. Table 4.1 provides topic areas of EELM as broken out by states; Table
4.2 presents an overview of the ten most common topics of EELM, representing almost half of
all EELM (53.9 percent).
Of the 469 EELM with U.S.-based hubs, 111 (24 percent) focused solely on pediatric issues;
a further 11 programs (2 percent) focused on both pediatric and nonpediatric issues.
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Health Systems Transformation

Geriatrics

Emergency Medicine

Endocrine Disorders

Developmental Behavioral Pediatrics

Digestive & Liver Disorders

Dermatologic Conditions

Complex Pediatrics

Clinical Leadership

Care Transitions/ Care Management

1
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Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
District of Columbia
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Puerto Rico
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming

Cardiovascular Health

Cancer

State

Mental Health: Depression

Table 4.1. State-by-State Topic Areas of EELM

1

2

1
1

1

1

2

1
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1
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1
1

2
1

1
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1
1

1

1

1

8
1

1

3
1
1
1

1

1

1

2
1
1

1

1

1

2

NOTE: For this table, programs were listed in a single state only—specifically, the location of the hub—even if operating
multiple states. ADHD = attention deficit hyperactivity disorder; LGBT = lesbian, gay, bisexual, and transgender; TB =
tuberculosis.
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1

1

Table 4.2. Most Frequent Health Content Areas Covered by EELM
Health Content Area

Number of Programs

Percentage of Total EELM

Mental health

51

8.7

Substance use disorders

40

6.8

Chronic pain management

39

6.7

Opioid use disorder

35

6.0

Hepatitis C

35

6.0

Autism spectrum disorders

30

5.1

Cancer care

24

4.1

Palliative care

22

3.8

HIV/AIDS

20

3.4

Diabetes

18

3.1

Other

271

46.3

Total

585

100

NOTE: Based on number of programs, not number of publications.

Funding. The most common funder based on number of programs, when reported
(n = 292 programs), was HRSA (n = 74, or 25.3 percent). This significantly surpassed the
frequency of other funding sources reported, with the next closest being VA (n = 23 programs,
7.9 percent). It should be noted that the funder was reported in 49.5 percent of cases, and that the
total dollar amounts were seldom available (see Figure 4.3).
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Figure 4.3. Funding Sources for EELM

NOTE: These data come from the 49.5 percent of programs with available funding information. Percentages reflect
the number of programs funded, not the total funding amount, which was often not available.

Key Messages
There are three clear take-away messages from surveying the online evidence around
implementation of EELM:
1. There has been substantial growth in the number of EELM over time, counted by the
number of hubs, both within the United States and abroad. Reported EELM have
increased from 24 new programs introduced in 2012 to 90 new programs in 2017, and
expansion continues to accelerate.
2. Within the United States, there are focused pockets of activity both geographically and
topically. The two most prolific states for implementing EELM—Colorado and New
Mexico—account for more activity than the bottom 25 states combined. Similarly, the
top ten topic areas for EELM account for a preponderance of programs, with a long tail
of topic areas that have been presented only once or twice. These most common topic
areas, such as pain, mental health, and SUD, correspond closely to the conditions that are
most common and impactful for patients, and those that many clinicians feel underequipped to address.
3. The quality of documentation associated with most EELM is minimal. Most websites
featuring EELM highlight a program name, topic area, training dates, location, and
general objective. Beyond this, it is difficult to infer a wide range of other characteristics
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about ongoing programs, such as frequency and duration of trainings, number of
attendees, funding sources, programmatic costs, and results of the program.

Summary and Looking Forward
The growing physician shortage and aging of the population in the United States are likely to
generate ongoing interest in potential interventions, such as EELM, to expand the capacity to
deliver care. The number of new EELM has increased in recent years for a variety of reasons,
and if EELM are ultimately shown to effectively address existing gaps in provider capacity, this
trend could continue. To support the evidence base, it will be important for EELM to better
describe the characteristics of their programs when publishing outcomes.
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5. Findings: Evidence Review

Though Project ECHO has undoubtedly expanded its scope and scale, the question of
whether EELM are having an impact still remains. An investigation of the evidence was
therefore warranted, given the extent of human and financial capital invested to date.
Part of the mandate associated with the ECHO Act is to report on the state of the science
associated with EELM, including analysis of their use, integration, and impact. Impact can be
assessed in terms of two broad categories of outcomes: provider-related outcomes and patientrelated outcomes. Provider-related outcomes include satisfaction with training, improved
confidence providing care, measures of clinical knowledge, behavior-related changes in care
provision, and patient retention. Patient-related outcomes include changes in processes of care
(such as frequency of treatment initiation, referrals, and prescriptions) and in direct outcomes
(such as rates of treatment success and failure and reductions in morbidity and mortality). EELM
could also impact costs by replacing visits to specialists with visits to primary care providers
(PCPs), increasing capacity of specialists to see additional patients with more complex
conditions, and broadening the kinds of patients that PCPs can manage, thereby adding
additional streams of revenue. Although it is important to measure all of these outcomes, some
might be more compelling than others. For example, demonstrating improved patient outcomes,
such as reductions in morbidity and mortality, is more compelling than demonstrating that
participants of EELM are satisfied with the programs.
Here we present our findings of a systematic review of peer-reviewed evidence of the impact
of EELM on provider- and patient-related outcomes between January 1, 2007, and December 1,
2018. We followed the Cochrane Collaboration’s GRADE framework to examine the quality of
evidence to date and use this review as a basis for highlighting potential next steps (Ryan and
Hill, 2016). (Methods are described in detail in Chapter 3.)

Results
After implementing search procedures, we reviewed 2,833 records—2,828 from database
searches and an additional five from bibliographic reviews and all other searches. There was an
acceptable degree of interrater reliability between screeners on whether articles should be
excluded from full text review: Raters agreed 97.3 percent of the time. Following screening,
211 articles were identified for full-text review for eligibility based on general topical relevance
to EELM. Based on inclusion and exclusion criteria, a total of 52 articles met eligibility for
inclusion based on presenting results of a study of the impact of EELM on some sort of outcome
(see Table C.1). The most frequent reasons for exclusion were either because the authors
discussed a telemedicine intervention in which specialists met remotely with patients rather than
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with providers, or because the trainings in the intervention did not use an interactive, case-based
method of pedagogy.
The most common health topics addressed by EELM were HCV, chronic pain management,
and dementia and elderly care. Of 52 articles, 39 focused on EELM implemented in the United
States, with Canada and Australia as the next most common countries. Year by year, there has
been a steady increase in the number of published evaluations of EELM (see Figure 5.1).
Figure 5.1. Publication Count on Provider- and Patient-Related Outcomes,
by Health Topic by Year

NOTE: “Other” category consisted of sleep medicine, oncology, nutrition, hypertension, osteoporosis, dermatology,
HIV care, smoking cessation, chronic liver disease, and multiple sclerosis. The figure includes data through
December 1, 2018.

Occurrence of discussion sessions held by EELM typically ranged from weekly to monthly,
lasting 60 to 180 minutes per session, with wide variation in the total number of sessions
conducted—in part because of the continuous nature of many intervention protocols. Similarly,
there was significant variability in the number of trainees and the number of patients served by
those trainees. In some instances, these numbers were not reported. Studies largely fell into one
of two categories, reporting either provider (trainee) outcomes or changes in processes of care or
patient outcomes as a consequence of provider trainings. Here, we present a topical synthesis of
these articles, organized by provider-related outcomes and patient-related outcomes.
Provider Measures

Of the 52 articles published between January 1, 2007, and December 1, 2018, 43 articles
presented quantitative and qualitative evidence outlining provider-related effects of EELM.
Studies most frequently measured outcomes in one of four areas: (1) provider satisfaction with
quality and content of trainings (n = 17; 40 percent); (2) provider knowledge acquired (n = 18;
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42 percent); (3) enhanced provider confidence or self-efficacy associated with care delivery
(n = 18; 42 percent); and (4) changes in self-reported provider behaviors associated with patient
care (n = 7; 16 percent). Additionally, study-specific provider outcomes apart from these four
groupings are referenced in Table C.2. In terms of study design, 23 of 43 (53 percent) involved a
counterfactual—either within subjects (pre versus post) or between them. Although only one of
the studies included an element of randomization, three studies involved both within-subject and
between-subject comparisons.
Provider satisfaction. Assessment of provider satisfaction has largely entailed administration
of post-intervention structured surveys, in which trainees are asked to assign ordinal or yes/no
responses to a range of prompts (Beste et al., 2016; Chaple et al., 2018; Cordasco et al., 2015;
Covell et al., 2015; Farris et al., 2017; Katzman et al., 2014; Kauth et al., 2015; Mehrotra et al.,
2018; Oliveira, Branquinho, and Goncalves, 2012; Rahman et al., 2010; Shipherd et al., 2016).
The median response rate was low (under 50 percent); however, self-reports consistently convey
positive ratings, at both the item level and the survey level. In several instances, satisfaction was
framed in terms of participation benefits, such as “Because of [EELM], I have expanded my
practice to include new skills” (Beste et al., 2016). In addition to structured surveys, a handful of
authors conducted focus group discussions (Carlin et al., 2018; Katzman et al., 2014; Volpe,
Boydell, and Pignatiello, 2014) and semistructured interviews (Cordasco et al., 2015; Fisher et
al., 2017; Ní Cheallaigh et al., 2017; Van Ast and Larson, 2007) to solicit more-detailed
feedback on aspects of EELM that worked well and less well—often with a focus on the
acceptability of the technology platform used. Here, responses were also generally positive,
although—given the nature of the design—samples were purposively selected and therefore
small.
Provider knowledge. In one study, Meins et al. (2015) evaluated provider knowledge on
topical content simply by asking participants after training to self-report whether they perceived
their knowledge had improved. More often, studies implemented a pre-post design in which
providers were asked to self-assess their knowledge at baseline and again at endline, with
statistically significant changes observed (Ball et al., 2018; Komaromy, Ceballos, et al., 2018;
Marciano et al., 2017; Masi et al., 2012; Mehrotra et al., 2018; Sockalingam et al., 2017; Swigert
et al., 2014; Wood et al., 2016). In a subset of pre-post assessments, specific assessments of
knowledge on the topic area of interest were constructed by the authors and administered
(Anderson et al., 2017; Masi et al., 2012; Rahman et al., 2012). Authors found significant
improvements in objectively measured content knowledge. In one instance on pain-related
knowledge, change scores among trainees were compared with a control group that had not
participated in sessions; improvements among trainees were significantly greater (Anderson et
al., 2017). However, a cluster randomized controlled trial (RCT) on the same topic did not find
any knowledge benefit among providers at participant clinics compared with those at
nonparticipant clinics (Eaton et al., 2018).
Provider confidence. Self-reported changes in confidence and self-efficacy were largely
focused on patient treatment; i.e., whether providers felt more confident in their ability to
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diagnose and treat patients following participation (Ball et al., 2018; Chaple et al., 2018;
Haozous et al., 2012; Johnson et al., 2017; Kauth et al., 2015; Mehrotra et al., 2018; Ray, Fried,
and Lindsay, 2014; Swigert et al., 2014; Wood et al., 2016). Metrics along these lines were
reported in most studies—post-intervention self-reported changes that were purely descriptive
(Johnson et al., 2017), within-subjects change from baseline to endline (Ray, Fried, and Lindsay,
2014), and between-subjects comparisons in perceived competence among trainees versus a
nonparticipant comparison group (Haozous et al., 2012). In most instances for which
comparisons were made, results were positive and statistically significant; a notable exception
came from the cluster RCT on chronic pain management that found no statistically significant
differences (Eaton et al., 2018).
Provider behavior change. Several
studies administered surveys in which
We wanted to do a good evaluation and
providers were asked to self-report behavior
speak to sustainability beyond the grant.
change as a result of case presentations. For
–Michael Hasselberg, program director of
example, Komaromy, Ceballos, and
Rochester ECHO (2018)
colleagues (2018) found that 77 percent of
participants reported that case discussion
changed their patient care plans for comorbid mental health and substance use disorders.
Likewise, Catic and colleagues (2014) observed recommendations for dementia treatment were
incorporated 89 percent of the time by case presenters. Qaddoumi and colleagues (2007) reported
that 91 percent of case presenters on pediatric neuro-oncology cases followed recommendations
by trainers. In other studies, providers were simply asked through a survey or interview whether
participation in EELM had altered or would alter their provision of care (Beste et al., 2016; Ní
Cheallaigh et al., 2017; Wood et al., 2018); on such occasions, providers generally responded
positively.
Patient Measures

In total, 15 of 52 identified studies (29 percent) discussed patient-related outcomes, including
changes in care processes and outcomes of care. Few studies examined costs of care as an
outcome. As anticipated, outcomes were particular to the health condition addressed in the
context of the study (see Table C.3). Results are presented by condition, separated into five
categories: (1) HCV; (2) chronic liver disease; (3) chronic pain management and opioid
addiction; (4) gerontology, including geriatric mental health and dementia; and (5) diabetes
management.
Hepatitis C. Four studies presented patient outcomes related to HCV. Arora and colleagues
(2011) compared sustained virologic response of patients treated at a central training site versus
at trainee sites and found no difference (p > 0.05). This was a positive finding, indicating that
generalists performed at a level comparable to specialists in managing HCV such that patient
outcomes were similar. They also found a lower rate of serious adverse events at trainee sites
(p = 0.02), likely attributable to selective referral. These findings were similar to those of a more
38

recent study by Mohsen and colleagues (2018). Here, authors compared 100 patients of providers
who participated in an EELM with 100 patients who received care in a tertiary liver clinic
(TLC). Initiation of direct acting antiviral therapy was similar between groups (EELM,
78 percent; TLC, 81 percent), as was completion of treatment (EELM, 89 percent; TLC,
86 percent) and—to a lesser extent—sustained virologic response (EELM, 87 percent; TLC,
96 percent). However, this study did not report whether these comparisons were statistically
significant.
Beste and colleagues (2017) identified PCPs participating in EELM that focused on HCV
and providers who had not participated and then compared the likelihood of the PCP initiating
medication treatment for the patient. The authors found that treatment initiation was higher
among trainees (hazard ratio [HR] 1.20, p < 0.01), but this effect was a result of increased
initiations among only those patients who were presented in case discussions (HR 3.30,
p < 0.01). By contrast, there was no difference in treatment initiation rates between the other
patients of ECHO-participating clinicians and patients of non-ECHO clinicians (HR 1.03,
p = 0.54), implying that ECHO sessions were functioning less like a capacity-building model and
more like a kind of e-consult that only changes care for patients who are presented; there was no
evidence of attendees increasing capacity to manage HCV independent of expert help. Lastly, Ní
Cheallaigh and colleagues (2017) conducted a series of semistructured interviews with trainees.
Interviewees reported that the patients attending their practices were beneficiaries of their ECHO
training. For example, in discussing an apparent freeing-up of specialist time by the model, one
trainee remarked, “Now, access to specialist clinics has improved. [The local specialist] has
actually taken back some people that he discharged. He’s also seen a couple of new people” (Ní
Cheallaigh et al., 2017, p. 149).
Chronic liver disease. We identified two studies on chronic liver disease that examined
patient-related outcomes. The first, a study by Glass and colleagues (2017), found that training
through EELM allowed patients to access care sooner and travel less distance compared with
those seeking in-clinic specialty care. The study did not examine changes in processes or
outcomes of care. A second study, by Su and colleagues (2018), examined the effect of receiving
a virtual consultation through the Ann Arbor VA SCAN-ECHO program on chronic liver
disease. Between 2011 and 2015, a total of 513 veterans with chronic liver disease received a
virtual consultation from a provider participating in the SCAN-ECHO program; 62,237 veterans
with chronic liver disease received no visits over this same time period. After propensity score
matching on characteristics predictive of receiving a visit, researchers found the HR of all-cause
mortality among those receiving a virtual consultation to be 0.54 (95-percent confidence interval
0.36–0.81, p = 0.003), meaning that those receiving the intervention were much less likely to die
than those who had no SCAN-ECHO consultation over the same time period.
Chronic pain management and opioid addiction. Four studies focused on pain management,
including among patients with opioid misuse. Anderson and colleagues (2017) compared
providers at community health centers who participated in training through EELM with those
who did not participate. They found that, among those who participated, frequency of opioid
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prescription declined significantly; with no such decline observed in the comparison group
(p = 0.02). Additionally, the number of opioid prescriptions per patient increased significantly
more among those in the control group (p = 0.001). Furthermore, patient referrals for both
behavioral health and physical therapy, both ways to address pain and opioid addiction,
increased among those with providers who participated in trainings, but not among those in the
comparison group (p < 0.001). Frank and colleagues (2015) compared the likelihood of referrals
among patients presented as cases with those not presented as cases. The authors observed
greater odds of patient referral to physical therapy among participants presented as cases
(p < 0.05), as well as greater odds of patients receiving an antidepressant (p < 0.05).
In a third study, Carey and colleagues (2016) performed a spatial reach analysis, concluding
that greater patient distance from home to specialty pain care was associated with slightly lower
odds of access to a provider trained through an EELM (p = 0.01), compared with much lower
odds of being seen in person at a specialty care clinic (p < 0.001). This implies that, although
EELM do not completely erase the adverse impacts of distance on access to specialty care for
pain, they do attenuate this impact. A fourth study, by Katzman and colleagues (2018), examined
opioid prescription rates across 1,382 clinics associated with the Army and Navy, 99 of which
participated in an EELM between 2013 and 2016. Compared with patients of a provider who did
not participate in EELM trainings (n > 1,000,000), those with a provider who did participate
(n > 50,000) observed a greater decline in prescriptions—from 23 percent to 9 percent
(p < 0.001). This finding remained even after employment of propensity score matching. Taken
together, data from these four studies consistently indicate that trainings positively affect care
processes for patients; but no evidence addresses direct patient outcomes, such as patientreported reductions in pain, or lower likelihood of opioid-related hospitalization or overdose.
Gerontology, including geriatric mental health and dementia. Three studies examined elderly
care for those with mental health conditions, including dementia; one additional study examined
transitional care among elderly populations. Catic and colleagues (2014) examined the effect of
adhering to expert recommendations during case presentations, specifically for long-term care
(LTC) residents with dementia and behavioral issues, and found that providers who followed
recommendations were more likely to report “clinical improvement” among patients (p = 0.03).
Fisher and colleagues (2017) examined the relative change in care utilization and costs among
geriatric patients with non-dementing geriatric mental health conditions, compared with geriatric
patients without such conditions, before versus after their providers participated in training
through EELM. The authors found that those with a mental health condition observed a
reduction in emergency department costs—from $406 to $311 (p < 0.05), which was not
observed in the comparison group. Over the same period, those without mental health conditions
observed significant increases in outpatient care utilization and costs (p < 0.05) not observed
among those with mental health conditions.
Gordon and colleagues (2016) compared patients at facilities of providers who were trained
through EELM with those who were not by inspecting 11 quality of care metrics, two of which
were considered primary outcomes (restraints and antipsychotic use). They observed
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nonsignificant differences on these two primary measures (p > 0.05) but did find lower rates of
urinary tract infections among patients seen at facilities with providers who were trained through
EELM (p < 0.05), a secondary outcome of the investigation. In a final study, by Moore and
colleagues (2017) examining transitional care, the authors concluded that patients with providers
at a skilled nursing facility who had been trained through EELM had shorter lengths of inpatient
stay (p = 0.01), lower 30-day hospital readmission rates (p = 0.03), and lower 30-day care costs
(p < 0.001) compared with providers who had not participated. This difference was significant
even after adjusting for baseline differences in patient composition between facilities.
Diabetes management. Watts and colleagues (2016) trained two PCPs on diabetes
management through a framework similar to EELM. Providers reported that among patients with
poorly controlled diabetes (i.e., all patients with hemoglobin A1c [HbA1c] > 9), the mean
HbA1c level decreased from 10.2 before training sessions to 8.4 after training (p < 0.001) five
months later, a clinically significant difference.
GRADE Scores

Patient-related and provider-related outcomes outlined in Table 5.1 reflect consensus
assignments mutually determined by all six members of our research team. Individual members
independently evaluated the quality of evidence for each outcome across the 52 studies that met
inclusion criteria based on Cochrane’s GRADE rubric (see Chapter 3). Because only one of the
studies involved randomization, baseline GRADE scores were ++, indicating low quality.
Research team members were in uniform agreement about the GRADE scores. We now provide
a brief rationale for the scores assigned.
Provider-related outcomes. To date, provider outcomes have relied heavily on self-reports
for providers self-selected (1) to participate in EELM, (2) to maintain participation in trainings
over time, and (3) to opt to complete feedback surveys. Only one study to date includes
randomization, although this is relatively common in the context of health services research
where the principle of equipoise (when the value of a new treatment compared with the
alternative is genuinely unknown) might otherwise be violated. The one RCT also concluded a
null result—meaning that the EELM did not demonstrate a positive effect on outcomes, though
the study might have been underpowered. Among those studies that collected data before and
after trainings, most offered no control comparison, raising the question of what would have
happened in the absence of training, or if trainings were substituted with a different set of
learning tools. In addition, many studies tested multiple endpoints without corrections for
multiple testing, which could lead to Type I error (finding evidence to support an effect when in
fact no effect existed) (Noble, 2009). Furthermore, studies might have been subject to
publication bias, the well-known phenomenon wherein studies with “null” findings (for example,
that EELM did not improve provider knowledge) would be less likely submitted for publication,
and less likely to be accepted once submitted (Easterbrook et al., 1991).
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Table 5.1. GRADE Scores on Patient-Related and Provider-Related Outcomes Associated with
EELM
Category

GRADE Score

Quality of Evidence

Provider satisfaction (n = 15)

++

Low

Provider knowledge (n = 18)

++

Low

Provider confidence (n = 18)

++

Low

Provider behavior change (n = 7)

+

Very low

Hepatitis C (n = 4)

++

Low

Chronic liver disease (n = 2)

++

Low

Chronic pain management and opioid
addiction (n = 4)

++

Low

Gerontology, including mental health
and dementia (n = 4)

+

Very low

Diabetes management (n = 1)

+

Very low

Provider measures

Patient measures

NOTE: GRADE scores range from 1 (+) to 4 (++++).

Patient-related outcomes. The quality and quantity of patient-reported outcomes varied
widely between and within health content areas. Although mental health and substance use
disorders are the most frequently implemented EELMs (as shown in Table 4.2), we found no
literature that specifically describes the impacts of EELMs on patient outcomes associated with
these conditions. With respect to such health content areas as osteoporosis, for which there were
reported provider outcomes, we identified no articles indicating patient outcomes. For HCV,
chronic pain management, dementia care, and diabetes, there was at least one article published
on patient measures in which a counterfactual comparator was presented. Two studies, one by
Anderson and colleagues (2017) and one by Katzman and colleagues (2018), employed quasiexperimental approaches to examine multiple outcomes over time. In the majority of instances,
authors identified statistically significant results in favor of EELM, although the limitations of
multiple comparisons and publication bias might partly explain this, as discussed earlier. With
the exception of virologic suppression in the context of HCV and HbA1c levels in the context of
diabetes, reported outcomes are process measures. Ideally, studies would examine changes in
both processes of care and direct patient outcomes: With only outcome measures, there are few
assurances of the causal pathway. By contrast, with only process measures, there are no
assurances about actual benefit to patients.

Summary
Based on our analysis, the empirical evidence for the effects of EELM on patient and
provider outcomes remains modest but often shows positive effects in the areas that researchers
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have measured. A discussion of the results of this evidence review, putting the results into a
broader context, can be found in Chapter 8.

43

6. Findings of Technical Expert Panel: Evaluation Options

On April 9, 2018, RAND and ASPE hosted a TEP meeting in Washington, D.C., with the
goal of evaluating the evidence base for EELM and identifying opportunities to inform a
potential research agenda to expand that evidence base. Details on our methods and approach for
the TEP are described in Chapter 3.
Although formal consensus was not a goal of the TEP meeting, seven key themes emerged
from the panel discussions. This chapter describes those key themes, which cover goals of
EELM, implementation considerations, limitations of existing evidence, resultant knowledge
gaps, barriers to conducting high-quality research and evaluation, proposed evaluation
approaches for addressing the gaps, and the balance between enthusiasm and evidence.
Well-designed evaluation studies can help policymakers, researchers, and clinicians gain a
better understanding of how EELM can be effective and under what circumstances. Potential
strategies to build the evidence base, mapped to the key themes, and linked to the intended
audience for each, are detailed in this chapter. Time frames for these potential strategies are also
considered.

Key Themes
Key Theme 1: Multiple Goals Exist Across EELM, So This Type of Intervention Should
Be Evaluated Using a Variety of Metrics Depending on the Intended Purpose(s) of a
Particular Program
Throughout the TEP discussion, participants identified several potential goals of EELM,
which means that evaluations should be tailored to address the particular intended purpose of the
particular model being studied. Examples of these purposes include:
•
•
•
•
•
•
•
•
•

improved health of the population
improved provider self-efficacy
increased provider job satisfaction and sense of belonging to a community of practice
improved provider retention in remote locations
improved access to care
improved quality of care
support of the PCMH
reducing unnecessary referrals to specialists
improved efficiency of care (e.g., enabling providers to work at the top of their
licenses)
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•
•

reduced stress, including financial stress, for patients and families, based on reduced
need to travel and miss work for specialist appointments
maintaining the capacity to rapidly bring networks of providers up to date in order to
respond to public health emergencies, as occurred with the Zika ECHO.

There was agreement among TEP members that Moore’s framework (Moore, Green, and
Gallis, 2009) is useful to convey a hierarchy of outcomes for any CME program, ranging from
rates of participation (level 1) and satisfaction (level 2) to patient health (level 6) and community
health (level 7) (see Table 6.1). Moore, Green, and Gallis (2009) note that most assessments of
CME tend to focus on levels 1, 2, 3A, and 3B. However, there has been increasing emphasis on
the importance of measuring outcomes of educational interventions that fall within levels 4–7.
The goal of CME activities is not simply that a provider is satisfied or even that he or she can
state the lesson that the CME activity intended. Rather, improved health at the community level
is the ultimate CME outcome, and each of these levels can be seen as an intermediate step along
the pathway toward this goal (Moore, Green, and Gallis, 2009).
Table 6.1. Moore’s Framework: An Outcomes Framework for Planning and Assessing CME
Activities
CME Outcome Level

Description

Source of Data for the Measures

Participation

1

The number of physicians and others who
participated in the CME activity

Satisfaction

2

The degree to which the expectations of the Questionnaires completed by attendees after
participants about the setting and delivery of a CME activity
the CME activity were met

Learning:
Declarative
knowledge

3A

The degree to which participants state what Objective: Pre- and post tests of knowledge.
the CME activity intended them to know
Subjective: Self-report of knowledge gain

Learning:
Procedural
knowledge

3B

The degree to which participants state how Objective: Pre- and post tests of knowledge
to do what the CME activity intended them Subjective: Self-report of knowledge gain
to know how to do

Competence

4

The degree to which participants show in an Objective: Observation in educational setting
educational setting how to do what the CME Subjective: Self-report of competence;
activity intended them to be able to do
intention to change

Performance

5

The degree to which participants do what
Objective: Observation of performance in
the CME activity intended them to be able to patient care setting; patient charts;
do in their practices
administrative databases
Subjective: Self-report of performance

Patient health

6

The degree to which the health status of
patients improves due to changes in the
practice behavior of participants

Objective: Health status measures recorded in
patient charts or administrative databases
Subjective: Patient self-report of health status

Community
health

7

The degree to which the health status of a
community of patients changes due to
changes in the practice behavior of
participants

Objective: Epidemiological data and reports
Subjective: Community self-report

SOURCE: Based on Table 1 in Moore, Green, and Gallis, 2009.
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Attendance records

The panel reflected that existing studies of EELM have been primarily focused on level 1–3
outcomes, with very few addressing outcomes in the 4–6 range, and virtually none reaching the
level 7 outcome of community health.
Relatedly, the scope of EELM is the subject of some debate among experts in the field, who
question how broadly or narrowly EELM should be defined. Must providers who participate in
EELM be the definitive providers (i.e., the prescribing physician or the clinician with ultimate
authority to treat the patient) to be included in interventions? Or are community health workers,
clinical social workers, and allied health professionals also part of this definition?
To grapple with the diversity of ECHO-like implementation and purposes, the panel
distinguished between two “poles” or groupings of models:
•

•

EELM that aim to increase access to care for a condition that generalist providers do
not feel comfortable managing (e.g., HCV, MAT for OUD, HIV, sickle cell anemia,
and other relatively rare or complex conditions). Although the treatment of these
conditions is unquestionably within their legal scope of practice, generalists do not
typically deliver care for these conditions without additional support or training. This
was referred to as capacity-building.
EELM that aim to improve care for conditions that are considered the “bread and
butter” of what generalists commonly manage (e.g., diabetes mellitus, asthma,
depression). Generalists treat these conditions on a regular basis, they feel
comfortable with uncomplicated cases of these conditions, and they will continue to
do so with or without EELM. The purpose of EELM in this instance is to help
generalists improve the quality of care for the most-complex cases they see and to
improve their ability to manage more-complex or more-severe cases. For example,
generalists might be comfortable managing diabetes with oral medications; a program
could then aim to help them become more comfortable managing insulin as well.
Alternatively, in a context of rapidly evolving treatments, EELM might aim to help
them master the use of newer medications, such as DPP-4 inhibitors, GLP-1 agonists,
and SGLT-2 inhibitors, none of which existed a decade ago.

Some conditions, such as ADHD, could fall somewhere along the continuum between these
two poles, with some clinicians comfortable managing only simpler cases and others not
comfortable managing it at all. It was also noted that some programs do not address direct
care delivery at all, but rather such activities as building capacity for quality improvement.
These EELM are probably not part of the continuum between improving access and
supporting the management of complex cases of common conditions; they occupy a separate
space. Another group of EELM aims to scale up a rapid response to an emerging health
crisis, as happened with the Zika ECHO. Again, these programs might not fall on the usual
continuum. Nevertheless, despite these counterexamples, the continuum between access and
quality improvement was felt to be a useful model to describe the vast majority of EELM.
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Key Theme 2: EELM Have Been Implemented in Diverse Ways, with Varying Fidelity to
the Original Project ECHO and for a Wide Range of Clinical Conditions and
Populations
Because of the variability in implementation of the model and the wide variety of use cases,
experts at the TEP meeting noted that it is difficult to draw overarching conclusions about
whether EELM “work.” Rather, the experts said they believed that designs of EELM should be
evaluated based on how they are implemented around a given topic. EELM are heterogeneous;
their implementation differs greatly from condition to condition and from context to context, and
definitions of success differ depending on the condition, on whether one is examining outcomes
at the level of a hub together with all its spokes or considering each spoke on its own, and on
who is doing the assessing (e.g., patient, provider, health system, or community). This
heterogeneity of implementation complicates evaluation but also leads to several of the key
questions for evaluation (see Key Theme 4).
Key Theme 3: Evaluations of EELM Have Generally Been Limited in Methodological
Rigor, Lack Appropriate Comparators, and Have Been Conducted over Short Time
Frames, All of Which Limit Confidence in Evaluation Reports of Their Effectiveness
The TEP noted that, as of April 2018, there had been no RCTs of EELM. (One by Eaton and
colleagues was published in September 2018.) RCT study design is considered the gold standard
in terms of methodological rigor, and the panel recognized that variations on the “classic”
placebo-controlled RCT could be conducted, as could other study designs that do not involve
randomization (see Key Theme 6).
Related to methodologic rigor, evaluations of EELM have not, in general, included
appropriate comparators (i.e., what the nonintervention group receives). The TEP emphasized
the importance of an appropriate counterfactual in evaluations of EELM, without which, as one
TEP member noted, an intervention such as ECHO might appear to be “good for everything.” In
many studies to date, the comparator (typically usual care) has not been consistently defined. The
panel questioned whether usual care is the ideal comparator, or whether EELM should (also) be
compared with direct telemedicine, e-consults,6 traditional CME, or some combination of these.
The choice among these different possible comparators might depend, in part, on the goal that
the particular program is trying to achieve. Using three arms of comparison (usual care versus
telemedicine versus an ECHO-type program; alternatively, usual care versus CME versus
ECHO-type program) might be the ideal structure, in some cases. Some evaluations of EELM
have also compared the quality of care delivered at the hub sites and the spoke sites, to examine
the question of whether spoke clinicians are delivering a comparable quality of care to specialists
at the hubs. This can be an additional level of comparison.
6
Note that e-consults are distinct from EELM because they are not intended to increase PCPs’ overall capacity to
treat patients with a given condition. They are intended to directly address the needs of a single patient with a given
condition.
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Evaluations of EELM have typically been conducted over short time frames, limiting our
understanding of the durability of effectiveness. Many studies of EELM compare provider
knowledge after the model ends with knowledge before the model began. This study design
provides minimal information about whether knowledge improvements are retained or “decay”
over time (i.e., when providers are no longer attending regular ECHO sessions). The effects of
EELM on job satisfaction, sense of belonging in a community of care, self-efficacy, and other
provider-related outcomes could also be sensitive to decay over time. Similarly, for those EELM
that have demonstrated improved processes or outcomes of care, such as improved HbA1c in the
case of diabetes, it is important to know whether these improvements persist. Previous studies
have not addressed these questions about the longevity of benefits due to EELM and how they
can be isolated, given other changes over time.
The strength of the evidence for EELM, or any intervention, can be assessed using the
GRADE framework (Ryan and Hill, 2016). Using this framework to examine the quality of
evidence for EELM, our evidence review found the quality to be “low” or “very low” for all
outcomes assessed at both the patient and provider levels. The TEP agreed with our assessment.
It should be noted that it is not unusual for the evidence for health services delivery intervention
to be of “low” quality; EELM are not unique in this regard.
Key Theme 4: In Addition to the Question of “Does ECHO Work?” There Are Important
Gaps in Knowledge About EELM

A big barrier to expanding ECHO beyond one’s state is that advice that works in one
place may not work in another.
–Rachel Mutrux, senior program director for the Missouri Telehealth Network, parent organization of
Show-Me ECHO, telephone communication with the authors, February 15, 2018

After considering the existing evidence base, TEP members articulated several unanswered
research questions about EELM. These questions can be grouped by themes as in Table 6.2.
From this extensive list, the panel identified several unanswered questions as priorities to
address, which will be discussed further in the next section on potential strategies.
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Table 6.2. Gaps in Evidence Base: Themes and Research Questions
Theme/Category
Implementation and
dissemination

Illustrative Questions
•

•
•

•
•

•

•

Impacts on health (and other)
outcomes for patients

•
•

•

Impacts on provider or
workforce outcomes

•
•
•
•

•
Impacts on population health
and health equity

•
•
•

What are the characteristics of successful EELM, and how replicable are
they? In particular, how much of the success of a specific program is
attributable to the quality of the facilitator?
What are appropriate conditions or topic areas for EELM, and how are they
selected?
What motivates hubs and spokes to participate? What explains the rapid
increase in demand for EELM across the United States (i.e., what is the
source of this popularity)?
What limits the potential spread of EELM? Of those sites and clinicians who
decided not to participate in EELM, what factored into that decision?
What is the optimal number of sessions, minutes per session, or time in the
program (i.e., dose–response analysis)? How does it vary across topic
areas? Why?
How can EELM help health care providers interface with non–health
institutions in the local community (e.g., municipalities) to address social
determinants of health?
To what extent is it important for hubs and spokes to be located in roughly
the same geographic area in order for hubs to make locally relevant
recommendations for patient management?
For what conditions do EELM improve health outcomes, and which
outcomes?
To what extent are EELM a “force multiplier”? For example, if providers
present some of their patients as cases but not others, does care improve
equally for all patients because of providers’ participation, or only for the
patients presented as cases? Does care for patients improve at the practice
(as opposed to individual provider) level? Does this vary by clinical
condition?
Besides improved health, what are the other potential benefits to the patient,
including savings in terms of lost work days, cost of travel, family burden,
etc.?
Do EELM lead to better provider retention (in a particular geographic area or
underserved setting)?
For whom do EELM “work best” in terms of provider satisfaction, retention in
EELM, avoidance of burnout, or connection to a care community?
What are the characteristics of spoke providers or spoke sites that promote
successful participation in EELM?
What are the characteristics of hubs that promote increased spoke
participation, measured in terms of the number of spokes that join, the
retention of spokes over time, or consistent attendance on the part of spoke
participants?
How do spoke providers accommodate or make up for the time taken out of
clinical work to participate in EELM?
Do EELM exacerbate existing disparities within the United States’ health
care system?
Given limited resources, what would be the most effective application of
EELM for population health (i.e., in the largest possible population)?
How do EELM impact patient-provider relationships? For instance, to what
extent do EELM facilitate PCPs continuing to manage patients in a PCMH
model?
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Theme/Category
Health system impacts, such as
cost, efficiency, and access

Illustrative Questions
•
•
•

•
•
•
Policy and funding
considerations

•
•
•
•
•
•
•
•

Optimal study designs

•

•

How cost-effective are EELM for different conditions and populations?
What is the return on investment for EELM?
What are the consequences, both intended and unintended, with respect to
referrals and potentially shifting groups of patients to certain locations or
providers with known capacity to manage different conditions, such as
chronic pain?
Do EELM lead to more efficiency in the system? Do they “unclog” the
system and lead to shorter wait times?
Do EELM actually lead to better access to care?
Do EELM increase the number of patients who receive high-value
treatments that are currently underused (e.g., MAT, HCV treatment)?
Can EELM create large-scale change in the U.S. health care system?
How do EELM fit into national health policy priorities?
At what level, and how, do federal, state, and local policies impact
implementation and outcomes of EELM?
What are funders paying for related to EELM?
What is the funding stream?
How do EELM work in different funding models (i.e., FFS or managed care
arrangements)?
To which providers are services of EELM being supplied?
What characteristics distinguish the patients cared for by providers that
participate in EELM from those of nonparticipants?
To what should EELM be compared? Traditional CME? E-consults?
Telemedicine? Standard of care, meaning existing care without any
educational or consultative intervention?
How should the effects of ECHO/EELM be isolated for evaluation, when
programs are often implemented as part of a multipronged approach that
might include e-consult, telemedicine, and other initiatives?

Key Theme 5: There Are Several Barriers to High-Quality Evaluation of EELM
Several barriers exist to high-quality evaluation of EELM. Some of these barriers are unique
to EELM, but most would apply to any evaluation of a health services intervention. These
barriers include lack of resources, perceived urgency to implement rather than evaluate, limited
evaluation capacity or expertise, challenges with collecting or obtaining high-quality data, and
challenges with defining and collecting meaningful measures of impact.
The First Barrier Identified by the Panel Was a Lack of Resources for Evaluation

Specifically, the panel noted that existing funding streams tend to focus on implementation of
EELM, and resources for evaluation tend to be more limited. This challenge is not unique to
EELM: Funding models that support the implementation of programs rarely include resources
for evaluation, necessitating such support to come from elsewhere.
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As with Other Innovations in Health Care Delivery, There Is a Perceived Urgency to Implement,
Not Study, EELM

The panel noted a significant emphasis to date on implementation, scale, and spread of
EELM. Enthusiasm for the model has led to fairly rapid uptake—yet without what the panel
viewed as a strong evidence base for the impact of EELM. The reasons for this relative emphasis
on implementation rather than evaluation are complex—and, again, not unique to EELM. The
panel did note that a focus on implementation rather than evaluation often comes from the top
and is often determined by funding priorities. When early results look promising or there is
conceptual validity for a given model, leadership of health care systems often prioritize
implementation and rapid uptake of care delivery innovations over evaluation or research, for a
variety of reasons. The clinician’s role is to care for the patient, and often this means
implementers are hesitant to delay rolling out a promising new intervention for a portion of their
eligible patient population to ensure the presence of a control group. Indeed, the time and
resources required for evaluation are likely to compete for resources needed for implementation,
absent specific funds dedicated to evaluation.
Many EELM Lack Evaluation Capacity or Access to Such Expertise

Even where there is interest in evaluation, some programs lack evaluation expertise, so there
is a clear need for capacity-building around conducting rigorous evaluations of EELM. This gap
is not unique to EELM; as previously mentioned, implementing institutions often focus on
implementation and therefore lack the expertise to conduct evaluations. Conducting evaluations
of education programs can be difficult, and evaluating programs over short time periods requires
careful study design. Multiple interventions are often rolled out at once, further complicating
evaluation. An additional complication, previously discussed, is that many EELM have not
clearly defined their goals. Supporting training and assistance for evaluation efforts is important.

We had a need to demonstrate the impact of our program to justify continued support.
–Susan Kirsh, former acting director of the VA Office of Specialty Care Transformation (2018)

Efforts to Evaluate EELM Could Be Limited by Access to High-Quality Data

The panel noted the difficulty of obtaining reliable data (both for processes and clinical
outcomes), particularly on patients or providers who did not participate in the intervention.
Although electronic health records (EHRs) have the potential to provide some relevant data,
there are limitations to the ability of these records to provide a window into other relevant
process measures (for example, changes in provider behaviors, such as opioid prescribing) or
adherence to evidence-based care guidelines, without a significant investment in data abstraction.
When programs span different institutions, incompatible EHR systems make it difficult to collect
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and aggregate consistent data. When a program is implemented within a single institution, it can
be hard to collect comparable data on a control population outside that institution for the same
reason.
Claims data are another option for evaluations of EELM, but these have their own limitations
related to accessibility, misclassification bias, and lack of clinical details. Statewide surveillance
data can be a source of outcomes data for certain conditions, especially for programs initiated at
a state level, but these data might lack the level of clinical detail available in many EHRs or in
prospectively collected data.
Additionally, the question of burden came up at the TEP meeting in considering who would
be primarily responsible for documenting the information to be abstracted for the evaluation,
outside of the regular clinical workflow. Would PCPs, who are already overstretched, have the
ability to collect yet another set of data elements for an evaluation of EELM? Who, at the spoke
sites, would be charged with documenting details of the model’s implementation, such as
attendance at regular sessions or reasons for provider attrition? Thus, although prospective data
collection can address the issues of completeness and accuracy, it is usually more resourceintensive. The panel suggested various potential approaches to address this challenge, which are
discussed in the next section.
Clear Outcome Measures Are Not Apparent for Many Conditions Addressed by EELM, and
There Are Challenges with Defining and Collecting Meaningful Measures of Impact (Both
Process and Outcome)

The panel discussed metrics to consider when evaluating EELM. There was agreement that
most EELM could measure common aspects of implementation, such as the proportion of
sessions attended or the duration and number of sessions. However, more-specific metrics vary
by disease state or condition (e.g., HbA1c change over time for diabetes, viral load for HIV), and
by the intended audience. For instance, it was noted that the research questions and outcomes
that are of interest to a clinical researcher (e.g., improvement in depression score, as measured by
the Patient Health Questionnaire [PHQ-9]) might differ from those important to a payer (e.g.,
demonstration of cost savings).
Several provider-level constructs (such as job satisfaction) and health system-level constructs
(such as appropriateness of referrals) can be complex to quantify. To some extent, this challenge
can be successfully addressed through the use of thorough surveys and in-depth qualitative
interviews to provide additional context. The TEP members expressed concern about the use of
self-reported measures, which are subject to both social desirability bias and recall bias.7 One of
the themes of the TEP meeting was that even relatively simple measures (such as changes in

7

Social desirability bias results from the tendency of some respondents to answer in a way they deem to be more
socially acceptable than their “true” answer would be. Recall bias arises from mistakes in recollecting events, both
from memory failures or from changing one’s recollection when looking at things with hindsight (Lavrakas, 2008;
Cochrane Collaboration, undated).
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provider knowledge or self-efficacy) are often marred by being measured in ways that are not
sufficiently rigorous.
Key Theme 6: Opportunities Exist to Use a Wider Variety of Study Designs, Some That
Involve Randomization and Some That Do Not, to Conduct Rigorous Evaluations of
EELM
As with other evaluations of real-world health care delivery models, the rigor of published
studies has been limited by challenges with randomization. Specifically, sites might not be
willing to be randomized and potentially not receive the intervention because of a perceived need
for immediate action (or the preconception that the intervention represents an improvement over
the status quo). Additionally, even if sites agree to be randomized, there might be differential
buy-in between intervention and control arms, which could in turn lead to less complete data
collection by control practices.
Randomization might be possible in certain situations and should be used when possible.
When randomized designs prove infeasible, however, there are rigorous nonrandomized study
designs that could be used in evaluating EELM and that could help compensate for the
challenges with randomization. However, the full spectrum of possible study designs has not
been used to evaluate EELM. TEP members cited a notable example of a well-designed study by
Anderson and colleagues (2017). In this study, the authors evaluated changes in pain
management from an ECHO-like model, incorporating a pre-post design with a control group
(one of the panel’s preferred options for causal inference in the absence of randomization). The
study encapsulated several of the options proposed by the panel for how to conduct a highquality evaluation with limited resources, including the following:
•
•
•
•

a strong design for causal inference despite not randomizing
use of available data from an EHR
a mixed-method evaluation, with qualitative inquiry to provide additional context
with which to understand the results of the effectiveness study
measurement of outcomes relevant to the condition, including not only patient
outcomes but also changes in provider knowledge, and changes in practice.

Key Theme 7: It Is Important to Balance Enthusiasm for the Promise of EELM, Which
Led to Significant Demand for This Model, with the Need for a Strong Evidence Base
The panel members agreed that there has been an emphasis to date on implementation and
dissemination of EELM, with a focus on scale and spread, with less attention to rigorous
evaluation of impact. However, the experts also noted that the enthusiasm for EELM is likely
based on some measure of effectiveness as perceived by end users, and one of the important
tasks ahead will be to understand the extent to which EELM is filling a perceived need—and if
so, whether EELM improve clinical outcomes. Multiple TEP members emphasized that a lack of
published evidence does not indicate that the model is ineffective; it simply means that there is a
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lack of evidence demonstrating that it is effective. They stressed that something about EELM has
generated growing demand and enthusiasm and that this should not be discounted in a quest for
rigorous evidence of impact on patient outcomes. The panel urged balance in interpreting the
thin evidence in light of the continued demand for this intervention across the United States and
internationally, and it noted that many health care interventions lack a strong evidence base.
The next section describes potential strategies to address each of these seven themes.

Potential Evaluation Strategies
Various potential strategies emerged from the TEP meeting that could address the key
themes discussed in the previous section. These are first mapped to each key theme and their
intended audience, then discussed in more detail individually, and finally organized by possible
time frame for implementation.
Potential Strategies by Intended Audience
With input from the panel, we identified 18 potential strategies to address the key themes that
emerged from the TEP meeting. Some of the options are specifically geared toward
implementers of EELM as they design their programs, with an eye toward the needs of future (or
even concurrent) evaluations of program impact. Others are more relevant to those conducting
the evaluations. Still others primarily apply to funders and policymakers as they consider the big
picture of how to facilitate building the evidence base for EELM to inform future investments in
this model. Although some of the suggested approaches that came out of the TEP meeting could
be addressed by only one of the stakeholder groups, many of them require collaboration among
different groups. Therefore, continued engagement and communication among the various
stakeholders is important when deciding how to move forward with these options.
Potential Strategies Organized by Key Theme
Key Theme 1: Diversity of Intended Purposes of EELM
Potential Strategy 1a: Build Consensus Around Definitions and Purposes of EELM

Although it was not the charge of the TEP to produce a consensus definition, more consensus
might help address the current lack of focus on a common set of outcomes to measure. The panel
observed that there are different intended purposes for EELM (e.g., increasing access to care for
patients with less common conditions, improving care for complex presentations of common
conditions, and potentially others). Reaching consensus about the purpose or purposes of EELM
would be an important first step toward evaluating the accomplishments of EELM.
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Potential Strategy 1b: Structure Evaluation Outcomes to Reflect Intended Purposes of Particular Types of
EELM.

Given the various intended purposes of EELM, it will be important to facilitate the
appropriate measurement of key outcomes in the context of diverse implementations of the
model (e.g., management of a particular disease and/or improving workforce retention). This
approach might not allow for robust cross-study comparisons because evaluations of some types
of EELM might not easily generalize to other types, but it might facilitate a more targeted
approach to answering the priority research questions that the TEP members identified (see
Potential Strategy 4a). One approach could be to assemble a list of evaluation outcomes and
define best practices for their measurement. For example, there is considerable variation
regarding how an outcome as simple as session attendance by generalist mentees is recorded and
analyzed. A basic recommendation on such metrics as this could help improve the consistency
and the rigor with which they are analyzed. These outcomes could be sorted by types of EELM
and purposes of the interventions (i.e., improvement target).
For instance, EELM that aim to increase access to a particular kind of care (e.g., HCV
treatment) might wish to focus on documenting expanded access and scope, such as an increase
in the number of patients treated. It might also be a priority to document that the quality of care
for this condition at the spoke sites is acceptable, as when the team from UNM demonstrated that
HCV outcomes (measured by sustained viral response) were at least as good at the spoke sites
compared with the hub (Arora, Thornton, et al., 2011). In contrast, EELM that aim to support the
management of complex cases of common conditions (e.g., diabetes) should focus on
documenting improvements in the processes, outcomes, or both of the care being delivered (e.g.,
improved HbA1c). Some EELM address conditions that fall somewhere between these two types
of programs (e.g., ADHD) or fall outside of this continuum (e.g., Zika virus, quality
improvement facilitation). These EELM might have to choose appropriate outcomes to measure
that are necessarily situation-dependent.
Finally, as previously noted, if the ultimate purpose of EELM were to address isolation and
burnout among PCPs, then the outcomes to be measured would be very different and might
include job satisfaction, retention, or a sense of belonging in a community of care.
Key Theme 2: Variable Implementation of the Model
Potential Strategy 2: Document Details of Model Implementation

Although not all EELM have the expertise, time, or money to conduct complex evaluations
of efficacy, it would be within the reach of almost any program to document certain basic
parameters of implementation. This would include the number of participants in each session and
the distribution of the number of sessions conducted; the type of provider(s) receiving the
intervention; attrition rate and reasons for noncompletion of sessions; how long the sessions last;
how frequently sessions are held; how many cases are presented at each session; a description of
how a didactic component was incorporated; how technology is used and how the end-user
experience is optimized; and the number of eligible patients treated before and after the
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intervention. The availability of certain materials (a ready-to-use “evaluation toolkit” consisting
of standardized but customizable consent forms, data collection instruments, and study
protocols) could help ensure consistency in the collection of these basic sorts of data about
program implementation and participation and would allow comparison across studies.
Key Theme 3: Limited Confidence in Evaluations
Potential Strategy 3a: Choose Meaningful Comparators

Various possible comparators were mentioned by the panel, including a more conventional
and lower-effort quality improvement intervention (e.g., audit and feedback)8 or an educational
intervention (e.g., a purely didactic webinar similar to a continuing medical education session).
These would seem to be apt choices to evaluate a program dedicated to supporting generalists in
managing the more complex cases of a condition they commonly treat (e.g., diabetes). For a
program dedicated to expanding access to a rarer condition (e.g., HCV), usual care might be an
appropriate comparator. Other potentially instructive comparators might be direct-care
telemedicine or e-consults; a comparison with these other forms of telemedicine might be more
useful for establishing which approach seems to work best in a given situation or for a particular
condition. In a multimodal evaluation with several sources of data (e.g., provider surveys, patient
interviews, and data abstraction from an electronic medical record), it might be necessary to
define several different comparators, each of which might be well-suited to addressing one study
question.
Potential Strategy 3b: Document Persistence, or Waning, of Effects of EELM over Time

Previous evaluations of EELM have typically collected “post-intervention” data—for
example, data about provider satisfaction, knowledge, self-efficacy, and behavior change—very
soon after the intervention ended. It might be useful to build in additional assessments after the
immediate post-intervention period to assess how long the impacts of EELM on various
outcomes persist when providers are no longer attending weekly or biweekly ECHO sessions. In
other words, how long does it take for the benefits of EELM to “decay” (if in fact this occurs),
and when might refresher sessions be needed?
Of note, options for using a variety of study designs to increase the methodological rigor of
evaluations of EELM are addressed in this report under Key Theme 6.
Key Theme 4: Numerous Knowledge Gaps
Potential Strategy 4a: Focus on Four Priority Research Questions for EELM

The panel identified several knowledge gaps around EELM, which can be broadly
categorized as questions around (1) implementation and dissemination; (2) patient, provider, and
8

Audit and feedback is a quality improvement strategy based on the belief that health care professionals modify
their practice when provided with feedback on their performance showing how their clinical practice meets, or fails
to meet, a desired target (Ivers et al., 2012).
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health system outcomes; (3) population health and health equity; (4) policies; and (5) study
designs. We synthesized this discussion into four high-level questions that can help guide future
evaluations of EELM:
1.
2.
3.
4.

What is the evidence for the impacts of EELM on patient health?
Across which conditions are EELM most effective in improving patient health?
For which conditions do EELM provide the most value (outcomes improvement/cost)?
To what degree do EELM achieve their intended purpose(s)?

Potential Strategy 4b: Prioritize Clinically Relevant Patient Outcomes over Processes of Care

Related to the first three of the above four priority research questions, the panel observed that
the majority of existing evidence around EELM focuses on the experience of participants in
EELM and changes in their knowledge and self-efficacy, which are important to understand but
serve as intermediate steps toward the true health outcomes of interest. Our systematic review
found that out of 52 studies, only 15 examined changes in process of care measures or patient
outcomes. In addition, the majority of the studies in the ECHO Institute’s research overview
report reach only level 1 of Moore’s framework, with none reaching level 7 (community health).
Thus, there is a need to increase focus on measuring the impacts of EELM on processes and
outcomes of care. More detail on measuring different types of outcomes can be found in Key
Theme 5.
Key Theme 5: Structural Barriers to High-Quality Evaluation
Potential Strategy 5a: Support Sustainable Funding Streams for Evaluations of EELM

Specific funding streams could be created to support evaluations of EELM, or existing
streams for implementation could include portions earmarked for evaluation. In addition, some
EELM have been successfully implemented and evaluated in partnership with payers. Payers are
interested in demonstrating value and, as an added benefit, could provide data for evaluation
purposes. One way to stimulate more evaluation work could be to align EELM with emerging
value-based payment models and evaluate their potential contribution when value is generated by
these broader models. One potential complication of this strategy, however, is that it might be
difficult to separate the effects of EELM from those of other contemporaneously deployed
strategies.
Potential Strategy 5b: Enlist Champions to Promote Evaluations of EELM

Strong, committed administrative and clinical leaders (at spoke sites, such as health centers,
in addition to a hub) are needed to ensure that evaluation of EELM goes hand-in-hand with
implementation. Specific actions could be (1) ensuring that job descriptions and performance
review criteria for clinical personnel include participation with evaluations of relevant programs,
such as of EELM; (2) providing implementers of EELM with opportunities to gain expertise with
evaluation through mechanisms described in Potential Strategy 5c (capacity-building seminars
and access to networks of other researchers); and (3) ensuring funding support for researchers’
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time spent on evaluating EELM. These types of approaches would be very context-specific, but
the theme of supporting the evaluation of innovations within health care delivery systems is a
broader goal.
Potential Strategy 5c: Provide Technical Assistance and Build Capacity to Conduct Evaluations of EELM

TEP members discussed several possible approaches to empowering members of EELM who
might not currently feel they have sufficient access to evaluation expertise. One approach would
be to provide technical assistance through the development of resource centers and the creation
of standardized tools to facilitate high-quality evaluation (which could include the toolkit to
assist with measuring key outcomes, as described in Potential Strategy 1b). Another possible
approach would be to focus on internal capacity-building to decrease reliance on external
technical assistance, which could include annual seminars for evaluators or a support network to
empower evaluators to share best practices. Analogous examples could be found in the growing
field of implementation science, which offers both training sessions (NIH, 2018), which build
internal capacity for evaluation, and resource centers (Mittman, 2009), which facilitate access to
external evaluation expertise.
Potential Strategy 5d: Support Data-Sharing and Interoperability

The panel identified lack of access to outcomes data for both participants and nonparticipants
as a challenge for EELM (and for other health services interventions). Three approaches could be
considered to support data-sharing and interoperability.
First, policies requiring improved data exchange and interoperability—whether at the local,
state, or federal level—can help facilitate ease of data-sharing for research between spokes and
hubs. An example of a relevant federal effort is the 21st Century Cures Act (Public Law 114255), signed into law in December 2016, which contains health information technology
provisions focused on improving interoperability among disparate electronic medical records by
envisioning a strong federal role in the regulation and development of health information
technology standards. It also directs the federal government to leverage public-private
partnerships in creating a Trusted Exchange Framework for health information, which is still in
draft form.
Second, the panel suggested that investigators consider how data collection will be
accomplished when initially designing the intervention, not well after it has been implemented.
For instance, study sites could be selected that use the same or interoperable EHRs when
possible, or at least have such systems set up to collect and measure data using the same format,
and studies could be designed to examine outcomes that are available in state databases. These
strategies facilitate collection of data on both the intervention and comparison groups, making it
easier to conduct controlled trials.
Third, the panel noted the benefits of implementing EELM as part of new payment models,
which could be beneficial both for providers and payers, as well as for implementation and
evaluation, specifically because of data availability. For example, situating the intervention and
evaluation within an ACO, and aligning it with the payment model, could facilitate access to
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both claims and outcome data—allowing for conclusions to be drawn both about cost savings
and clinical impact. This approach might help to encourage implementation of EELM, but it
could also complicate efforts to separate the impacts of EELM from those of other strategies that
are deployed simultaneously.
Finally, the panel noted that, for some diseases, data availability might be enhanced,
providing an opportunity for improved evaluations of EELM. For example, HIV care and cancer
care have both benefited from strong research networks and relatively standardized outcomes
that are measured across studies. HIV studies almost universally measure viral suppression and
time to viral suppression, guideline-concordant use of anti-retroviral therapy, resistance testing
before starting therapy, and other relatively well-defined and standardized measures that are
often available across a population. Having these measures in common could help facilitate
cross-institutional collaborations to evaluate EELM focused on HIV, potentially more easily than
could be done with another disease.
Potential Strategy 5e: Focus on Patient-Level Outcomes

As noted in Key Theme 5, the evidence for improved patient outcomes from EELM is
limited. The panel suggested several options for capturing the impacts of EELM on patients.
First, TEP members noted that retrospective chart abstraction could help measure processes of
care, such as rates of guideline-concordant care and rates of initiation of care, but that process
measures vary regarding how strongly they have been linked to definitive outcomes, such as
morbidity and mortality. CMS’s Meaningful Measures Initiative is an example of one
government effort to focus on measures that are most meaningful to patients (Durham, 2018). In
keeping with a growing emphasis on measuring patient-relevant outcomes, quality of life and
disease-free survival were suggested as two patient-specific outcomes for measurement,
depending on the condition being studied. General global functioning and health-related quality
of life scales, such as the Patient-Reported Outcomes Measurement Information System
(PROMIS) (Ader, 2007), were also mentioned as potentially important patient-level measures.
Again, qualitative methods—such as in-depth interviews and other creative elicitation techniques
such as photo-elicitation—could provide rich data on patients’ experiences with their conditions
and with EELM specifically (UNM, undated-a).
Some process-of-care measures might also involve the patient perspective. For example,
studies could measure the development of a seizure action plan, or an asthma action plan being
completed for the patient. Earlier entry into clinical care (for maternal health EELM), earlier
diagnosis of developmental delays and autism, and increases in diagnosis rates for conditions
thought to be underdiagnosed at baseline (e.g., autism) are other potential measures of increased
access to important services.
Potential Strategy 5f: Expand Provider-Level Satisfaction and Engagement Measures

Various underused options exist for measuring provider satisfaction and retention, such as
the number of new providers being attracted to a particular underserved area, how long they stay
(full-time equivalent years, also known as new provider longevity), and retention rate (the latter
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being slightly different than new provider longevity). Measuring the Maslach Burnout Inventory
(Maslach and Jackson, 1981) to document the impact of EELM on burnout directly as part of
evaluations of EELM could also be helpful. Qualitative research might be a very effective way to
measure or, more precisely, learn about provider self-efficacy and some of the other providerrelated goals, such as satisfaction and knowledge.
Potential Strategy 5g: Use a Range of Measures to Examine System-Level Outcomes

For system-related metrics, the number of providers offering a particular service, such as
buprenorphine therapy, could be used; so could the number of cases that were treated versus
what would have happened without a program.
Wait time is another potential measure of access but represents just one dimension of the
complex issue of access, and this metric is affected by other factors, such as the rate of patients
eligible for treatment and provider referral behavior. It is important to take a population-based
approach and think about what the counterfactual is when measuring wait times. When
comparing shorter versus longer wait times for initiating treatment (or receiving high-quality
care, whether delivered by a specialist or a generalist), it is important to consider the alternatives
to EELM: seeing a specialist in person, which might require a very long wait time; continuing to
be cared for by a generalist who has not received mentorship through the EELM; or not receiving
care for that condition at all, as happened with HCV before Project ECHO launched. In many
cases, the counterfactual would be that patients are referred to a specialist and the specialist has
long waits; therefore, EELM might be able to both eliminate this delay in treatment initiation for
certain patients who no longer need to see a specialist (because their generalists received
mentorship through EELM) and to reduce the wait time for those patients who do still need to
see a specialist (i.e., their PCP does not participate in EELM). One TEP member referred to this
effect of EELM as “unclogging the system.” The challenge is obtaining the denominator:
Evaluations should examine the entire population cared for in a region or catchment area,
including patients of providers who do and do not participate in EELM, and look at their rates of
treatment and wait times.
To measure appropriateness of referrals, one panelist suggested performing ratings of the
appropriateness of referrals to specialists over time, with the assessor blinded to whether the
patient’s provider is a participant in EELM.
Key Theme 6: Limited Use of a Variety of Possible Study Designs for Rigorous Evaluation

As with any real-world study, designs for evaluating EELM should fit within the context of
the participating clinics and providers, including limitations of resources and exigencies of
clinical workload at spoke—and hub—sites that are focused on managing operations of the
EELM. Furthermore, significant forethought is required in that future plans for evaluation should
guide the implementation of EELM because some evaluation strategies are only possible when
planned in advance of the start of implementation. There are multiple potential pathways to
achieving high-quality causal inference. The panel mentioned several strategies that might be
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considered, such as options for designs involving randomization and for designs that do not
require randomization.
Potential Strategy 6a: Consider Strategies to Facilitate Randomization

The “classic” RCT, which has intervention and control arms (and is sometimes termed
“placebo-controlled” because at least one arm does not receive an active ingredient or
intervention), is considered the gold standard for causal inference. Randomization might be ideal
from a scientific point of view, but it is not always feasible in real-world settings. TEP members
proposed study designs that might enhance the rigor of evaluations while also being more
feasible when a classic RCT is not possible: crossover, non–placebo-controlled parallel, and
stepped-wedge designs. These variations could help address a hesitancy on the part of sites to
enter a study in which they might be randomized to the control group and not receive the
intervention. Ultimately, however, the crossover option, in which study sites are randomized to
receive one of two programs, then switch and receive the other after a certain period of time, was
rejected by the panel. There was concern that the effects of the first program would persist after
its conclusion, thereby “contaminating” the measurement of outcomes in a period when the site
is supposedly in the control group.
With the non–placebo-controlled parallel design in this context, there are at least two and
potentially more study arms examined in parallel, and each arm receives an intervention. In the
two-arm example, sites are randomized to implement one of two unrelated programs, such as for
HCV and chronic pain. The conditions (and the outcomes to be measured) would have to be
chosen carefully to ensure that they are as distinct as possible, lest the efforts of one program
affect treatment for the other condition. Every participating site would be guaranteed to receive
an intervention in this scenario. All sites would then submit outcomes data relevant to both
conditions; every site would therefore serve as both an intervention site (for one condition) and a
control site (for the other). This study design could help ensure that participating sites are similar
(because all agreed to the same study design and all implemented a program), and it might also
help ensure a similar level of enthusiasm on the part of all sites for submitting data. In addition,
there would be potential cost savings, in that two programs could be evaluated at a rate of
expense or level of effort that likely would not be significantly higher than that required to
evaluate one, and certainly less than it would take to run two independent evaluations.
Although this idea generated some enthusiasm, some TEP members expressed concern about
possible contamination by patients who have both conditions (in this example, HCV and chronic
pain). It would be possible that the management of the unrelated condition might be improved by
the EELM—for example, better management of chronic pain at a site randomized to the pain
program—might permit better management of the patient’s HCV as well. The magnitude of this
issue might be small, and if it were a matter of great concern, it would be possible to exclude
those overlapping patients in the analysis phase. Alternatively, these patients could be considered
as a separate population in the analysis to examine the degree of contamination (which would be
an interesting finding in and of itself about the spillover effects of EELM).
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Another possible randomized design mentioned at the TEP meeting was a stepped-wedge
cluster randomized trial, a method that is increasingly used for studies of care delivery modalities
(Hemming, Haines, et al., 2015; Hemming, Lilford, and Girling, 2015). In a stepped-wedge
design, the rollout of an intervention occurs in a phased manner that is randomized at the facility
level or provider level. This design is typically responsive to the fact that rollout is not always
possible across all geographies at once, given logistical constraints. Therefore, randomizing the
sequence of rollout provides the ability for more complex causal inference. Although
randomized, the control population often eventually gets the treatment; in other cases, a pure
control might also be selected.
Potential Strategy 6b: Leverage Nonrandomized Study Designs That Have Advantages over Study
Designs That Have Been Used to Date

Finally, although most evaluations of EELM have used pre-post designs without a control
group, TEP members also proposed a pre-post design with the addition of a control group. The
rigor of such a design could be further enhanced with the use of difference-in-differences
analysis with a propensity score-matched control group, which can approximate the rigor and
causal inference achieved with randomization.
Unit of analysis. In the view of many TEP participants, evaluations of EELM should focus
on the level of the practice rather than on the patient or the provider; by extension, randomization
should occur at the level of the practice. This was expressed as an ideal because of the
conceptual focus of EELM on improving care at the practice level—although this was by no
means expressed as the only option. Part of the reason is that patients might see more than one
provider, providers might see each other’s patients, and providers within the same practice might
confer among themselves about how to treat certain types of patients, leading to concerns about
contamination under provider-level evaluations. EELM are often discussed as force multipliers,
with the expectation that new provider knowledge could affect colleagues as well. As discussed
in the review of the evidence for EELM, the degree to which this actually occurs is still an open
question. For that reason, analysis at the practice level was considered best for evaluations,
particularly ones with intervention and control groups, such as the stepped-wedge model.
A summary of potential study designs brought up by the TEP members for evaluating
EELM, with associated advantages and disadvantages, is shown in Table 6.3.
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Table 6.3. Potential Study Designs for Evaluating EELM
Potential Study
Design

Advantages

Disadvantages

Randomized
RCT, placebocontrolled

•

•

When done at the practice level, can
provide high-quality evidence about the
impacts of EELM on population health
The gold standard for addressing
unmeasured confounders that might
otherwise bias the results

•
•

•

•

RCT, non–
placebocontrolled (e.g.,
all arms receive
an intervention)

•

•
•

Stepped-wedge

•

•

•

Addresses a major implementation
weakness of other designs in that
controls are also adopters of EELM (of
another focus topic)
Factors contributing to adoption do not
differ between sites
This approach might help address
reluctance to be randomized to a control
group because it does not require
randomization to a nontreatment group

•

All patients can eventually get the
intervention, but staggered and delayed
roll-out facilitates causal inference
Works like a randomized trial, with those
not yet receiving the intervention serving
as controls, leveraging the fact that there
are logistical constraints associated with
rolling out the study everywhere at once
Responsive to ethical concerns about
withholding an intervention from a group
of people

•
•
•

Frequently used in health services
research to evaluate health care delivery
interventions where there is not a profit
motive to fund a more expensive
randomized trial
Most studies thus far have used pre-post
design; the addition of a control group
only requires additional data collection
from the comparison group and greatly
improves study design strength
Does not require randomization
Can use strategies, such as propensity
score matching, to create an appropriate
control group when analyzing secondary
data sources, such as claims

•

•

•
•

Can be expensive
Sites might be hesitant to sign up for a
study in which they could be
randomized to the control group
Possibly lesser engagement among
practices in the control group, which
could lead to incomplete data collection
If randomizing at the practice level, can
be difficult to recruit a sufficient sample
size of practices
Patients might have both conditions
being addressed by EELM, which will
need to be accounted for in the analysis
Expensive (Despite some savings
compared with a classic RCT because
two programs can be evaluated for a
similar cost to one program, this option
remains high in cost)

Can be expensive
Cluster randomization is required
Logistics of staggering the roll-out of the
intervention can be complex and require
specialized analytical expertise
Takes longer than starting everyone at
once
If an additional control group is
included, can add to costs

Nonrandomized
Pre-post design
with a control
group

•

•

•
•
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•
•
•
•
•

A weaker design than others because
sites that choose to implement EELM
might be different from sites that do not,
for reasons that cannot be
observed/measured in the data (limiting
the ability to find an appropriately
matched control group)
Requires twice as much data collection
Sometimes difficult to collect data on
non-intervention group
Can be difficult to find an appropriately
matched control group
Requires implementers to anticipate the
need for evaluation
Cannot easily be added after the fact

Key Theme 7: Enthusiasm for EELM
Potential Strategy 7a: Generate Evidence for the Expressed Aspirations of the Model

There is a growing, albeit incomplete, understanding of why EELM are viewed with promise,
and what needs the models are meeting. Indeed, evaluating the extent to which EELM achieve
their intended purpose or purposes is among the four highest-priority research questions
identified by the TEP (see Key Theme 4). The panel noted that mixed-methods and qualitative
research could be useful in ascertaining the sources of enthusiasm among current participants of
EELM. Also, such methods would be useful to better understand what factors lead to successful
implementation, such as the role of dynamic, charismatic individuals (i.e., session leaders, hub
leaders, and specialists); the importance of high-functioning hub teams; and the quality of the
specialist’s expertise and usefulness of his or her recommendations. Qualitative studies could
include both interviews and a direct observation component (i.e., observation of sessions).

Potential Strategies by Time Frame of Options
There was broad agreement among TEP members that, given the sheer number of
unanswered questions about the impacts of EELM on various outcomes (primarily health
outcomes but also provider capacity and other metrics; see Table 6.2), building the evidence base
for EELM will take time and cannot be accomplished all at once. As noted in Key Theme 4, TEP
members identified a list of general, high-level research questions they thought were critical to
answer in evaluating EELM. But underlying each of those questions are a series of more focused
research questions around specific conditions and objectives.
Therefore, it is important to articulate what steps could be taken in the very near term to
address those questions and what steps could be taken in the intermediate or longer term. The
strategies vary in terms of how resource-intensive they might be to implement, and thus, over
what time horizon they could likely be achieved.
The approaches that could begin to be implemented in the next few months to years include
the following:
•

•
•
•

•

coming to consensus around the various intended purposes of EELM; i.e., defining
the goal or goals of the different ways it is implemented and what variations work
best under what circumstances
capacity-building through the development of a ready-to-use (but customizable)
“evaluation kit” for sites to use
carrying out qualitative evaluations that use existing programs as the “laboratory,”
that is, unit of study, to answer questions such as “What makes a hub successful?”
conducting pre-post studies with a control group, with specific attention to choosing
comparators and patient outcomes that are clinically meaningful rather than
examining only process outcomes
building an evaluation component into grant funding, both public and private.
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Goals that might require more time to achieve (e.g., three to five years or more) include the
following:
•
•
•
•

building capacity related to evaluation of EELM through annual
seminars/conferences or the creation of a resource center
conducting studies of the persistence of the effects of EELM on providers and on care
outcomes
performing stepped-wedge trials with rolling implementation of the intervention over
time
developing policies to support more-consistent funding opportunities for evaluation
of EELM.

Summary
Based on the thorough evidence review and the expertise of the TEP, we identified gaps in
the literature and potential strategies to address those gaps. Further implications of the TEP
findings are discussed in the final chapter of this report, Chapter 8.
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7. Example Evaluation Study Designs

One of the key findings from the TEP was that future evaluations of EELM have an
opportunity to increase methodological rigor. We were asked to give three examples of different
EELM evaluation designs, ranging from relatively straightforward to more-complex designs.
Here, we present three possible scenarios for evaluation designs, informed in part by a review of
the literature to identify evaluations of other health services interventions (i.e., not EELM) of
similar scope and complexity, and based in part on panelists’ comments.
The three evaluation scenarios that we present cover a spectrum of study design options that
vary in terms of health conditions addressed, complexity of study design, type of evidence
generated, and likely cost. They respond to the priority research areas, research questions, and
research methodologies identified by TEP members. The PICOTSS framework, which is often
used for the identification and evaluation of research questions, was used to guide discussions of
the TEP and to describe elements of the scenarios: populations, interventions, comparators,
outcomes, timing, settings, and study design.
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Scenario #1: Lower-Complexity Evaluation Design
Research Question(s): Are EELM more effective than alternative technology-based
platforms for improving provider and patient outcomes?
Rationale: No studies to date have assessed whether the framework of EELM outperforms
other approaches to technology-enabled distance learning. Alternative didactic approaches are
potentially less expensive—insofar as they necessitate less provider time by experts (for
example, whether trainings are prerecorded and therefore can be replicated without their
continued involvement)—and are also potentially more flexible, insofar as sessions could be
administered whenever participants are available. By comparison, the approach of EELM is
hands-on, case-based, and occurs in real-time, offering a set of distinct advantages but also
different costs.
Scenario Vignette. A university-based hub wants to implement a new program on complex
presentations of pediatric asthma. To test whether the program is more effective than a
traditional web-based didactic training series, the hub also creates a series of online training
videos, quizzes, and resources over a four-month period. The research team recruits
16 providers, who have an average caseload of four pediatric patients with complex asthma
(64 patients total). Eight providers are assigned to the program, and eight providers are
assigned to the training videos. Both interventions comprise eight training sessions, conducted
biweekly in 60-minute increments, over four months. Researchers evaluate provider
participation frequency, retention in trainings, satisfaction, test-based knowledge, and
confidence at baseline and post-intervention. They also compare patient-level outcomes:
frequency of emergency department visits, sick visits for asthma exacerbations, and oral steroid
use among patients at baseline and six months after training—within the patient panels of
participating providers. Inclusive of developing materials, implementation, and analysis, the full
trial funding period lasts 12 months. Writing and publication of results occurs after completion
of the funding period. See Table 7.1.

Table 7.1. Overview of Scenario #1 Study Components
Population
One hub
Six practices
16 providers

Intervention(s)
EELM-based
training on
pediatric asthma

Comparison
EELM-based
sessions vs.
didactic
sessions

Outcomes
Provider
metrics

Time Frame
Four-month
implementation
period

Patient metrics
12-month trial period

Web-based
didactic sessions

64 patients
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Study Design
Prospective,
nonrandomized
pre-post comparison
with control

Setting
University
and clinics
Regional

Scenario #2: Moderate-Complexity Evaluation Design
Research Question: Are EELM effective in improving practice-level outcomes in the
specific content areas of training? Are these effects sustained over time?
Rationale. No studies to date have examined the comparative effectiveness of two unrelated
EELM in terms of content-specific training (e.g., diabetes care vs. OUD treatment) on contentspecific patient benefits (e.g., improved HbA1c levels). Additionally, few studies have examined
whether training effects of EELM are distributed throughout a practice in a multi-provider
practice versus only within a provider’s own panel, and whether training effects are sustained
after conclusion of participation in EELM. The approach outlined here and the extended time
line of data collection would allow researchers to explore all such elements. One limitation is
that practice-level evaluations imply a multilevel approach to analysis in which observations are
nested, leading to a reduction in statistical power to detect a significant effect of the intervention.
Scenario Vignette. A hub at a university-affiliated teaching hospital wants to examine
whether there are positive practice-level benefits of two programs they are implementing—one
on type 2 diabetes and another on MAT for OUD. They recruit 20 practices to participate in both
programs and randomize ten practices (n = 24 providers) to receive the program on diabetes,
and the other ten practices (n = 26 providers) to receive the MAT program. Both are
implemented biweekly for 12 sessions over a six-month period and then followed for a
subsequent 18 months to assess the durability of the effects. At baseline, six months, 12 months,
and 18 months, all practices report on a set of patient-level metrics for the entire practice-level
patient panel, with a focus on outcomes relevant to diabetes and OUD: HbA1c levels among
diabetics, hospital admissions, opioid prescribing rates, and patient functioning. Outcomes are
analyzed among those operationally defined as “retained in care”—i.e., those who attend all
scheduled medical appointments. Outcome are also analyzed using an intent-to-treat framework
in which all patients are included in analysis, regardless of retention. Inclusive of developing
materials, recruitment, implementation, and analysis, the full trial funding period lasts 24
months. See Table 7.2.
Table 7.2. Overview of Scenario #2 Study Components
Population
One hub
20 practices
50 providers

Intervention(s)
Comparison
EELM-based
Program 1 vs.
training on diabetic program 2
care

Outcomes
Patient metrics
at practice
level

EELM-based
training on MAT

Time Frame
Six-month
implementation
period
24-month trial
period

300 patients
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Study Design
Practice-level
randomization to
the diabetes or
the MAT program

Setting
University
hospital and
clinics
State level

Scenario #3: Higher-Complexity Evaluation Design
Research Question(s): Are EELM effective in improving health-related quality of life among
patients? Are effects observed consistently across hubs and spokes? Are effects sustained?
Rationale: No studies of EELM to date have used a stepped-wedge design, which includes an
element of randomization and approximates an experimental trial. This approach would provide
significantly improved internal validity regarding the effects of EELM, and the larger scale of
implementation would allow for both greater statistical power to detect an effect and the ability to
examine generalizability of EELM across different geographies. Improved quality of life is also an
ultimate objective of clinical care and has yet to be studied in detail in the context of EELM.
Scenario Vignette. Five hubs in different states agree to randomize the timing for rollout of
a program on dementia care for elderly individuals in nursing homes. The hubs all participate in
designing the curriculum and cofacilitating sessions, and each works with an average of three
spoke practices. The EELM-based training consists of ten sessions, 60 minutes per session, over
a 4-month period. A total of ten providers per hub participate, with an average caseload of
n = 4 elderly patients with dementia. Over a 20-month period, the hubs sequentially roll out the
program, collecting information in four-month increments on provider knowledge and
confidence providing care and on patient-reported health-related quality of life using dementia
care mapping. Following implementation, a series of key informant interviews are held with ten
providers and ten patients regarding perceived quality of care, care satisfaction, and benefits
and challenges associated with EELM. Inclusive of developing materials, recruitment,
implementation, interviews, and analysis, the full trial funding period lasts 48 months. See
Table 7.3.
Table 7.3. Overview of Scenario #3 Study Components
Population
Five hubs
15 practices

Intervention(s)
EELM-based
training on
dementia care

50 providers

Comparison
Hubs that have
received EELMbased training
vs. those that
have not yet

Outcomes
Provider
metrics

Time Frame
20-month
implementation
period

Study Design
Stepped-wedge
cluster
randomized trial

Setting
Nursing homes
Multistate

Patient healthrelated quality 48-month trial
of life
period

200 patients

Summary
Each of the proposed scenarios described sets the stage for what is possible from a research
perspective, given a finite budget and necessary trade-offs, and based on the recommendations of
TEP members. We find that key research questions pertaining to EELM, identified by TEP
members, have the potential to be investigated with a range of more- and less-complex study
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designs. These different designs are likely to provide information of differing definitiveness and
emphasis, but all have the potential to add to what is currently known.
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8. Implications and Conclusions

We conducted a series of analyses on behalf of ASPE regarding the evidence base for the
effectiveness of EELM and developed steps that can be taken to advance that evidence base.
Among the results presented already, the results of the evidence review and of the evaluation
report (based on feedback from the TEP) warrant further discussion and contextualization here.
This chapter discusses these findings, followed by a brief summative section.

Implications of Evidence Review Findings
We conducted a review of the evidence of the effectiveness of EELM (see Chapter 5)
regarding both provider-relevant and patient-relevant outcomes. As mentioned previously, we
found that the empirical evidence for the effects of EELM on patient and provider outcomes
remains modest, though consistently showing positive effects in the areas that researchers have
measured.
One of the main findings of this evidence review was that the quality of evidence for the
effectiveness of EELM is generally rated as “low” or “very low” based on the GRADE system.
However, it is important to note that this is by no means limited to EELM; many models of care
delivery are supported only by low-quality evidence. It is a broader issue in the field of health
services research that implementation complexities and constraints are liable to affect choice of
study design. Nevertheless, it is appropriate to continue to strive for higher-quality evidence,
which could be difficult (but not impossible) to produce in a health services context. In
particular, our evidence review pointed to a need for more and better evidence regarding impact
on improving processes of care, outcomes of care, and provider-relevant outcomes (such as
improved retention, especially in underserved areas).
Our findings indicate a need for targeted funding to evaluate EELM. The intention of
EELM—to educate and empower health providers, particularly those in locales with limited
access to specialist care, such as rural and remote areas—is both principled and strategic.
However, relative to the scope and scale at which programs have proliferated over the past
decade, the evidence base has yet to keep pace. Some of the options for evaluation designs could
include experimental and quasi-experimental trials that permit stronger causal inference
regarding the effects of EELM than was possible with many previous studies. It would be even
more ideal to conduct randomized controlled trials that compare EELM with alternative modes
of CME that can also be remotely accessed, although conducting randomized trials in a health
services context is admittedly challenging. Given the capacity-building orientation of EELM, it
would also behoove study designers to provide longer periods of follow-up that would allow
researchers to assess not only the initial effects of EELM but also the sustainability of those
effects over time. Lastly, only a small number of studies to date have included measurements of
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cost, such as the cost of implementing EELM and the costs of patient care delivered under these
programs and under comparison conditions. Such information would be especially useful to
funders as they consider potential expansions of EELM.

Implications of TEP Findings
We conducted a TEP meeting to examine the state of the evidence for EELM and options for
what could be done to advance that evidence base. The panel identified several opportunities to
strengthen the evidence base on the impacts of EELM. Of the numerous potential approaches to
build the evidence base, four broad points should be re-emphasized.
First, it is critical to develop a clear understanding of EELM: the diversity of what it is
intended to accomplish and the critical components of the model. Building the evidence base
requires a recognition that different EELM are implemented in unique ways with various
adaptations to the original Project ECHO, and evaluations should account for this diversity.
Second, an expanded focus on rigorous reporting of program characteristics of EELM is
important to encourage those who implement EELM to carefully document implementation
details so that evaluators can assess how the model is put into practice and what “ingredients”
might lead to better outcomes and are worth replicating.
Building capacity to evaluate EELM is a third critical opportunity and is two-pronged.
Capacity-building could help implementers design EELM to facilitate improved evaluations and
also help researchers to more effectively choose populations, outcomes, comparators, and study
designs.
Fourth, it will be important for implementers and evaluators of EELM to continue to engage
with policymakers, funders, and others to explore mutually beneficial mechanisms for
supporting rigorous evaluation. Ideally, such mechanisms would address care delivery
imperatives in the near term and enable more-rigorous evaluations that expand the evidence base
to support long-term investments in EELM.
The panel took care to emphasize that the relatively weak evidence base in the academic
literature does not imply that EELM are ineffective. Rather, to date, only limited data are
available to objectively assess its effectiveness. There was a high level of agreement among TEP
members that more data are needed to assess the impacts of EELM. The panel noted the
complexities of studying this model of care delivery and, even while articulating those
significant challenges, showed enthusiasm for the potential for more-rigorous evaluation.

Summary and Next Steps: Advancing the Evidence Base for EELM
Since Project ECHO began in 2003, EELM have expanded to encompass hundreds of hub
sites and thousands of spoke sites, with multiple participating clinicians at many sites. EELM
now address conditions that extend far beyond the initial application of the concept to HCV
treatment in primary care. Many thousands of patients have been discussed in case presentations,
and possibly millions of patients have been treated by clinicians who are participants or alumni
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of EELM. Many participants express enthusiasm for the model, stating that it provides a learning
community, enhances their practice, and increases their professional satisfaction.
Although EELM have expanded rapidly, important challenges remain, as described in this
report. The success at rapidly scaling up EELM has not yet been matched with rigorous
evaluation and evidence of impact on patient outcomes (i.e., processes or outcomes of care), or
even provider outcomes (such as retention). In this report, and with the help of the TEP, we
identified many of the barriers to expanding the evidence base for the effectiveness of EELM
and proposed several potential strategies to facilitate higher-quality evaluation and higher-quality
evidence.
Policy solutions should be informed by facts and evidence. Policymakers, researchers, and
clinicians all share a goal of bringing high-quality health care to patients who have trouble
accessing care for such reasons as living in a rural location or a health care shortage area. More
research is needed to determine the extent to which EELM provide a solution to these problems
and how EELM compare with other options that could be used. This report can inform efforts to
advance the evidence base for EELM and ultimately help answer those questions. In turn, the
answers will help guide choices of when and where to implement EELM—and how best to do
so—to make the greatest strides possible in improving access to high-quality care, regardless of
location.
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Appendix A. Search Technique for Inventory

Search Terms

Search term I:
• State or territory name
Search term II:
• Government agency name, medical school name, large hospital name, or top hospital
name
Search term III:
• “Project ECHO”
• “Extension of Community Healthcare Outcomes”
• “Extension of Community Health Care Outcomes”
• “Telementor”
• “Telementoring”
• “Technology-enabled collaborative learning”
• “Technology-enabled learning collaborative”
• “Technology-enabled capacity building”
Search Approach

Search term I/State territory name AND search term II (running through list) AND
Search terms III (linked by OR)
For example, for Alabama, searches included:
• (“ALABAMA” Department of Public Health) AND (“Project ECHO” OR “Extension of
Community Healthcare Outcomes” OR “Extension of Community Health Care
Outcomes” OR “Telementor” OR “Telementoring” OR “Technology-enabled
collaborative learning” OR “Technology-enabled learning collaborative” OR
“Technology-enabled capacity building”)
• (“ALABAMA” Brookwood Medical Center) AND (“Project ECHO” OR “Extension of
Community Healthcare Outcomes” OR “Extension of Community Health Care
Outcomes” OR “Telementor” OR “Telementoring” OR “Technology-enabled
collaborative learning” OR “Technology-enabled learning collaborative” OR
“Technology-enabled capacity building”)
• (“ALABAMA” Flowers Hospital) AND (“Project ECHO” OR “Extension of Community
Healthcare Outcomes” OR “Extension of Community Health Care Outcomes” OR
“Telementor” OR “Telementoring” OR “Technology-enabled collaborative learning” OR
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“Technology-enabled learning collaborative” OR “Technology-enabled capacity
building”)
In addition, the category III search terms (about EELM) were searched within the websites of
each of the following government agencies:
Government agencies:
• HHS
• HHS—Administration of Children and Families
• HHS—Administration for Community Living
• HHS—AHRQ
• HHS—Office of the Assistant Secretary for Preparedness and Response
• HHS—CDC
• HHS—CMS
• HHS—HRSA
• HHS—IHS
• HHS—National Institute on Drug Abuse (NIDA)
• HHS—NIH
• HHS—SAMHSA
• DoD
• DoD—Army
• DoD—Navy
• DoD—Air Force
• VA—SCAN-ECHO
The full inventory can be found in Appendix F.

75

Appendix B. Search Technique for Evidence Review

PubMed
2007–2018; English
(Telementoring[title/abstract] OR tele-mentoring[title/abstract] OR tele-mentor[title/abstract] OR
videoteleconferencing[title/abstract] OR video-teleconferencing[title/abstract] OR
videoconferencing[title/abstract] OR video-conferencing[title/abstract] OR teletraining[title/abstract] OR teletraining[title/abstract] OR tele-conference[title/abstract] OR
teleconference[title/abstract] OR tele-education[title/abstract] OR teleeducation[title/abstract]
OR tele education[title/abstract] OR teleECHO[title/abstract] OR tele-ECHO[title/abstract] OR
boot camp*[title/abstract] OR bootcamp*[title/abstract] OR mini-residenc*[title/abstract] OR
learning collaborative[title/abstract] OR collaborative learning[title/abstract] OR crash
course[title/abstract])
AND
(psycholog*[title/abstract] OR psychiatr*[title/abstract] OR “mental health”[title/abstract] OR
“behavioral health”[title/abstract]OR counselor*[title/abstract])

Embase
2007–2018; English
(Telementoring OR tele-mentoring OR tele-mentor OR videoteleconferencing OR videoteleconferencing OR videoconferencing OR video-conferencing OR tele-training OR teletraining
OR tele-conference OR teleconference OR tele-education OR teleeducation OR “tele education”
OR teleECHO OR tele-ECHO OR “boot camp*” OR bootcamp* OR mini-residenc* OR
“learning collaborative” OR “collaborative learning” OR “crash course”):ab,ti
AND
(psychology* OR psychiatr* OR “mental health” OR “behavioral health” OR counselor*):ab,ti

PsycInfo
2007–2018; English
TI ((Telementoring OR tele-mentoring OR tele-mentor OR videoteleconferencing OR videoteleconferencing OR videoconferencing OR video-conferencing OR tele-training OR teletraining
OR tele-conference OR teleconference OR tele-education OR teleeducation OR “tele education”
OR teleECHO OR tele-ECHO OR “boot camp*” OR bootcamp* OR mini-residenc* OR
“learning collaborative” OR “collaborative learning” OR “crash course”)) OR AB
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((Telementoring OR tele-mentoring OR tele-mentor OR videoteleconferencing OR videoteleconferencing OR videoconferencing OR video-conferencing OR tele-training OR teletraining
OR tele-conference OR teleconference OR tele-education OR teleeducation OR “tele education”
OR teleECHO OR tele-ECHO OR “boot camp*” OR bootcamp* OR mini-residenc* OR
“learning collaborative” OR “collaborative learning” OR “crash course”))
AND
TI (psychology* OR psychiatr* OR “mental health” OR “behavioral health” OR counselor*) OR
AB (psychology* OR psychiatr* OR “mental health” OR “behavioral health” OR counselor*)
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Appendix C. Studies Used in Evidence Review

In Tables C.1–C.3, we include the studies identified in the evidence review, organized by
first author. Relevant features of each implementation of EELM are listed, where known,
including health content area, number of sessions, session frequency, and number of patients or
providers studied.
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Table C.1. Reviewed Studies—Overview (n = 52 studies)

Citation

Health
Content Area

Hub Name
and Location

Anderson
et al., 2017

Pain
management

Integrative Pain 16
Center of
Arizona,
Tucson, Arizona

Spokes

Trainees
Evaluated
12 in the
intervention
group; 11 in
the control
group

Evaluation
Implementation
Period

Training
Sessions

Frequency Duration of
of Training Training
Patients in
Sessions
Sessions
Evaluation

2013

8

Weekly

120
minutes

Exposure
group: 1,586 at
baseline; 1,485
at follow-up
Control group:
2,020 at
baseline; 1,695
at follow-up

Arora
et al., 2010

Hepatitis C

UNM Health
Sciences
Center,
Albuquerque,
New Mexico

Unknown

Varied by
year:
17–52
providers

2006–2008

Unknown

Weekly

120
minutes

NA

Arora,
Thornton,
et al., 2011

Hepatitis C

UNM,
Albuquerque,
New Mexico

21

Unknown

2004–2008

Unknown

Weekly

Unknown

261 patients in
exposure
group; 146
patients in
control group

Ball
et al., 2018

Pain
management

3
Louis Stokes
Cleveland
Veterans Affairs
Medical Center,
Cleveland, Ohio

25 (surveys); 2011–2014
14 (focus
group
discussions)

Unknown

Weekly

Unknown

NA

Beste
et al., 2017

Hepatitis C

VA,
Washington,
D.C. (National
Program)

376

Unknown

1–2 weeks

60–90
minutes

6,431 patients
in exposure
group; 32,322
patients in
control group

152

2011–2015
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Trainees
Evaluated

Evaluation
Implementation
Period

Training
Sessions

Frequency Duration of
of Training Training
Patients in
Sessions
Sessions
Evaluation

Veterans Affairs Unknown
Puget Sound
Health Care
System, Seattle,
Washington
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2014

Unknown

Weekly

60–90
minutes

NA

Pain
management

VA,
Washington,
D.C. (National
Program)

Unknown

Unknown

2010–2013

Unknown

Unknown

Unknown

371,646

Carlin
et al., 2018

Chronic pain
management

University of
Toronto,
Toronto,
Canada

3

37

2014–2015

Unknown

Weekly

120
minutes

NA

Catic
et al., 2014

Dementia

Beth Israel
11
Deaconess
Medical Center,
Boston,
Massachusetts

Unknown

2012–2013

Unknown

Bimonthly

90 minutes

47

Chaple
et al., 2018

Substance use
disorder

National
Development &
Research
Institutes, New
York, New York

Unknown

20

2016–2017

12

Biweekly

60 minutes

NA

CoftaWoerpel
et al., 2018

Tobacco
cessation

University of
Unknown
Texas M. D.
Anderson
Cancer Center,
Houston, Texas

23

2015

16

Weekly to
biweekly

60 minutes

NA

Health
Content Area

Hub Name
and Location

Beste
et al., 2016

Infectious
diseases;
hepatitis C;
pulmonology;
nephrology

Carey
et al., 2016

Citation

Spokes
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Evaluation
Implementation
Period

Training
Sessions

Frequency Duration of
of Training Training
Patients in
Sessions
Sessions
Evaluation

2012–2013

14

Monthly

60 minutes

NA

8 (provider- 2012–2013
level);
11 (programlevel)

Unknown

Monthly

90 minutes

NA

41

2012–2016

13

Weekly

90 minutes

NA

8
Beth Israel
Deaconess
Medical Center,
Boston,
Massachusetts

12

2013–2015

Unknown

Weekly

Unknown

NA

University of
35
Rochester
Medical Center,
Rochester, New
York

154 (cohort); 2014–2016
26
(qualitative
interviews)

33

Unknown

Unknown

> 70,000

Health
Content Area

Hub Name
and Location

Women’s health

Veterans Affairs Unknown
Healthcare
Systems of Los
Angeles, San
Diego and
Oklahoma City

Varied by
type of
survey:
18–53

Covell et al., Co-occuring
2015
mental and
substance use
disorders

Center for
Practice
Innovations,
Columbia
University and
New York State
Psychiatric
Institute; New
York, New York

11

Eaton et al.,
2018

Chronic pain
management

University of
Washington,
Seattle,
Washington

29

Farris et al.,
2017

Dementia

Citation
Cordasco
et al., 2015

Fisher et al., Dementia
2017

Spokes

Trainees
Evaluated
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Trainees
Evaluated

Evaluation
Implementation
Period

Training
Sessions

Seven regional 195
Veterans Affairs
Healthcare
Systems

159

2011–2013

Unknown

Every 1–2
weeks

Unknown

22,454
patients in
exposure
group; 299,981
in nonexposure
group

Chronic liver
disease

VA Ann Arbor
23
Healthcare
System Liver
Clinic, Ann
Arbor, Michigan

106

2011–2015

157

Weekly

60–90
minutes

582 in
exposure
group; 1,395 in
comparison
group

Gordon
et al., 2016

Dementia

Beth Israel
11
Deaconess
Medical Center,
Boston,
Massachusetts

Unknown

2012–2013

Unknown

Biweekly

120
minutes

Unknown

Haozous
et al., 2012

Cancer-related
pain
management

UW, Seattle,
Washington

24
(education
sessions);
32 (case
conference
sessions)

Unknown

4 education Monthly
sessions;
9 case
conference
sessions

60 minutes

NA

Jansen
et al., 2018

Pain
management in
end-stage
dementia

Queen’s
Unknown
University,
Belfast,
Northern Ireland

18

2016

5

Weekly

75 minutes

NA

Johnson
et al., 2017

Multiple sclerosis UW, Seattle,
Washington

15 trainees
participated
in
evaluation;
24 trainees
total

Unknown

12

Weekly

60–90
minutes

NA

Health
Content Area

Hub Name
and Location

Frank et al.,
2015

Chronic pain

Glass et al.,
2017

Citation

Spokes

11
(education
sessions);
16 (case
sessions)

13

82

Frequency Duration of
of Training Training
Patients in
Sessions
Sessions
Evaluation

Training
Sessions

Frequency Duration of
of Training Training
Patients in
Sessions
Sessions
Evaluation

763
2010–2013
(surveys);
9 (focus
group
discussants)

136

Weekly

60 minutes

NA

80 spoke
locations;
99 clinics

Unknown

2013–2016

Unknown

Weekly

120
minutes

52,431 in
exposure
group;
1,187,945 in
comparison
group

VA,
Washington,
D.C. (National
Program)

5

13

2014–2015

14

Biweekly

60 minutes

NA

Integrated
addictions and
psychiatry

ECHO Institute,
UNM Health
Sciences
Center,
Albuquerque,
New Mexico

Unknown

41

2015–2016

Unknown

Weekly

120
minutes

NA

Komaromy,
Ceballos,
et al., 2018

Community
health worker
training: obesity
prevention and
addiction
recovery

ECHO Institute,
UNM Health
Sciences
Center,
Albuquerque,
New Mexico

Unknown

16 (obesity
2010–2015
prevention);
46 (addiction
recovery)

16
(obesity);
20
(addiction)

Weekly

120
minutes

NA

Lewiecki
et al., 2017

Osteoporosis

New Mexico
Clinical
Research and
Osteoporosis
Center,
Albuquerque,
New Mexico

Unknown

16

Unknown

Weekly

75 minutes

NA

Health
Content Area

Hub Name
and Location

Katzman
et al., 2014

Chronic pain

UNM,
Albuquerque,
New Mexico

191

Katzman
et al., 2018

Chronic pain
management

Seven military
medical
treatment
facilities in the
United States
and Germany

Kauth et al.,
2015

Transgender
health

Komaromy,
Bartlett,
et al., 2017

Citation

Spokes

Trainees
Evaluated

Evaluation
Implementation
Period

2015–2017

83

Trainees
Evaluated

Evaluation
Implementation
Period

Training
Sessions

Frequency Duration of
Patients in
of Training Training
Sessions
Evaluation
Sessions

Hospital Italiano 12
de Buenos
Aires, Buenos
Aires, Argentina

14

2015

12

Biweekly

90 minutes

NA

Hypertension

6
University of
Chicago,
Chicago, Illinois

9 in the
intervention
group; 3 in
the control
group

2010–2011

12

Biweekly

Unknown

NA

Mazurek
et al., 2017

Autism spectrum
disorders

University of
Missouri,
Columbia,
Missouri

14

Unknown

12

Biweekly

120
minutes

NA

Mehrotra
et al., 2018

Mental health

11
National
Institute of
Mental Health
and
Neurosciences,
Bangalore, India

12

2017–2018

12

Biweekly

Unknown

NA

Meins et al.,
2015

Chronic pain
management

UW Center for
Pain, Seattle,
Washington

Unknown

58

Unknown

Unknown

Weekly

Unknown

NA

Mohsen
et al., 2018

Hepatitis C

Liverpool
Hospital,
Sydney,
Australia

Unknown

42

2017–2018

Unknown

Weekly

60–120
minutes

100 in
exposure
group; 100 in
comparison
group

Health
Content Area

Hub Name
and Location

Marciano
et al., 2017

Hepatitis C

Masi et al.,
2012

Citation

Spokes

9

84

Evaluation
Implementation
Period

Training
Sessions

Frequency Duration of
of Training Training
Patients in
Sessions
Sessions
Evaluation

2014

52

Weekly

90 minutes

Exposure
group: 213 at
baseline, 148
at end;
comparison
group: 220 at
baseline, 214
at end

6

2015

10

Biweekly

120–180
minutes

Unknown

848

2009–2010

Unknown

Unknown

Unknown

NA

39

2015

20

Weekly

60 minutes

NA

Unknown

2004–2006

20

Monthly

60 minutes

NA

Unknown

Unknown

8

Monthly

60–90
minutes

NA

Hub Name
and Location

Spokes

Moore et al., Geriatric care
2017

Beth Israel
Deaconess
Medical Center,
Boston,
Massachusetts

6
Unknown
intervention
sites; 41
comparison
sites

Ní
Cheallaigh
et al., 2017

Hepatitis C

St James
4
Hospital, Dublin,
Ireland

Oliveira,
Branquinho,
and
Goncalves,
2012

Varies: e.g.
dermatology,
neurology, and
gastroenterology

Regional Health 52
Administration
of Alentejo

Parsons
et al., 2017

Sleep medicine

VA Puget
Sound Health
Care System,
Seattle,
Washington

Qaddoumi
et al., 2007

Pediatric
neuro-oncology

1
Division of
Neurosurgery,
The Hospital for
Sick Children,
Toronto,
Canada

Rahman et
al., 2012

Geriatric nutrition Davis School of
Gerontology,
University of
Southern
California, Los
Angeles,
California

Citation

Health
Content Area

25

9

Trainees
Evaluated
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Spokes

Trainees
Evaluated

Evaluation
Implementation
Period

Training
Sessions

Frequency Duration of
of Training Training
Patients in
Sessions
Sessions
Evaluation

Unknown

101

Unknown

16

Monthly

60 minutes

NA

VA Ann Arbor
Unknown
Healthcare
System, Ann
Arbor, Michigan

24

2011–2012

Unknown

Biweekly

Unknown

NA

LGBT Program, 16
VA,
Washington,
D.C.

111

2014–2015

14

Biweekly

60 minutes

NA

Sockalingam Mental health
et al., 2017

Centre for
Addictions and
Mental Health
and University
of Toronto,
Toronto,
Canada

Varied by
type of
survey:
22–27

2015

32

Weekly

120
minutes

NA

Su et al.,
2018

Chronic liver
disease

VA Ann Arbor
11
Healthcare
System Liver
Clinic, Ann
Arbor, Michigan

Unknown

2011–2015

Unknown

Unknown

Unknown

513 in VA
SCAN-ECHO
group; 62,237
in comparison
group

Swigert
et al., 2014

Diabetes

U.S. Air Force
Unknown
Diabetes Center
of Excellence,
San Antonio,
Texas

Unknown

2012

20

Biweekly

Unknown

NA

Health
Content Area

Hub Name
and Location

Ray, Fried,
Palliative care
and Lindsay,
2014

Centre for
Health System
Strengthening,
James Cook
University,
Townsville,
Australia

Salgia et al., Hepatitis C
2014

Shipherd
et al., 2016

Citation

Transgender
care

Unknown

86

Citation
Van Ast and
Larson,
2007

Health
Content Area

Hub Name
and Location

Disability care

Western
Australian
Country Health
Service
Midwest,
Geraldton,
Western
Australia,
Australia

Spokes

Trainees
Evaluated

Evaluation
Implementation
Period

Training
Sessions

Frequency Duration of
of Training Training
Patients in
Sessions
Sessions
Evaluation

12

8

2004–2005

21

Unknown

120
minutes

NA

Unknown

2010–2011

12

Biweekly

90 minutes

NA

2012–2014

Unknown

Biweekly

60 minutes

39

28

2014

24

Weekly

120
minutes

NA

Volpe,
Psychiatric
Boydell, and services
Pignatiello,
2014

The Hospital for 14
Sick Children,
Toronto,
Ontario, Canada

Watts et al.,
2016

Diabetes

Louis Stokes
Cleveland
Veterans Affairs
Medical Center,
Cleveland, Ohio

White et al.,
2015

Palliative care

Northern Ireland 9
Hospice,
Belfast,
Northern Ireland

Wood et al.,
2018

HIV/AIDS (PrEP) University of
Washington,
Seattle,
Washington

Unknown

45

2015–2017

88

Monthly

Unknown

NA

Wood et al.,
2016

HIV/AIDS

21

45

2012–2015

172

Weekly

60 minutes

NA

University of
Washington,
Seattle,
Washington

2
2
intervention
sites; 2
comparison
sites
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Table C.2. Reviewed Studies Reporting Provider Measures (n = 43 studies)

Citation

Health Content
Area

Number of
Trainees
Evaluated

Evaluation
Design

Main Provider Outcome Measures

Main Provider Outcomes Reported

Anderson
et al., 2017

Pain management

12 in the
intervention
group; 11 in
the control
group

Pre-post study
design with
comparison
group

Pain-related knowledge and selfreported self-efficacy; frequency of
formal assessment tool utilization;
frequency of opioid agreements
developed; patient concern about
addiction to opioids

Increased pain knowledge in the
intervention group (p < 0.001), not
observed in the control group (p = 0.11);
nonsignificant group difference in
frequency of opioid agreement usage
(p = 0.05); lower concern about patient
addiction to opioids in the intervention
group (p = 0.006)

Arora et al.,
2011

Hepatitis C

Varied by
year: 17–52
providers

Pre-post study
design without
comparison
group

Self-reported satisfaction with ECHO
training; self-reported self-efficacy
before versus after ECHO training;
self-reported perceived benefits of
ECHO training

Satisfaction with ECHO training ranged
from 4.3 to 4.9 on 1–5 ordinal scale
(2006); self-efficacy increased significantly
across all categories (p < 0.001) (2006–
2007); moderate-major benefits selfreported across eight categories 82–98
percent of time (2008)

Ball et al.,
2018

Pain management

25 (surveys);
14 (focus
group
discussions)

Pre-post study
design without
comparison
group; focus
group
discussions

Self-reported confidence and
knowledge treating patients with
chronic pain before versus after ECHO
training; barriers and facilitators to
participation in ECHO

Increased provider confidence (p < 0.01)
and increased provider knowledge
(p < 0.05) on chronic pain; focus group
discussions indicated increased provider
self-efficacy and knowledge, as well as
increased workload associated with
participation

Beste et al.,
2017

Hepatitis C

376

Retrospective
Rate of PCPs who initiate Hepatitis C
cohort study with treatment with antiviral treatment
comparison
group

88

Providers who received at least one
SCAN-ECHO training were more likely to
initiate antiviral treatment (p < 0.01),
compared with those with no SCANECHO training. This was attributable to
more frequent initiation among those
presented as cases during trainings.

Citation

Health Content
Area

Number of
Trainees
Evaluated

Evaluation
Design

Main Provider Outcome Measures

Main Provider Outcomes Reported

Beste et al.,
2016

Infectious diseases; 78
hepatitis C;
pulmonology;
nephrology

Participant
survey

Self-reported benefits of ECHO
participation, such as perceived impact
on providers and perceived impact on
care delivery; association between
duration of participation and perceived
benefits

Strong agreement with trainings’ impact
on providers ranged from 34.2 to
46.8 percent across questions; strong
agreement with trainings’ impact on care
delivery ranged from 28.6 to 38.4 percent
across questions; participation for more
than one year was associated with greater
perceived impact, particularly perceived
patient access to specialty care
(p = 0.005)

Carlin et al.,
2018

Chronic pain
management

37

Focus group
discussions (6)

Qualitative feedback on barriers and
facilitators to ECHO, as well as
perceived benefits and drawbacks

Respondents reported insights defined
under such themes as challenges of
managing chronic pain; ECHO
participation and improvement in patientprovider interaction and participant
knowledge; ECHO participation
generating a sense of community; and
disadvantages associated with
participating in ECHO

Catic et al.,
2014

Dementia

Unknown

Prospective
cohort study
without
comparison
group

Self-reported adherence to
recommendations of the ECHO-AGE
expert team

Self-reported adherence to expert
recommendations in 39 of 44 cases
(89 percent) presented

Chaple et al., Substance use
2018
disorder

20

Participant
survey

Participant satisfaction in quality of
training; self-reported enhancement in
clinical skills

General participant satisfaction was 4.69
of 5; self-reported enhancement of clinical
skills as a result of training was 4.45 of 5

CoftaWoerpel et
al., 2018

23

Participant
survey

Self-reported confidence treating
tobacco use; satisfaction with
participation; tobacco-related
knowledge survey

All respondents (22) reported moderateto-high confidence to address tobacco
use; a majority of knowledge questions
yielded 69–85 percent correct answers;
77 percent agreed the program was
satisfactory

Tobacco cessation

89

Citation

Health Content
Area

Number of
Trainees
Evaluated

Evaluation
Design

Main Provider Outcome Measures

Main Provider Outcomes Reported

Cordasco
et al., 2015

Women’s health

Varied by
type of
survey:
18–53

Participant
surveys;
participant
semistructured
interviews

Self-reported impact of training on
care; self-reported satisfaction with
participation

47 of 53 survey respondents (89 percent)
reported that SCAN-ECHO information
would influence their patient care; 18 of 18
interviewees (100 percent) reported
SCAN-ECHO was useful for building and
maintaining knowledge

Covell et al.,
2015

Co-occurring
mental and
substance use
disorder

8 (providerlevel);
11 (programlevel)

Participant
survey (provider
level);
prospective
cohort study
without
comparison
(program level)

Provider-level: self-reported
satisfaction. Program-level: increased
knowledge about integrated treatment;
percent of charts with stage of
treatment recorded.

All providers reported that the online
learning collaborative was helpful, the
implementation model was helpful, and
strategies supporting implementation were
helpful. At program-level, sites showed
significant increase in dual disorder
treatment knowledge survey (p < 0.05);
sites showed increase in chart
documentation (p < 0.05)

Eaton et al.,
2018

Chronic pain
management

41

Cluster
randomized
controlled trial
(clinic
participation in
TelePain
sessions)

Pain management knowledge
measured by KnowPain-12; selfreported knowledge and attitudes
regarding pain; self-reported perceived
competence

No significant change in knowledge
scores or self-perceived competence
when compared between intervention and
control group PCPs (p > 0.05)

Farris et al.,
2017

Dementia

12

Participant
survey

Self-reported benefits of ECHO
participation, including on patient
treatment plans

Satisfaction on features of ECHO ranged
from 3.25 to 3.58 on scale of 1 (strongly
disagree) to 5 (strongly agree); providers
demonstrated an average score of 3.64 on
agreement that they incorporated training
advice into treatment plans

Fisher et al.,
2017

Dementia

154 (cohort); Semistructured
Semistructured interviews explored
26 (qualitative interviews;
participant perceptions and
interviews)
retrospective
experiences in the program
cohort study with
comparison
group

90

Interviewees reported the program led to
improvements in clinician geriatric mental
health care knowledge and treatment
practices

Number of
Trainees
Evaluated

Citation

Health Content
Area

Glass et al.,
2017

Chronic liver
disease

Haozous
et al., 2012

Cancer-related pain 24 (education
management
sessions);
32 (case
conference
sessions)

106

Evaluation
Design

Main Provider Outcome Measures

Main Provider Outcomes Reported

Retrospective
Association between complexity of
cohort study with trainee cases presented and number
control
of cases presented
comparison

Providers who presented more than ten
SCAN-ECHO cases were more likely to
present complex cases about a specific
treatment or a procedure, compared with
those presenting ten or fewer cases
(p < 0.001)

Retrospective
cohort study with
and without
control
comparison

Self-reported satisfaction survey on
pain management educational
sessions; self-reported perceived
competence proceeding case
conference calls

Providers who attended pain management
sessions reported mean item-level
satisfaction scores ranging from 2.75 to
3.47 on a 0–4 ordinal scale; providers who
attended case conference calls reported
significantly higher competence on pain
management than a control comparison
group (p < 0.01)

Mixed-methods
prospective
cohort study

Participant self-efficacy and
knowledge, based on KnowPain-50
and KnowPain-12 questionnaires; two
focus group discussion interviews

Overall knowledge and self-efficacy
scores were significantly higher postECHO than pre-ECHO for physicians
(p = 0.01) and nurses (p = 0.04). Key
themes that emerged were knowledge
and skills development and dissemination,
protected time, areas for improvement,
and the future of ECHO.

Jansen et al., Pain management
2018
in end-stage
dementia

18

Johnson et
al., 2017

Multiple sclerosis

15 trainees
Participant
participated in surveys
evaluation;
24 trainees
total

Self-reported confidence treating
multiple sclerosis; self-reported
satisfaction with program; self-reported
feedback on program format

Mean self-reported confidence treating
multiple sclerosis after training was 4.53
out of 5; 9 of 15 participants indicated the
program met their expectations; 15 of 15
participants indicated that sessions
expressed good value

Katzman
et al., 2014

Chronic pain

763 (surveys);
9 (focus
group
discussants)

Percentage of providers who reported
that trainings were “excellent” on five
dimensions; exploratory feedback on
utility of presentations and impact of
participation

From 2010 to 2012, the percentage of
providers reporting “excellent” increased
significantly across categories (p < 0.01);
provider feedback on utility of ECHO
trainings and impact of participation were
generally positive

Participant
survey; focus
group
discussions
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Kauth et al.,
2015

Transgender health 13

Participant
survey; pre-post
study design with
comparison
group

Post-intervention self-reported
satisfaction on training; pre- and postintervention self-reported confidence
providing care

92.3 percent of providers described the
didactics as somewhat or very helpful.
The majority (76.9 percent) reported that
receiving consultation was somewhat or
very helpful, and nearly everyone (92.3
percent) felt that they benefited from
listening to other cases being discussed;
39.7 percent of providers increased in
self-reported confidence to treat
transgender veterans after SCAN-ECHO
(p = 0.007)

Komaromy,
Bartlett,
et al., 2017

Integrated
addictions and
psychiatry

41

Participant
survey

Percentage of participants who
reported changing their patient care
plan as a result of presenting a case;
percentage who rated the value of
expert input received as 5 on a scale
of 1–5; percentage who reported
training as useful in caring for their
own patients

77 percent of case presenters reported
that the case discussion changed their
patient care plan; 86 percent reported the
value of the input they received as a 5 out
of 5; 93 percent reported training as useful
in caring for their own patients

Komaromy,
Ceballos,
et al., 2018

Community health
worker training:
obesity prevention
and addiction
recovery

16 (obesity
prevention);
46 (addiction
recovery)

Pre-post study
design without
comparison
group; trainerrated pre-post
survey

Self-reported change in obesity
prevention knowledge and abilities;
trainer-reported change in motivational
interviewing skills for addiction
recovery

Self-reported obesity prevention
knowledge and abilities increased on 12 of
13 dimensions (p < 0.05); trainer-reported
provider performance on motivational
interviewing improved (p < 0.001)

Lewiecki
et al., 2017

Osteoporosis

16

Pre-post study
design without
comparison
group

Pre-post intervention change in selfreported self-efficacy, based on selfefficacy questionnaire

Overall increase in reported self-efficacy
among participants who completed the
survey (p = 0.005). It uses a pre-post
framework.

Marciano
et al., 2017

Hepatitis C

14

Pre-post study
design without
comparison
group

Self-assessed provider knowledge on
HCV

Increase in self-assessed knowledge on
all ten aspects of HCV care from pre- to
post-intervention (p < 0.05)
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Masi et al.,
2012

Hypertension

9 in the
intervention
group; 3 in
the control
group

Pre-post study
design with
comparison
group

Knowledge surveys administered at
baseline and endline; self-reported
knowledge reported at baseline and
endline

Tested knowledge of how to treat
hypertension increased among
intervention providers (p < 0.01) but not
among controls. Self-assessed knowledge
increased among intervention providers
(p < 0.01) but not among controls

Mazurek
et al., 2017

Autism spectrum
disorders

14

Pre-post study
design without
comparison
group

Self-reported self-efficacy; selfreported use of M-CHAT or another
screening tool; self-reported
adherence to American Academy of
Pediatrics autism spectrum disorder
screening guidelines; self-reported use
of 15 possible resources for autism;
satisfaction with program

Self-efficacy improved significantly
(p = 0.002); use of resources increased
from 0.29 out of 15 to 4.07 out of 15, on
average (p = 0.003); high satisfaction with
ECHO trainings was reported

Mehrotra
et al., 2018

Mental health

12

Pre-post study
design without
comparison
group; participant
survey

Self-reported responses to satisfaction
survey; pre- and post-intervention
knowledge test and pre- and postintervention self-reported self-efficacy

Mean participant satisfaction was 4.5 or
higher on a scale of 1–5 for five survey
questions. Topical knowledge increased
significantly (p < 0.01), as did selfreported self-efficacy (p < 0.05).

Meins et al.,
2015

Chronic pain
management

58

Participant
survey;
participant
observation

Self-reported belief that participation
enhanced knowledge of pain
management; self-report that
participant intends to use new
knowledge gained

On scale of 1–4, mean score for
statement that participation enhanced
knowledge was 3.94; mean score for
statement that participant intended to use
new knowledge gained was 3.77

Ní Cheallaigh Hepatitis C
et al., 2017

6

Participant
semistructured
interviews

Self-reported care management skills
following ECHO training

Respondents generally reported that
ECHO participation increased their ability
to manage HCV infection

Oliveira,
Branquinho,
and
Goncalves,
2012

848

Participant
survey

Overall participant satisfaction

Overall satisfaction was reported as
medium, high, or very high (range: very
low, low, medium, high, very high) by
90 percent of respondents in 2009 and
94 percent in 2010

Varied: e.g.
dermatology,
neurology, and
gastroenterology

93

Health Content
Area

Number of
Trainees
Evaluated

Parsons
et al., 2017

Sleep medicine

39

Participant
surveys

Self-reported comfort treating sleep
Increased provider comfort reported by
disorders; self-reported clinical practice 77 percent of respondents; a majority
change
(85 percent) of respondents reported
“some” or significant” practice change
across practice domains

Qaddoumi
et al., 2007

Pediatric
neuro-oncology

Unknown

Prospective
cohort study
without
comparison
group

Percentage of patients for whom
expert recommendations differed from
original care plan; percentage of
patients for whom there was a
significant change in the original care
plan, conditional on recommendations

In 23 patients (36 percent), major changes
from original plan were recommended on
different aspects of the care; in 21 patients
(91 percent), those recommendations
were followed

Rahman
et al., 2012

Geriatric nutrition

Unknown

Participant
survey;
prospective
cohort study
without
comparison
group

Post-intervention participant
satisfaction; pre-post intervention
change in knowledge

89 percent of participants reported that
they would participate in a similar project
and recommend the course; knowledge
scores on trainer-administered quiz
improved significantly (p < 0.05)

Ray, Fried,
and Lindsay,
2014

Palliative care

101

Pre-post study
design without
comparison
group

Increased confidence to provide
palliative care pre- versus postintervention; post-intervention rating of
content usefulness

Provider confidence increased
significantly (p < 0.05); average rating of
content usefulness was 3.50 on scale of
1–4

Salgia et al.,
2014

Hepatitis C

24

Participant
survey

Self-reported change of care provision
following the intervention

The majority of participants (20,
83 percent) reported having encountered
a case similar to the one presented in
SCAN-ECHO; of these participants, 18
(90 percent) reported improvements in
their perceived diagnostic approach, 16
(80 percent) reported having developed a
better treatment plan, and 16 (80 percent)
reported perceived improvements in
follow-up plan development

Citation

Evaluation
Design

Main Provider Outcome Measures

94

Main Provider Outcomes Reported

Health Content
Area

Number of
Trainees
Evaluated

Shipherd
et al., 2016

Transgender care

111

Sockalingam
et al., 2017

Mental health

Citation

Evaluation
Design

Main Provider Outcome Measures

Main Provider Outcomes Reported

Post-session knowledge test score;
post-session self-reported satisfaction
survey scores; post-intervention
feedback survey; self-perceived
confidence treating transgender
veterans before versus after
participation

Session participation ranged from 11 to
57, with 93 percent receiving a postsession knowledge survey score greater
than 80 percent; average session
satisfaction was 4.28 on 0–5 scale;
participants rated all aspects of the
intervention to be useful; 92 percent of
participants increased in treatment
confidence (p-value unreported);
63 percent of participants expected to
care for more transgender patients in the
future

Varied by
Pre-post study
type of
design without
survey: 22–27 comparison
group

Self-reported knowledge and selfefficacy

Increased mental health and addictions
knowledge (p < 0.001); increased provider
self-efficacy approaching statistical
significance (p = 0.06)

Swigert et al., Diabetes
2014

Unknown

Pre-post study
design without
comparison
group

Self-reported knowledge and
confidence levels (including
retrospective report of baseline
knowledge and confidence); selfreported intention to change current
clinical care practices

Self-reported increase in diabetes
knowledge (p < 0.001) and increased
confidence (p < 0.001) after individual
ECHO sessions; a majority of participants
(95 percent) reported an intention to
change clinical practice after ECHO
sessions

Van Ast and Disability care
Larson, 2007

8

Semistructured
interviews

Perceived acceptability of technology;
perceived benefits of participation

Participants generally reported favorable
feedback about the technology platform;
participants reported positive behavioral
changes in caregiving

Focus group
discussion; key
informant
interviews

Overall participant satisfaction;
acceptability of televideo technology

Focus group discussants and interviewees
reported overall satisfaction; televideo
technology was regarded as an effective
tool for learning

Volpe,
Boydell, and
Pignatiello,
2014

Psychiatric services Unknown

Participant
surveys

95
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White et al.,
2015

Palliative care

Wood et al.,
2018

Wood et al.,
2016

Citation

Evaluation
Design

Main Provider Outcome Measures

Main Provider Outcomes Reported

28

Mixed-methods
prospective
cohort study

Provider knowledge score; selfreported self-efficacy scores, provider
self-reported satisfaction with program

Mean knowledge score improved
significantly (71.3 percent to 82.7 percent,
p < 0.001); self-efficacy significantly
improved (p = 0.063); 96 percent reported
gains in learning; 90 percent felt ECHO
had improved the care they provide;
83 percent would recommend ECHO to
other health care providers; 70 percent
said ECHO’s technology gave them
access to education they would have had
difficulty accessing

HIV/AIDS (PrEP)

45

Participant
survey

Self-reported knowledge of PrEP,
comfort level discussing PrEP, and
prescribing practices

93.3 percent of survey respondents
reported that the intervention helped them
stay up to date on PrEP guidelines
“extremely” or “moderately” well;
91.1 percent reported an “extremely” or
“moderately” increased likelihood to
prescribe PrEP; 40.0 percent reported
that, without the intervention, they would
have referred patients seeking PrEP to
another provider

HIV/AIDS

45

Prospective
cohort study
without
comparison
group

Self-assessed confidence to perform
essential components of HIV care;
self-reported feeling part of a
community of practice; self-reported
overall HIV care knowledge

Self-assessed confidence improved over
time in several clinical skill areas on 14 of
18 dimensions of care provision
(p < 0.05); feelings of professional
isolation decreased while degree to which
participants felt part of an HIV community
of practice increased (p < 0.05); selfreported HIV care knowledge increased
(p = 0.004)
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Table C.3. Reviewed Studies Reporting Patient Measures (n = 15 studies)
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Main Patient Outcome
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Anderson et
al., 2017

Pain
management

Pre-post study
design with
comparison
group

Percentage of patients with
chronic pain treated with an
opioid medication; average
number of opioid prescriptions
written per patient with pain;
frequency of referrals for
behavioral health and physical
therapy

Greater reduction in the intervention group
for percentage of patients with chronic pain
treated with an opioid medication
(p = 0.002); smaller increase in the
intervention group for number of opioid
prescriptions written per patient with pain
(p = 0.001); frequency of referrals to
behavioral health and physical therapy
(p < 0.001)

Prospective
cohort study
with comparison
group

Percentage of patients with
sustained viral response;
percentage of patients among
whom a serious adverse event
occurred

No difference in percentage of patients with
sustained viral response (p = 0.89); greater
prevalence of serious adverse events
reported in the control group (p = 0.02)

Retrospective
cohort study
with comparison
group

Rate of patients with sustained
virologic response

No significant difference in rates of
sustained virologic response between
providers with versus without SCAN-ECHO
training (p = 0.32)

Exposure group:
1,586 at baseline;
1,485 at follow-up
Control group:
2,020 at baseline;
1,695 at follow-up

Arora,
Thornton, et
al., 2011

HCV

261 patients in
exposure group
146 patients in control
group

Beste et al.,
2017

HCV

6,431 patients in
exposure group
32,322 patients in
control group

Main Patient Outcomes Reported

Carey et al.,
2016

Pain
management

371,646

Spatial reach
analysis

Association between distance to
specialty pain care and being
seen in person at a specialty
clinic; association between
distance to specialty pain care
and access to a Pain SCANECHO participating PCP

Patient distance from home to specialty pain
care associated with 22 percent lower odds
of being seen in person at a specialty care
clinic (p < 0.001); distance from home to
specialty pain care associated with
2 percent lower odds of access to a Pain
SCAN-ECHO participating PCP (p = 0.01)

Catic et al.,
2014

Dementia

47

Prospective
cohort study
without
comparison group

Association between provider
self-reported adherence to
expert recommendations and
provider self-reported (1) clinical
improvement and (2)
hospitalization of their patients

Clinical improvement among patients was
self-reported as greater among those who
adhered to expert recommendations
(p < 0.05); hospitalization among patients
was self-reported as lower among those
who adhered to expert recommendations
(p-value unreported)
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Fisher et al., Dementia
2017

More than
70,000

Semistructured
interviews;
retrospective
cohort study
with comparison
group

Patient health care utilization
and costs at participant
practices, before and after
enrollment in study

Reduction in emergency department costs
($406 to $311; p < 0.05) among those with
mental disorder; increase in outpatient care
utilization and costs among those without a
mental disorder (p < 0.05)

Frank et al.,
2015

22,454 patients in
exposure group

Prospective
cohort study
with comparison
group

Association between case
presentations and (1) delivery of
outpatient care (physical
medicine, mental health, SUD,
and pain medicine), and (2)
medication initiation
(antidepressants,
anticonvulsants, and opioid
analgesics)

Patients whose case was presented during
training sessions had greater likelihood of
utilizing physical therapy (p < 0.05), but not
care for mental health, SUD, or specialty
pain medicine (p > 0.05), compared with
patients whose cases were not discussed.
Patients with presented cases also had
greater likelihood of initiation on
antidepressants and anticonvulsants
(p < 0.05), but not an opioid analgesic
(p > 0.05)

Retrospective
cohort study
with control
comparison

Patient time to liver
consultation; patient distance
traveled to care

SCAN-ECHO liver consults were completed
an average of 9.6 days sooner than in the
Liver Clinic (p-value unreported); average
patient distance traveled to the Liver Clinic
was 250 miles round-trip (p-value
unreported)

2:1 matched
cohort study

Percentage of patients
receiving antipsychotic
medications; percentage of
patients physically
restrained; nine other
secondary outcomes

Patients at participant facilities were
marginally less likely to be physically
restrained than patients at nonparticipant
facilities (p = 0.05), and less likely to be
prescribed antipsychotic medication (p =
0.07). Patients at participant facilities were
less likely to experience a urinary tract
infection

Chronic pain

299,981 in nonexposure group

Glass et al.,
2017

Chronic liver
disease

582 in exposure group
1,395 in comparison
group

Gordon et al., Dementia
2016

Unknown
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Katzman et
al., 2018

Chronic pain
management

Unknown

Prospective
cohort study
with comparison
group

Prescription rates of opioid
Clinics participating in the intervention
analgesics and coprescribing of (ECHO Pain) showed greater declines in
opioids and benzodiazepines
opioid prescriptions than did comparison
facilities (–23 percent versus
–9 percent, p < 0.001); days of coprescribed
opioids and benzodiazepines also declined
more (p < 0.001)

Mohsen et
al., 2018

Hepatitis C

100 in exposure group

Retrospective
cohort study with
a comparison
group

Percentage of patients with
direct acting antiviral therapy
initiated; percentage of patients
who complete their regimen;
percentage of patients with
sustained virological response

Treatment was initiated among 78 percent
of intervention patients versus 81 percent of
those in a TLC; 89 percent of intervention
participants completed treatment—of those,
87 percent had sustained virological
response compared with 86 percent and 96
percent, respectively, in the TLC group.
Statistical significance not reported

Prospective
cohort study
with comparison
group

30-day readmission rates;
30-day total cost of care;
average length of stay at the
skilled nursing facility; 30-day
mortality rate

Readmission was lower in the intervention
group (p = 0.04); adjusted 30-day cost was
lower in intervention group (p < 0.001);
average length of stay at skilled nursing
facility was shorter in intervention group
(p < 0.001); 30-day mortality rate was not
significantly different between groups
(p = 0.11)

Provider-reported benefits to
patients

Respondents reported that patients
attending their practice benefited from
ECHO training

100 in comparison
group

Moore et al., Geriatric care
2017

Exposure group:
213 at baseline,
148 at endline
Comparison group:
220 at baseline,
214 at endline

Ní Cheallaigh Hepatitis C
et al., 2017

Unknown

Participant
semistructured
interviews

Su et al.,
2018

513 in VA
SCAN-ECHO group;
62,237 in comparison
group

Retrospective
All-cause mortality among
cohort study with patients who received a SCANcomparison group ECHO visit, propensity score
matched to patients who
received no visits

Chronic liver
disease

99

Main Patient Outcomes Reported

Propensity-adjusted mortality rates showed
that a SCAN-ECHO visit was associated
with a hazard ratio of 0.54 (p = 0.003)
compared with no visit

Citation
Watts et al.,
2016

Health Content Patients in
Area
Evaluation

Evaluation
Design

Diabetes

Pre-post study
Mean glycated HbA1c value
design without
(glycemic control) at intervention
comparison group sites before and after
intervention; comparative levels
of HbA1c > 9.0 percent at
intervention and comparison
sites at baseline and endline

39

Main Patient Outcome
Measures

100

Main Patient Outcomes Reported
Mean HbA1c improved from 10.2+/–
1.4 percent to 8.4+/–1.8 percent (p < 0.001)
over the average follow-up period of five
months, not explained by systemwide
changes or improvements; comparative
increase in HbA1c scores at comparison
sites (p < 0.05)

Appendix D. Studies Considered as Examples of EELM
Evaluations

The studies in this appendix were considered when developing examples of potential
evaluations of EELM with differing levels of methodological rigor and complexity. These
studies were all program evaluations, although none evaluated an EELM program.
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Table D.1. Example Program Evaluations (n = 41 studies)

Content
Area

Population and
Setting
Time Line

Digital Tools for
Coping with
Chronic Pain
Study Record:
USNLM, 2018i

Chronic
pain

200 adult and
older adult
patients with
opioid
prescriptions for
chronic pain at
sites in different
geographic
regions of the
United States

Extension
Connection
Evaluation
Study Record:
USNLM, 2017as
Project
Description:
USNLM, 2018n

Dementia 60,000 older
adult patients,
2 cohorts:
(1) Medicare
beneficiaries with
dementia;
(2) Medicare
beneficiaries
residing in
nursing homes
(with or without
dementia) in
Iowa

Study Title

•
•

•
•

Funder

Intervention: My
2017–2019 Strength,
Inc.
Study
funding:
Unknown

Intervention:
Unknown
Study
funding:
2013–2018

Outcome
Measurement Primary
Award Amount Study Design Period
Outcome(s)
Unknown

PatientTotal:
Centered $1,626,680
Outcomes
Research
Institute
(PCORI)
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Contact

Double-arm
Baseline
RCT with wait + 6 months
list control and
1:1
randomization

Improved
function;
outlook on
pain;
perception of
prescription

Krista
Schladweiler, PhD
(kschladweiler@
mystrength.com);
Abigail Hirsch,
PhD (ahirsch@
mystrength.com)

Retrospective Baseline
observational + up to
analysis of
4 years
county-level
controlled
intervention

Antipsychotic
use;
anticholinergic
use

Ryan Carnahan,
PharmD, MS
(ryan-carnahan@
uiowa.edu)

Study Title

Content
Area

Population and
Setting
Time Line

Dementia 221 adult and
older adult
Hispanic family
member
caregivers of
patients with
dementia in New
York, New
Jersey, and
Connecticut

•

Translation of
Dementia 582 older adult
COPE for Publicly
patients in a
Funded Home
public home care
Care Clients and
programs in
Their Families
Connecticut with
Study Record:
dementia or
USNLM, 2018g
Alzheimer’s
Project
Description:
USNLM, 2018r

•

Optimizing Care
for Patients with
Dementia
Study Record:
USNLM, 2018h
Project
Description:
USNLM, 2018p

•

NorthernManhattan
Hispanic
Caregiver
Intervention
Effectiveness
Study
Study Record:
USNLM, 2016c
Project
Description:
USNLM, 2018o

Dementia 80 nursing home
practices that
serve older adult
patients with
dementia or
Alzheimer’s
residing in LTC
facilities in 10
geographic
regions of the
United States

•

•

•

Funder

Outcome
Measurement Primary
Award Amount Study Design Period
Outcome(s)

Contact

Intervention: NIH
2014–
unknown
Study
funding:
2013–2018

2013:
$533,205
2014:
$542,090
2015:
$754,811
2016:
$594,828
2017:
$520,583

Double-arm
Baseline
RCT with
+ 6 months
active
comparator
and 1:1
caregiver-level
randomization

Caregiver
depressive
symptoms;
caregiver
burden

José A.
Luchsinger,
MD, MPH (jal94@
columbia.edu)

Intervention: NIH
Unknown
Study
funding:
2014–2019

Total:
$671,600

Double-arm
Baseline
RCT with
+ 4 months
usual-care
comparator
and 1:1
patient-level
randomization

Functional
dependence

Richard H.
Fortinsky, PhD
(fortinsky@
uchc.edu)

Intervention: PCORI
Unknown
Study
funding:
2018–2023

Total:
$4,722,108

Double-arm
Baseline
RCT with
+ 18 months
active
comparator
and practicelevel
randomization

Receipt of
off-label
psychotropic
medications

Natalie E. Leland,
PhD
(NEL24@pitt.edu)
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Study Title

Content
Area

Population and
Setting
Time Line

Care Ecosystem: Dementia 780 adult and
Navigating
older adult
Patients and
patients with
Families Through
dementia who
Stages of Care
are insured by
Study Record:
Medicaid or
USNLM, 2017ak
Medicare and
Project
their primary
Description:
caregivers in
USNLM, 2017e
California,
Nebraska, and
Iowa

•

A FamilyCentered
Intervention for
Acutely Ill
Persons with
Dementia
Study Record:
USNLM, 2017av
Project
Description:
USNLM, 2017ad

Dementia 438 older adult
patients who are
hospitalized with
very mild to
moderate
dementia; and
their caregivers,
at 3 hospitals in
Pennsylvania

•

EPIC: An
Intervention for
Early-Stage AD
[Alzheimer’s
Disease] Dyads
Study Record:
USNLM, 2018c
Project
Description:
USNLM, 2017g

Dementia 160 adults and
older adult
patients with
early-stage
dementia who
live at home; and
their family
member
caregivers in
Arizona and
Nevada

•

•

•

•

Intervention:
Unknown
Study
funding:
2017–2022

Funder

Outcome
Measurement Primary
Award Amount Study Design Period
Outcome(s)

NIH/
2017:
National
$1,168,825
Institute on
Aging (NIA)

Double-arm, Baseline
Quality of life
RCT with a no- + 12 months
intervention
arm and
patient-level
randomization

Intervention: NIH/NIA
2017–2021
Study
funding:
2017–2022

2017:
$612,352

Double-arm
RCT with a
no-intervention
arm and
cluster
patient-level
(dyad-level)
randomization
within hospital
site

Intervention: NIH/NIA
2017–2021
Study
funding:
2016–2021

2016:
$772,914

Double-arm
Baseline
RCT with a
+ 12 months
wait list active
comparator
arm and
patient-level
(dyad-level)
randomization
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Hospital
admission,
hospital
discharge
+ 6 months
postdischarge

Contact
Bruce L. Miller, MD
(Bruce.Miller@
ucsf.edu)

Physical
Marie Boltz, PhD,
function;
RN
functional
(mpb40@psu.edu)
performance;
physical
activity; delirium
(occurrence
and severity);
neuropsychiatric
symptoms;
depression
Emotional wellbeing of patient
and caregiver;
patient quality
of life

David W. Coon,
PhD
(David.w.coon@
asu.edu)

Study Title

Content
Area

Population and
Setting
Time Line

Aggression
Prevention
Training for
Caregivers of
Persons with
Dementia
Study Record:
USNLM, 2018e
Project
Description:
USNLM, 2017a

Dementia 228 adult
patients with
dementia and
pain or
depression; and
their caregivers
in Texas

•

Aligning Patient
Preferences: A
Role Offering
Alzheimer’s
Patients,
Caregivers, and
Healthcare
Providers
Education and
Support
Study Record:
USNLM, 2017ar
Project
Description:
USNLM, 2017u

Dementia 206 urban and
rural nursing
home practices
in 14 states
(22,650 adult
and older adult
patients)

•

Educational
Dementia 360 older adult
Video to Improve
adults with
Nursing Home
advanced
Care in End-stage
dementia
Dementia
currently residing
Study Record:
in 20 nursing
USNLM, 2017ao
homes in
Project
Massachusetts
Description:
USNLM, 2017ac

•

•

•
•

Intervention:
2015–2018
Study
funding:
2014–2019

Funder

Outcome
Measurement Primary
Award Amount Study Design Period
Outcome(s)

NIH/
Total:
National
$1,184,306
Institute
2015:
of Nursing $507,781
Research

Contact

Baseline
Double-arm
RCT with an + 12 months
enhanced
usual-care
comparator
arm and
patient-level
(dyad-level)
randomization

Aggressive
behaviors

Mark Kunik, MD,
MPH (mkunik@
bcm.edu)

Susan E. Hickman,
PhD
(hickman@Iu.edu);
Kathleen Unroe,
MD
(kunroe@iu.edu)

Intervention: NIH/NIA
2019–2022
Study
funding:
2017–2019

2017: $371,281

Double-arm
Baseline
cluster RCT
+ 12 months
with a usualcare
comparator
arm and
cluster
randomization

Hospital
transfers
(admissions
and
emergency
department
visits)

Intervention: NIH/NIA
2013–2017
Study
funding:
2012–2018

2012: $674,113
2013: $636,622
2014: $664,047
2015: $634,183
2016: $551,506

Baseline
Double-arm
+ 12 months
cluster RCT
with an active
comparator
and 1:1
practice-level
cluster
randomization

Decisions to
Susan Mitchell,
forgo
MD, MPH
hospitalization (smitchell@
hsl.harvard.edu)
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Study Title

Content
Area

Population and
Setting
Time Line

Team-Based Safe Chronic
Opioid Prescribing pain
Project
Description:
USNLM, 2017ae

14 remote, rural
primary care
clinics in
Washington and
Idaho

•

Evaluation of the Chronic
Extension for
pain
Community
Healthcare and
Outcomes
(ECHO) Model for
Pain and Opioid
Stewardship in
Ontario
Study Record:
Canadian
Research
Information
System, 2012
Project
Description:
USNLM, 2017i

Unknown
number of PCPs
from urban and
rural clinics in
Ontario, Canada
at ~19 spoke
clinics in Ontario

•

•

•

Funder

Intervention: AHRQ
Unknown
Study
funding:
2015–2018

Intervention:
Unknown
Study
funding:
2014–2017

Canadian
Institutes
of Health
Research

Outcome
Measurement Primary
Award Amount Study Design Period
Outcome(s)

Contact

2015: $497,386

Unknown

Baseline
+ 12 months

Proportion of
patients with
data in
registry;
change in
monthly
average daily
morphine
equivalent
dose;
proportion of
clinics that
revise policies;
change in staff
self-assessed
use of best
practices

2014–2015:
$105,544
2015–2016:
$126,594
2016–2017:
$143,243
2017–2018:
$24,429
Total: $399,810

Unknown

Unknown

Clinician
Andrea Furlan,
knowledge
PhD (afurlan@
about chronic iwh.on.ca)
pain; clinician
self-efficacy,
attitudes, and
behaviors
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Michael
Parchman, MD,
MPH
(parchman.m@
ghc.org)

Study Title

Content
Area

Population and
Setting
Time Line
•

Medical
Chronic
Strategies for the pain/MAT
Management of
Pain in the
Addicted Patient
Project
Description:
USNLM, 2017r

66 adult patients
with co-occurring
chronic pain
(spinal surgical
procedure) and
OUD at 6
community
practices in
Buffalo, New
York

Virtual
Chronic
Environment
pain
Training in the
Proper Use of
Prescription Pain
Medications
Project
Description:
USNLM, 2017aj

Unknown
number of health
care providers
who prescribe
opioid pain
medications

•

Toward Safer
Chronic
Opioid Prescribing pain
for Chronic Pain
in High-Risk
Populations:
Implementing the
CDC Guideline in
the Primary Care
HIV Clinic
Project
Description:
USNLM, 2017ah

10 HIV PCPs
who have
patients with HIV
and chronic pain
for whom they
prescribe
opioids; and their
patients (~5 per
provider) in New
York

•

•

•

•

Funder

Outcome
Measurement Primary
Award Amount Study Design Period
Outcome(s)

Contact

Intervention: NIH/NIDA
Unknown
Study
funding:
2011–2013

Unknown

Double-arm
Baseline
RCT with an + 9 months
active
comparator
arm and
patient-level
randomization

Self-reported
patient pain
levels

Intervention: NIH/NIDA
Unknown
Study
funding:
2013–2019

2013: $288,784
2015: $493,559
2016: $499,721
2017: $385,867

Double-arm
Unknown
RCT with an
active control
arm and
provider-level
randomization

Provider
Bradley Tanner,
competence, MD (bradtanner@
communication gmail.com)
skills, and
opioid
treatment
behavior

Intervention: AHRQ
Unknown
Study
funding:
2017–2020

2017: $496,708

Double-arm
Baseline + 6
RCT with a
months
usual-care
comparator
arm and
provider-level
randomization

Opioid misuse;
pain control;
antiretroviral
therapy
treatment
adherence;
patient
relationship
with provider
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Richard Blondell,
MD (blondell@
buffalo.edu)

Jessica RobinsonPapp, MD, MS
(jessica.robinson@
mssm.edu)

Study Title

Content
Area

Population and
Setting
Time Line
•

Facilitating Lower Chronic
Opioid Amounts pain
Through Tapering
Project
Description:
USNLM, 2017k

Unknown

Targeting
Effective
Analgesia in
Clinics for HIVIntervention
(TEACH)
Study Record:
USNLM, 2018b
Project
Description:
USNLM, 2017o

41 providers who
are the main
provider for 1+
adult and older
adult patients on
chronic opioid
therapy who are
living with HIV in
Boston,
Massachusetts,
or Atlanta,
Georgia

•

377 adult and
older adult
patients with
chronic pain
receiving
treatment at two
large primary
care clinics in
California

•

Chronic
pain

Patient Activation Chronic
to Address
pain
Chronic Pain and
Opioid
Management in
Primary Care
Study Record:
USNLM, 2017ap
Project
Description:
USNLM, 2017aa

•

•

•

Funder

Outcome
Measurement Primary
Award Amount Study Design Period
Outcome(s)

Contact

Intervention: NIH/NIDA
Unknown
Study
funding:
2017–2020

2017: $381,922

Mixed-method Unknown
study (detail
unknown)

Unknown

David H. Smith,
RPh, PhD
(David.H.Smith@
kpchr.org)

Intervention: NIH/NIDA
Unknown
Study
funding:
2014–2019

2014:
$1,105,595
2015:
$1,106,535

Double-arm
Baseline
RCT with a
+ 12 months
standard of
care control
arm and
collaborative
care teamlevel (i.e.,
provider-level)
randomization

Patient receipt
of urine drug
testing;
percentage of
patients with
early refills;
provider
satisfaction

Jeffrey Samet, MD,
MA, MPH
(Jsamet@bu.edu);
Carlos del Rio, MD
(cdelrio@
emory.edu)

Intervention: PCORI
Unknown
Study
funding:
2014–2018

Total:
$1,928,560

Double-arm
Baseline
RCT with a
+ 12 months
usual care
control arm
and
collaborative
care teamlevel (i.e.,
provider-level)
randomization

Patient
activation
(with regard
to chronic
pain
treatment)

Cynthia I.
Campbell, PhD,
MPH
(cynthia.i.campbell
@kp.org)
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Content
Area

Population and
Setting
Time Line

PRescribing
INterventions for
Chronic pain via
the Electronic
health record
(PRINCE)
Project
Description:
USNLM, 2017z

Chronic
pain

40 primary care
clinics in
Minnesota

A Method to
Increase
Buprenorphine
Treatment
Capacity and
Effectiveness
Project
Description:
USNLM, 2017s

MAT

Study Title

Intervention to
MAT
Expand Opioid
Use Disorder
Treatment
Pharmacotherapy
Prescribers
Study Record:
USNLM, 2017at
Project
Description:
USNLM, 2017ag

•
•

Unknown
number of
patients with
OUD at an
unknown number
of buprenorphine
-certified primary
care settings

•

70 addiction
treatment
organizations in
Wisconsin

•

•

•

Funder

Outcome
Measurement Primary
Award Amount Study Design Period
Outcome(s)

Contact

Intervention: NIH/NIDA
Unknown
Study
funding:
2017–2019

2017: $210,673

RCT with
Baseline
practice-level + 12 months
randomization

Provider
behavior
(detail
unknown)

Ezra Golberstein,
PhD (egolber@
umn.edu)

Intervention: NIH/NIDA
Unknown
Study
funding:
2016–2017

2016: $293,694

Double-arm
Unknown
RCT with a
maintenance
treatmentcontrolled arm

Increased
treatment
retention;
reduction in
illegal drug
use

Julia Shi, MD
(julia.shi@
yale.edu);
Rosalyn Liss

Intervention: NIH/NIDA
2016–2020
Study
funding:
2016–2020

2016: $631,016

Double-arm
Baseline
RCT with a
+ 50 months
control arm
and cluster
practice-level
1:1
randomization

Buprenorphine Todd Molfenter
prescribing
(todd.molfenter@
capacity;
chess.wisc.edu)
extendedrelease
naltrexone
capacity
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Study Title

Content
Area

Outcome
Measurement Primary
Award Amount Study Design Period
Outcome(s)

Contact

Intervention: NIH/NIDA
2014–2021
Study
funding:
2013–2018

2013: $628,726
2014: $678,642
2015: $672,308
2016: $677,777

(1) Double-arm Baseline
+ 24 weeks
RCT with an
enhanced
treatment-asusual control
arm and
individual
patient-level
randomization;
(2) quasiexperimental,
nonrandomized
methadone
treatment
program
observational
arm recruited
in parallel

Time to
relapse to
OUD

Joshua D. Lee,
MD, MS
(Joshua.Lee@
nyumc.org)

Intervention: NIH/NIDA
Unknown
Study
funding:
2017–2018

2017: $223,217

SteppedBaseline
wedge, cluster + 3 months
RCT with
randomization
stratified by
rural vs.
nonrural area

MAT treatment Yih-Ing Hser, PhD
retention
(yhser@ucla.edu);
Larissa J. Mooney,
MD (lmooney@
mednet.ucla.edu)

Population and
Setting
Time Line

ExtendedMAT
Release
Naltrexone Opioid
Treatment at Jail
Re-Entry
Study Record:
USNLM, 2018m
Project
Description:
USNLM, 2017j

255 adults and
older adults with
OUD leaving
New York’s
Rikers Island jail

•

Pilot Test of
MAT
Patient Decision
Aid for Opioid Use
Disorder
Study Record:
USNLM, 2018a
Project
Description:
USNLM, 2017w

60 adult and
older adult
patients with
OUD at an
unknown number
of sites in
California

•

•

•

Funder
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Study Title

Content
Area

Population and
Setting
Time Line

Evaluating the
MAT
Implementation
and Impact of a
Novel MedicationAssisted
Treatment
Program in a
Unified Jail and
Prison System
Project
Description:
USNLM, 2017h

Unknown, at jails
and prisons in
Rhode Island

•

Onsite
MAT
Buprenorphine
Treatment at
Syringe Exchange
Programs
Study Record:
USNLM, 2018l
Project
Description:
USNLM, 2017d

250 adult and
older adult
patients with
OUD who are
not receiving
treatment and
who use needle
exchange
programs in New
York City

•

•

•

Funder

Outcome
Measurement Primary
Award Amount Study Design Period
Outcome(s)

Contact

Intervention: NIH/NIDA
Unknown
Study
funding:
2017–2019

2017: $215,157

Mixed-method Unknown
assessment
(detail
unknown)

Rates of fatal
opioid
overdose

Intervention: NIH/NIDA
Unknown
Study
funding:
2017–2022

2017: $721,387

Double-arm
Baseline
RCT with an + 30 days
active
enhancedreferral
comparator
arm and
patient-level
1:1
randomization

Buprenorphine Aaron Fox, MD
engagement (adfox@
(patients
montefiore.org)
having an
active
buprenorphine
prescription)
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Josiah Rich, MD,
MPH (jrich@
lifespan.org)

Study Title
Long-Acting
Naltrexone for
Pre-Release
Prisoners
Study Record:
USNLM, 2018d
Project
Description:
USNLM, 2017q

Content
Area

Population and
Setting
Time Line

MAT

240 adult and
older adult
patients with a
history of OUD
who are not
currently using
opioids, who are
incarcerated at
one of four
prisons in
Baltimore City
and Baltimore
County,
Maryland, and
who are eligible
for release

•

329 adult and
older adult
patients with
OUD who
present at the
emergency
department in
New Haven,
Connecticut

•

Models of
MAT
Screening, Brief
Intervention with a
Facilitated
Referral to
Treatment
(SBIRT) for
Opioid Patients in
the Emergency
Department
Study Record:
USNLM, 2016b
Project
Description:
USNLM, 2017t

•

•

Funder

Outcome
Measurement Primary
Award Amount Study Design Period
Outcome(s)

Contact

Intervention: NIH/NIDA
2017–2020
Study
funding:
2016–2021

2016: $644,996

Double-arm
Baseline
RCT with an + 12 months
active
comparator
arm and twogroup block
patient-level
randomization
within gender

Treatment
adherence;
illicit opioid
use; re-arrest;
reincarceration;
criminal
activity (selfreported);
injection drug
use; HIV
sexual risk
factors

Michael S.
Gordon, DPA
(mgordon
@friendsresearch
.org)

Intervention: NIH/NIDA
2008–2013
Study
funding:
2008–2013

Total:
$4,818,496
2012: $650,599

Three-arm
Baseline
RCT with a
+ 30 days
usual care
comparator
arm (and 2
experimental
arms), with
patient-level
randomization

Engagement
in SUD
treatment
(self-reported)

Gail D’Onofrio,
MD, MS
(gail.donofrio@
yale.edu)
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Content
Area

Population and
Setting
Time Line

Linking
Hospitalized
Injection Drug
Users to
Buprenorphine
Study Record:
USNLM, 2015b
Project
Description:
USNLM, 2017p

MAT

147 adult
medically
hospitalized
patients with
OUD who inject
opioids and are
completing
inpatient
detoxification in
Providence,
Rhode Island,
and Boston,
Massachusetts

•

Buprenorphine
and Substance
Abuse Services
for Prescription
Opioid
Dependence
Study Record:
USNLM, 2017au
Project
Description:
USNLM, 2017c

MAT

300 adults with
OUD receiving
large outpatient
SUD treatment
program in
Sacramento,
California

•

PeerAdministered
Asthma SelfManagement
Intervention in
Urban Middle
Schools
Study Record:
USNLM, 2018f
Project
Description:
USNLM, 2017y

Asthma

432 Latino
pediatric patients
with current
persistent
asthma at middle
schools in
Providence,
Rhode Island,
and San Juan,
Puerto Rico

•

Study Title

•

•

•

Funder

Outcome
Measurement Primary
Award Amount Study Design Period
Outcome(s)

Contact

Intervention: NIH/NIDA
2009–2014
Study
funding:
2012–2017

2012: $498,068
2013: $461,306
2014: $480,526
2015: $477,241
2016: $475,128

Double-arm
Baseline
RCT with a
+ 6 months
treatment-asusual control
arm and
patient-level
randomization

Opioid use;
HIV risk
behavior

Michael Stein, MD,
(Michael_Stein@
brown.edu)

Intervention: NIH/NIDA
2015–2019
Study
funding:
2014–2018

2014: $543,878
2015: $571,363

Double-arm
Baseline
RCT with a
+ 12 months
usual-care
comparator
arm and
patient-level
randomization

MAT
adherence;
substance use
abstinence;
SUD treatment
utilization
costs; MAT
drug testing
adherence

Cynthia Campbell,
PhD, MPH
(cynthia.i.campbell
@kp.org);
Monique Does,
MPH
(monique.does@
kp.org)

NIH/
2013: $212,708
National
2014: $229,520
Institute of
Child
Health and
Human
Development

Three-arm
Baseline
RCT with an + 12 months
active
comparator
arm and notreatment
control arm,
and with
patient-level
randomization
within site

Asthma
control;
number of
symptom-free
days; asthmarelated school
absence ratio;
lung function

Daphne KoinisMitchell, PhD
(Daphne_KoinisMitchell@
brown.edu);
Glorisa Canino,
PhD
(glorisa.canino@
upr.edu)

Intervention:
2018–2023
Study
funding:
2013–2015
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Study Title

Content
Area

Population and
Setting
Time Line

Promoting
Asthma
Asthma
Guidelines and
Management
Through
TechnologyBased
Intervention and
Care Coordination
(PRAGMATIC)
Study Record:
USNLM, 2017al
Project
Description:
USNLM, 2017ab

512 pediatric
patients with
persistent or
uncontrolled
asthma at 20
practices in the
Bronx, New York

•

Patient
Asthma
Empowered
Strategy to
Reduce Asthma
Morbidity in Highly
Impacted
Populations;
PeRson
EmPowered
Asthma RElief
(PREPARE)
Study Record:
USNLM, 2018k
Project
Description:
USNLM, 2017x

1,200 African
American and
Hispanic/Latino
adult and older
adult patients
with asthma who
are receiving
daily
maintenance
therapy; in ten
states and
Puerto Rico

•

•

•

Intervention:
2017–2021
Study
funding:
2016–2021

Funder
NIH/
National
Heart,
Lung, and
Blood
Institute
(NHLBI)

Intervention: PCORI
2017–2020
Study
funding:
2016–2022

Outcome
Measurement Primary
Award Amount Study Design Period
Outcome(s)
2016: $848,392
2017: $832,065

Double-arm
Baseline
RCT with an + ~5 years
enhanced
usual-care
comparator
arm and
cluster
randomization

Total:
$13,857,788

Double-arm
RCT with an
enhanced
usual-care
comparator
arm
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Adherence to
clinical
guidelines

Baseline
Rate of
+ ~15 months asthma
exacerbations
per year
(related to
number of
emergency
department
visits or
hospitalizations
requiring
corticosteroids
per patient
year)

Contact
Marina Reznik, MD,
MS (mreznik@
montefiore.org);
Guadalupe Salazar
(guadalupe.salazar
@einstein.yu.edu)

Elliot Israel, MD
(eisrael@
partners.org);
Nancy Maher,
MPH (nmaher@
bwh.harvard.edu)

Content
Area

Population and
Setting
Time Line

Asthma

10,400 asthma
patients at 26
primary care
clinics in
Colorado

•

Guidelines to
Asthma
Practice:
Reducing Asthma
Health Disparities
Through
Guideline
Implementation
(G2P)
Study Record:
USNLM, 2015a
Project
Description:
USNLM, 2017l

550 African
American,
Hispanic/Latino,
and low-income
adult and older
adult patients
with uncontrolled
asthma at 40
primary care
clinics in
Minnesota

•

Coordinated
Asthma
Healthcare
Interventions for
Childhood Asthma
Gaps in
Outcomes
(CHICAGO)
Study Record:
USNLM, 2015c
Project
Description:
USNLM, 2017f

640 English and
Spanishspeaking
pediatric patients
with uncontrolled
asthma who
present to the
emergency
department; and
their caregivers,
at clinical centers
in Chicago

•

Study Title
The Breathewell
Program to
Improve Asthma
Outcomes
Project
Description:
USNLM, 2017b

•

•

•

Funder

Outcome
Measurement Primary
Award Amount Study Design Period
Outcome(s)

Contact

Intervention: NIH/
NHLBI
Unknown
Study
funding:
2015–2020

2015: $831,168

Double-arm
RCT with a
usual-care
comparator
arm

Unknown

Asthma
exacerbations;
quality of life;
cost

Intervention: PCORI
2014–2016
Study
funding:
2014–2018

Total:
$3,397,813

Four-arm
factorial RCT
with a usual
care
comparator
arm

Baseline
+ 12 months

Symptom-free James Stout, MD
days; asthma (jstout@uw.edu)
control (selfreported and
spirometry
assessment);
asthma-related
quality of life

Intervention: PCORI
2015–2017
Study
funding:
2014–2018

Total:
$3,999,821

Three-arm
Baseline
RCT with a
+ 6 months
usual care
comparator
arm and
patient-level
randomization
stratified by
race (black vs.
not black) and
clinical center

115

Asthma
impact;
caregiver
satisfaction

Bruce Bender,
PhD
(bruce.bender@
ucdenver.edu)

Jerry Krishnan,
MD, PhD
(jakris@uic.edu);
Helene A. Gussin,
PhD
(hgussin@uic.edu)

Study Title

Content
Area

Population and
Setting
Time Line

Using IT to
Asthma
Improve Access,
Communication
and Asthma in
African American
and
Hispanic/Latino
Adults
Study Record:
USNLM, 2017am
Project
Description:
USNLM, 2017ai

300 African
American,
Hispanic/Latino,
and low-income
adults with
asthma in
Philadelphia

•

A Patient
Advocate to
Improve RealWorld Asthma
Management for
Inner City Adults
(HAP2)
Study Record:
USNLM, 2018j
Project
Description:
USNLM, 2017v

312 adult and
older adult
patients (primarily
African American,
Hispanic/Latino,
and low-income)
with moderate to
severe persistent
asthma and
evidence of
reversible airflow
obstruction in
Philadelphia

•

Asthma

•

•

Funder

Outcome
Measurement Primary
Award Amount Study Design Period
Outcome(s)

Contact

Intervention: PCORI
2014–2017
Study
funding:
2014–2019

Total:
$1,968,004

Double-arm
Baseline
RCT with an + 12 months
active
comparator
arm and
patient-level
randomization

Asthma
symptom
control

Andrea J. Apter,
MD, MSc, MA
(apter@mail.med.
upenn.edu)

Intervention: NIH/
2013–2019 NHLBI
Study
funding:
2013–2018

2013: $693,595
2014: $741,378
2015: $726,347
2016: $720,146

Double-arm
Baseline + 6
RCT with a
months
usual-care
comparator
arm and
patient-level
randomization

Asthma
symptom
control

Andrea J. Apter,
MD, MSc, MA
(apter@mail.med.
upenn.edu)
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Study Title

Content
Area

Population and
Setting
Time Line

Telemedicine
Asthma
Enhanced Asthma
Management
Through the
Emergency
Department
Study Record:
USNLM, 2017aq
Project
Description:
USNLM, 2017af

430 pediatric
patients with
persistent and
poorly controlled
asthma who
present to the
emergency
department with
acute asthma
exacerbation in
Rochester, New
York

•

Breathe with
Asthma
Ease: A Unique
Approach to
Managing Stress
(BEAMS)
Study Record:
USNLM, 2017an
Project
Description:
USNLM, 2017n

250 African
American and
Hispanic
pediatric patients
with uncontrolled
asthma; and
their parents in
Washington,
D.C.

•

•

•

Funder

Outcome
Measurement Primary
Award Amount Study Design Period
Outcome(s)

Contact

Intervention: NIH/
2016–2021 NHLBI
Study
funding:
2008–2021

2009: $774,857
2010: $755,575
2011: $747,418
2012: $743,678
2013: $702,271
2016: $764,084
2017: $748,322

Double-arm
Baseline
RCT with an + 12 months
enhanced
usual care
active
comparator
arm and
patient-level
randomization

Number of
asthma
symptom-free
days

JIll Halterman, MD,
MPH
(Jill_Halterman@
urmc.rochester.edu)
Maria Fagnano,
MPH
(maria_fagnano@
urmc.rochester.edu)

Intervention: PCORI
Unknown
Study
funding:
2014–2018

Total:
$2,245,126

Double-arm, Baseline
single-blind
+ 12 months
RCT with a
usual care
active
comparator
arm and
patient-level
(parent-child
dyad-level)
randomization

Number of
asthma
symptom-free
days

Stephen Teach,
MD, MPH
(steach@childrens
national.org)

Transforming
Chronic
53 PCPs who
Baseline
Provider
Karen Lasser, MD,
• Intervention: NIH/NIDA 2012: $547,501 Double-arm
Opioid Prescribing pain
treat patients
2013: $527,794 cluster RCT
+ 12 months adherence to MPH
2014–2016
in Primary Care
with opioid
2014: $542,116 with an active
chronic opioid (Karen.Lasser@
• Study
(TOPCARE)
medication; and
2015:
$519,474
control
care
treatment
bmc.org);
funding:
Study Record:
their patients
2016: $16,994
comparator
guidelines
Jane Liebschutz,
2012–2017
USNLM, 2016a
(~500 total) in
arm and
MD, MPH
Project
Boston
provider-level
(jane.liebschutz@
Description:
randomization
bmc.org)
USNLM, 2017m
NOTE: DPA = doctorate of public administration; MA = master of medicine; MD = doctorate of medicine; MPH = master of public health; MS = master of surgery;
MSc = master in science; PharmD = doctorate of pharmacy; PhD = doctorate of philosophy; RN = registered nurse; RPh = registered pharmacist.
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Appendix E. Case Studies: Technology-Based Health Care
Collaborative Learning & Capacity-Building Models

With input from the ASPE, we selected EELM that are noteworthy in terms of program
scope, organization, funding, ability to meet local needs, and potential for lessons learned. We
list these cases here as an appendix because many readers of this report might not be very
familiar with EELM. The case studies can serve as a useful complement to the other parts of the
report, enabling readers to gain a more intuitive understanding of what these programs are and
how they might function in practice. In addition, the case studies illustrate the broad variety of
EELM that exist.
There were no formal inclusion or exclusion criteria for a program to be the subject of a case
study. Our main goals were to ensure that each case would embody a unique aspect of EELM.
One case (the Vermont Hub-and-Spoke Program) was included because we had been under the
impression that it was an ECHO-like model, but we later found out that their program did not
quite meet our definition. This illustrates the fact that, in some cases, it can take some additional
research to determine whether a program belongs in this category.
The case studies draw on such information sources as the program’s website and
semistructured discussions with key informants or leaders from each program. We spoke with at
least one leader from each program, usually its founding leader or current director. In many
cases, we had additional semistructured discussions with the program manager or other key
informants, and followed up with additional clarifying questions. In all cases, key informants
reviewed our case study summaries to ensure that there were no factual errors. We also
conducted a purposive review of program websites to fill in gaps in our summaries and to ensure
that we had a full understanding of the programs about which we would be writing.
To facilitate comparisons across cases, each case study follows a similar structure:
•
•
•
•

introduction and brief history of the program
unique aspects of the program
challenges faced and how they were addressed
lessons learned.

In addition, some case studies contain maps or other materials to further illustrate EELM.
Table E.1 provides an overview of the case studies and our rationale for their inclusion.
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Table E.1. Programs Featured as Case Studies
Program

Year Founded

Unique Features/Rationale for Inclusion

Project ECHO UW

2008

First replication of ECHO outside New Mexico; serves a large,
multi-state area

ECHO-Chicago

2010

Focus on underserved urban communities and the issues
impacting them

University of Rochester

2014

Strong integration of sophisticated evaluation, state evaluation
funding, private payer engagement through data-sharing, and
incorporating EELM into new and existing delivery system
reform initiatives

VA SCAN-ECHO

2013

Adaptation of the ECHO model by a federal agency, VA

Vermont Hub-and-Spoke

2013

Statewide learning collaborative as an alternative strategy to
address a demonstrated need; a closely related but not
identical model to EELM

Oregon ECHO

2017a

ECHO with an independent oversight board that includes local
health care payers (Oregon is one of only a few states with a
waiver to use Medicaid funds to support the ECHO model.)

Show-Me ECHO

2015

An example of EELM founded with proactive (and ongoing)
involvement by state-level officials

ECHO Colorado

2016

Program that uses EELM as one of several telehealth delivery
strategies to serve the needs of a state

Weitzman Institute

2012

ECHO program run by, and run for, clinicians practicing in
FQHCs across the nation

a

A pilot program began in 2013; the Oregon ECHO in its current form launched in 2017.

Main Findings from Case Studies
The case studies in this appendix describe the experiences of different organizations with
implementation of EELM, both in response to a range of challenges with health care delivery in
their local contexts and to address the needs of providers in other regions. The programs attempt
to overcome such challenges as physical barriers to accessing specialty care, lack of access to
expertise in a subject area, and lack of resources and support to manage certain health conditions.
Each program has pursued its own mix of support from university advocates, state funding,
federal grants, and private sources. What many of these programs share are (1) a general
enthusiasm on the part of specialist mentors to help their primary care colleagues who are
practicing in remote and underserved areas, and (2) an eagerness on the part of generalist
mentees to learn about subject areas and conditions relevant to their practices with the ultimate
goal of expanding capacity and improving care.
One of the key themes we found was that many EELM exist alongside other mechanisms of
telehealth, including direct-care telehealth and e-consults. Some programs, such as the Show-Me
ECHO, explicitly exist within a broader telehealth initiative and are run by the same entity. Other
programs, such as the Rochester ECHO, emphasized the fluid nature of different telehealth
strategies and frequently refer patients from one telehealth strategy to the other, in the manner of
choosing an appropriate level of care to suit the complexity of the case. EELM, therefore, should
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not be thought of in isolation, but as part of a suite of strategies for telehealth delivery—and
frequently used alongside the other strategies.
We found that EELM are actively involved in learning from each other, adopting best
practices, and soliciting advice across entities. However, EELM must be tailored to their unique
environments, and no one solution can work across all situations. Accordingly, each program
offers its own lessons in how to creatively address barriers, maximize resources, and innovate.
Most sites had one or more strong champions of the program whose dedication and tenacity
seem key to their success.
Another theme we encountered was the importance of human connections in making EELM
“work” for generalist mentees. Investing in understanding the needs of generalist mentees and
engaging in outreach to them are key to sustaining interest in EELM on the part of spokes, and in
securing leadership support for continued participation (as was seen with UW). Key informants
frequently commented on how different subject areas require different designs, different
implementations, perhaps different frequencies and durations of sessions, and even different
approaches to evaluation. The ability to tailor EELM to local needs and to link them with other
interventions is a tremendous strength, conceptually, but measuring their impact can be difficult
when they run concurrently with other service delivery and quality improvement efforts. In
addition, most funding to date has been focused on implementation rather than evaluation.
One of the important sources of variation seen across these case studies is in the role of a
defined geographic area. Programs used EELM as a way to recruit effective specialist
mentors from far away (e.g., Weitzman), to deliver content across state lines (e.g.,
Washington), or, in contrast, to bound their offerings tightly to a particular state because of
funding (e.g., Missouri, Oregon, Colorado, New York) and consequently to the needs of that
state. Some ECHO programs actually focus only on one part of a state; Rochester initially
took this approach, though it shows signs of becoming a statewide program for all of New
York. One program explicitly mentioned the importance of local knowledge by ECHO
specialist mentors as being important for generalist mentees to absorb not only how to
practice medicine (or related disciplines) but also how best to access locally available
resources and feel part of a practice community.
Many programs noted both the advantages and disadvantages of organizing at a state level.
Key advantages include staying close to the needs of the generalist mentees, especially with an
understanding of local issues, such as obtaining needed resources (e.g., food assistance,
medication affordability programs). Key disadvantages of staying within one state include
limiting the possible supply of specialist mentors or possibly forgoing particularly dynamic and
effective hubs located out of state.
Although these case studies represent a snapshot of the diversity of EELM that are in
operation around the United States, they provide important insights into the origins of EELM in
different settings, the features that are unique and common across programs, the challenges that
different programs face and the approaches that they have taken to overcome these challenges,
and the ways they are approaching the evaluation of their work.
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University of Washington
ECHO Across the Pacific Northwest
“Taking the time to do a site visit to a potential spoke before the program begins
goes a long way toward obtaining support.”
—Brian Wood, medical director of the Mountain West AIDS Education and Training
Center ECHO telehealth project (interview, 2018)

Introduction
The UW School of Medicine is the only academic medical center serving the five-state area
of Washington, Wyoming, Alaska, Montana, and Idaho. This area accounts for 27 percent of the
land mass of the United States but less than 5 percent of the population (Scott et al., 2012; UW,
undated). One in four Pacific Northwest residents lives in a rural community, which presents
challenges with access to specialty care. Rural residents are more likely to lack health insurance
or to be part of the American Indian, Alaska Native, or Hispanic minority groups, two factors
associated with difficulty in accessing care.
Brief History of the Program
To address the challenges of geographic access, a team at the UW School of Medicine
established the first ECHO program outside the founding UNM. In 2008, UW launched an HCV
treatment program to connect generalists and specialists across the Pacific Northwest; the
program received funding from RWJF in 2009 (Johnson et al., 2017; Wood interview, 2018;
Wood et al., 2016). In subsequent years, modules were added for other conditions, such as
HIV/AIDS in 2012, tuberculosis in 2015, and antibiotic stewardship in 2017 (Table E.2). There
are currently ten ECHO programs under way at UW, with the aim of serving rural populations
without requiring patients to travel significant distances to be seen in person (Wood interview,
2018).
Recruitment of generalists into the program varies by condition and subject area. For
instance, the HIV program initially focused on recruiting primary care doctors with fewer than
25 HIV patients on their panels. The rationale was that these providers would have less
experience and fewer resources to manage these patients. Over time, the program has expanded
to include any provider who can demonstrate a lack of such resources as clinical support,
colleagues for consultation, or resources for continuing medical education.
UW has developed a method of engaging PCPs by developing personal relationships through
in-person visits to providers to encourage them to join the program, assess technology needs,
begin the mentoring process, and meet with site administrators to encourage buy-in and support.
For example, when starting the HIV program, the UW team spent six months recruiting
generalists, visiting potential sites, meeting administrators, and providing information about the
benefits and functions of the program. They credit this approach to successful recruitment and
retention of sites.
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Table E.2. Project ECHO UW Participating Sites and Clinicians
Service

Launch
Date

Participating
Clinicians

Participating
Sites

Hepatitis C

2008

163

57

HIV/AIDS

2012

157

46

Technical Cooperation Group: Leadership, Surveillance, and Field
Servicesa

2014

169

31

Tuberculosis

2015

175

62

Geriatrics

2015

200

18

Heart Failure

2015

67

27

Psychiatry and Addictions

2016

223

24

Psychosis and Dialectical Behavior Therapy

2017

15

7

Antibiotic Stewardship

2017

71

28

SOURCE: Wood, 2018.
a
The Technical Cooperation Group is not a traditional ECHO program. It was formed as a “pragmatic think tank’” to
allow discussions around best practices and innovation for HIV prevention and care. More details can be found at the
HIV Technical Cooperation Group website (undated).

Unique Features of the Program
In addition to being the first replication site outside New Mexico, UW’s ECHO program is
unique among EELM in various ways. It has expanded to cover several subjects that other
EELM have not addressed, such as antimicrobial stewardship, which focuses on appropriate use
of antibiotics. The geographic reach of the program is extensive, with program sites for their
HIV ECHO, for example, located beyond Washington in seven different states (Figure E.1).
The UW program focuses on evaluating the end-user experience across the range of subjects.
Examples of studies that UW has undertaken include an early study that reported the number of
ECHO conferences and generalist mentees participating (Scott et al., 2012; Scott interview,
2018): 23 different videoconference clinics for HCV, with 263 participating providers at spoke
sites, caring for a total of 399 patients. Of these patients, 167 had started antiviral therapy for
HCV, including 50 who started protease inhibitors, which at the time were newly approved by
the U.S. Food and Drug Administration. Since this 2012 study, participation has increased: As of
early 2018, the program has had more than 2,500 cases presented. Another study, this one on
HIV, focused on provider self-efficacy assessments, reporting a significant increase in
participants’ self-reported confidence to provide various essential elements of HIV care (Wood
et al., 2016). They also found an increase in reports of feeling part of an HIV community of
practice and decreased feelings of professional isolation.
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Figure E.1. Map of UW ECHO Spokes

SOURCE: Map based on data from Wood, 2018.
NOTE: TCG = technical cooperation group.

Although UW was the first site to replicate the ECHO model, the UW program has also
added several customizations and innovations. For example, UW has an informatics specialist
who is tasked with optimizing provider engagement, thinking about details such as camera
angles for the videoconferences and ensuring it is clear who is speaking (Scott et al., 2012; Scott
interview, 2018). Another innovation is the use of interactive polling during ECHO sessions.
Mentees answer questions in real time using their cell phones, which helps keep them engaged
when there are a large number of generalist mentees participating in a session. This strategy has
received excellent feedback from the mentees. Anecdotally, retention of spoke providers in the
UW HIV ECHO program is quite high, with only five providers leaving the program; of these,
two retired and one moved away, leaving only two who actually stopped attending.
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Program Challenges and How They Were Addressed
Three main challenges were identified by UW: funding, recruitment and retention of spoke
sites, and running a program across multiple states.
Securing consistent funding to operate the program has been an ongoing challenge. In
addition to the initial funder (RWJF), UW’s ECHO program has received funding from the
Washington State Department of Health, the CDC, and HRSA, as well as internal funding from
the UW School of Medicine (Scott interview, 2018). Intense effort has been devoted to writing
grants, soliciting contracts, working with policymakers, and thinking about creative ways to pay
for the program. Most of the funding now goes to cover salaries of people involved (most
significantly the specialist mentors) and, as technology to execute the program has become
inexpensive, to cover the administrative time required to organize sessions. Funding is critical
for sustainability, but grants are often time-limited and typically do not include resources for
evaluation.
A second challenge relates to the rolling enrollment and its impact on cultivating
relationships with and between sites. New providers join those who have participated in an
ECHO program for years, so each of the spoke sites has different experience levels and baseline
knowledge of the subject. UW has handled this challenge by calling upon more-experienced
participants to act as experts or answer questions for less-experienced participants—mainly to
engage the former more fully despite their growing expertise.
The UW hub reaches to sites far outside of Washington state, which presents other
challenges. Although ECHO’s design allows for spoke sites to be located at a distance, the
geographical dispersion across multiple states and time zones can make recruitment and site
visits more laborious. UW has also faced challenges of local and state differences in medical
practice, including local reporting guidelines and differing reimbursement, making it sometimes
hard to offer practical or logistical guidance about topics associated with accessing medical care
through a broad program. The approach of using experienced generalists as experts, along with
the relationship-building emphasized by this hub, has helped with some of these challenges.
Lessons Learned
•

•

•

Efforts to obtain buy-in (such as in-person visits to recruit generalists) and to
maximize retention through careful attention to the structure of each session
(including technology use, such as live polling) have yielded high retention rates in
certain programs.
Although EELM can benefit patients in many ways, such as decreased wait times or
improved quality of care, these models are ultimately a provider-focused intervention,
and recruitment efforts need to focus on those providers who require the most support.
Grants to support EELM thus far have supported implementation more than
evaluation.

• It is feasible to have spokes spread across several states, with some challenges.
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University of Chicago
Building Capacity Across the Greater South Side with ECHO-Chicago
“ECHO fits perfectly with what I’m trying to do, which is to build capacity.”
—Daniel Johnson, director of ECHO-Chicago (interview, 2018)

Introduction
Improving primary care workforce capacity and ameliorating racial and ethnic disparities in
access to quality care are two primary objectives of ECHO-type programming at ECHOChicago. The average wait time to see a pediatric psychiatrist for a child receiving primary care
through an FQHC in South Side Chicago has been as many as 93 days (Patrick et al., 2011)—an
issue that ECHO-Chicago has been helping to address with its work on pediatric ADHD. At free
and charitable clinics or safety-net health care organizations that do not receive federal funding,
there are similar challenges in securing specialty referrals for low-income and Medicaid-insured
patients. Barriers in access to specialty care for residents of South Side Chicago, the population
of which is at least 93 percent black, are especially troubling given increasing black-white
disparities in health and disproportionate mortality among blacks because of preventable
conditions (Hunt and Whitman, 2015).
Brief History of the Program
ECHO-Chicago was the second replication of Project ECHO outside of UNM, and it was the
first to apply the ECHO model to an urban area (Johnson interview, 2018). Its program features
collaborations with the Illinois Association of Free and Charitable Clinics, the South Side
Healthcare Collaborative, American Academy of Pediatrics, Americares, the University of
Chicago’s Urban Health Initiative, and an extensive list of FQHCs and area health departments,
among others (University of Chicago, undated-a).
The founding leadership of ECHO-Chicago first learned about the Project ECHO model in
2009. Later that year, members of leadership at several Chicago FQHCs accompanied ECHOChicago leadership on a trip to UNM to learn more about ECHO. Seeing the value of the model
for existing efforts to build workforce capacity, the Chicago team selected resistant hypertension,
one of the most prominent health problems in its FQHC communities at the time, as its first
subject area (Johnson interview, 2018).
It took approximately a year for the ECHO-Chicago team to prepare, identify a funding
stream for the program, and build relationships with six interested FQHC community partners. In
November 2010, ECHO-Chicago launched its first ECHO project, delivering two complete
series of the curriculum in the first year of operation. The program was well received by the six
FQHC partners, who heartily expressed interest in establishing additional ECHO-Chicago
programs. Program organizers received feedback from FQHC spoke sites that their clinicians
were “happy” and “seemed to be learning more” (Johnson interview, 2018).
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Before selecting another subject area, the ECHO-Chicago team approached its FQHC
partners to ask where the need and interest was greatest. The suggestion by the providers at the
time was to establish a pediatric ADHD program. Although the prevalence of diagnosed ADHD
was approximately 1 percent among the pediatric populations of the FQHC partners,
epidemiological data suggested an actual prevalence of ADHD closer to 7–9 percent. In
accounting for the disparity, providers explained that they were electing not to diagnose ADHD
or even screen for it in many cases, given that wait times were more than a year for referrals to
specialists. In other words, the inability to adequately treat or refer for ADHD in these settings
had been affecting the rate of diagnosis. Three years into the ECHO-Chicago Pediatric ADHD
program, data showed that 4–6 percent of pediatric populations in the spoke clinics were being
diagnosed with ADHD, which is closer to the estimated prevalence (Johnson interview, 2018).
Building on the success of these early programs, ECHO-Chicago continued to expand into
new subject areas (Figure E.2).
Figure E.2. Time Line of ECHO-Chicago Series Launch Events
Complex pediatric
asthma
Risk-based
approach to
women's health

Resistant
hypertension

2010

HCV

2011

2012

2013

2014

Comprehensive care learning
collaborative

Geriatrics

Trauma-informed care

BHI systems
collaborative care

SMI

2015

2016

2017

2018

Geriatrics for SNFs
Pediatric ADHD

Pediatric obesity &
comorbidities

OUD
Child & youth epilepsy
(terminated in 2016)

BHI clinic management
HCV case management

SOURCE: Johnson interview, 2018; Migliaccio et al., 2017.
NOTE: BHI = behavioral health integration; SMI = serious mental illness; SNF = skilled nursing facility

Although HCV was a signature condition treated by Project ECHO, providers at ECHOChicago spoke sites did not initially think that the condition was much of an issue in the patient
populations served by their clinics (Johnson interview, 2018). The CDC estimates that 45–85
percent of the 3.5 million Americans living with HCV are unaware of their infection (Smith et
al., 2012), and many of the providers in ECHO-Chicago spoke sites not commonly treating HCV
in their clinics were not testing for HCV infection (Johnson interview, 2018). In response, the
ECHO-Chicago Hepatitis C Community Alliance to Test and Treat (HepCCATT) collaboration
was launched, establishing a network of public health departments, advocacy and community
groups, academic medical centers, and corporate partners to raise HCV awareness, improve the
quality of care in safety net primary care settings, and support the development of an HCV
surveillance and monitoring system for the city of Chicago (University of Chicago, undated-b).
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The HepCCATT programs are funded by the CDC, and approximately 15 percent of HepCCATT
programming and activities are ECHO-related (Johnson interview, 2018).
In 2015, ECHO-Chicago launched its sixth subject area: Child and Youth Epilepsy. This
curriculum was not very popular with generalist mentees: In its second year, the only interested
generalist mentees were school nurses who said that they were witnessing seizures in classrooms
and wanted training on how to handle those situations and manage the follow-up for children and
youth with epilepsy. A combination of different factors could have played a role in determining
provider interest, including epilepsy not affecting a sizable percentage of patients in their
practices and providers feeling uncomfortable with the initial management and follow-on
treatment of the condition. Many providers also did not seem to view pediatric epilepsy as a
significant threat to public health, and it is possible that this perception also influenced the lack
of interest in this series (Johnson interview, 2018).
Chicago’s ECHO program is now a superhub, meaning it can train other ECHO hub sites.
Unique Features of the Program
FQHCs and Free and Charitable Clinics

A strength of the ECHO-Chicago program is its relationships with FQHCs and free and
charitable clinic partners. Improving health care access and health outcomes for medically
underserved populations (MUPs) and in medically underserved areas (MUAs) is one of the
stated goals of EELM (Public Law 114-270), and the FQHCs and free and charitable health
clinics that make up the primary care safety net are the chief providers of care to the medically
underserved.9 MUPs and MUAs in the Greater Chicago area are shaded in Figure E.3.

9

HRSA defines MUAs as geographic areas (census tracts in metropolitan areas or counties in nonmetropolitan
areas) with a shortage of primary care health services according to the population to provider ratio, the percentage of
population living below the federal poverty level, the percentage of the population over age 65, and the infant
mortality rate (Kleinsorge, 2016). Population MUPs are defined as populations living within an MUA, such as
homeless, low-income, Medicaid-eligible, Native American people, or migrant farmworkers (HRSA, 2016).
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Figure E.3. Chicago MUAs/MUPs

SOURCE: Data from HRSA, undated.

Urban Focus

As previously mentioned, ECHO-Chicago was the first to use the concept of EELM to apply
the solutions that address barriers to continuing education in rural settings to the workforce
capacity challenges in urban safety net settings. PCPs at clinics that do not have an affiliation
with a hospital or academic medical center, in particular, might find it difficult to keep up with
best practices and evolving treatment recommendations. Patients using these clinics might be
challenged by economic and social distance and by the difficulties arising from the cost and time
required to travel from one location to another within a city.
Focus on Black Populations

ECHO-Chicago’s focus on blacks is a significant aspect of its program. Disparities in health
and associated mortality between black and white populations are prominent across many
different disease areas and conditions (e.g., HIV, heart disease, diabetes, cancer) (U.S.
Department of Health and Human Services, Office of Minority Health, 2017). Perceived
discrimination is among the factors thought to contribute to racial disparities in health in the
United States (Bacon et al., 2017; Bailey et al., 2017; Cozier et al., 2014; Lukachko,
Hatzenbuehler, and Keyes, 2014). By increasing the quality of culturally competent care
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provided to black patients by PCPs within their communities, ECHO-Chicago seeks to
ameliorate racial disparities in health.
Program Challenges and How They Were Addressed
Product Branding

Success of each program, in terms of participation and interest, depends on whether potential
generalist mentees think that a subject is of value to them. Provider interest in a given curriculum
might be determined by perceptions about the prevalence of a condition among the patients in
their practices or the extent to which generalists think an intervention has the potential to make
them competent in a particular clinical area. In the case of ECHO-Chicago, the way that projects
were named and marketed had a great deal to do with the degree of provider interest. In
designing a program to address racial disparities in women’s health and breast cancer outcomes,
for example, the team discovered that an ECHO called “Cancer Survivorship” generated very
little interest among potential generalist mentees while an ECHO with a very similar curriculum
named “Risk-Based Approaches to Women’s Health” was broadly appealing. Potential generalist
mentees, reacting to the way the program was being promoted, told organizers that “cancer is a
scary word,” and the project leadership concluded that the way programs are publicized is
important (Johnson interview, 2018).
Funding

Securing and sustaining program funding is another challenge. ECHO-Chicago has not
received any state or city funding. It is seeking funding through Section 1115 of the Social
Security Act (Johnson interview, 2018), which provides for funding of pilot and demonstration
projects that serve Medicaid populations (Centers for Medicare and Medicaid Services, undated).
The primary source of ECHO-Chicago funding has been from private foundations, and the
program has had success in seeking federal money for projects that combine ECHO into other
programs. The HepCCATT program, for example, was primarily designed for testing and
treatment, but 15 percent of the total funding is allocated to be spent on ECHO curriculum for
HCV. Despite securing federal funding for some ECHO programing, the long-term sustainability
of the model at ECHO-Chicago remains challenging (Johnson interview, 2018).
Evaluation

Another challenge has been the difficulty of gathering data for evaluation. The program has a
standard set of procedures built into every curriculum in which generalist mentees complete prepost surveys focused on self-efficacy and an additional post-survey asking about the quality of
the program and any self-reported behavior changes that have resulted from completing the
ECHO curriculum. Determining individual patient outcomes via chart reviews is costly and
requires the program to bring in an evaluation team or to work with students at the University of
Chicago. As another strategy, in the past, the ECHO-Chicago team has obtained state Medicaid
data to look at prescribing patterns. The process of requesting and obtaining the data from the
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state took a year and a half, in addition to considerable staff time to fill out paperwork and follow
up on various stages of the application. The Medicaid data set was also large enough that the
program needed to hire an outside evaluator to complete the analysis.
The need to demonstrate program impact and return on investment makes evaluation of the
ECHO-Chicago curricula an important program objective. To address the challenge of cost and
time required for systematic data collection and analysis, the program has built a partnership
with Alliance-Chicago, a nonprofit committed to providing health information technology
support to community health agencies that treat underserved populations. Through its
collaboration with Alliance-Chicago, ECHO-Chicago spoke sites at nine FQHCs have obtained
access to an electronic medical record platform and corresponding data warehouse that are
designed specifically for FQHC treatment settings, and which could help support future analyses
(Johnson interview, 2018).
Lessons Learned
•

•
•

•

EELM might have utility in cities and in rural areas, especially in underserved
neighborhoods and communities of color, by increasing access to specialty care. An
estimated 54 percent of people worldwide resided in urban areas in 2014, and
projections suggest that 70 percent of the global population will be living in urban
locales by the year 2050 (United Nations, Department of Economic and Social
Affairs, Population Division, 2015).
Diagnosis rates might be suppressed when there is inadequate access to specialists.
How a program is framed and publicized matters: Programming with the title “Cancer
Survivorship” was intimidating to providers whereas similar programming titled
“Risk-Based Approach to Women’s Healthcare” attracted more interest (Johnson
interview, 2018).
Providers’ perceptions of the extent to which a health condition is a public health
issue, or is a condition they commonly manage, could shape provider willingness to
participate.
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University of Rochester
EELM Supported by State Funding
“We wanted to do a good evaluation and speak to sustainability
beyond the grant.”
—Michael Hasselberg, Rochester ECHO program director (interview, 2018)

Introduction
In 2013, the University of Rochester Department of Psychiatry was having trouble keeping
up with the demand for geriatric psychiatry consults, and there were long waits to see a provider.
The private New York State Health Foundation was specifically interested in funding an effort
that relied on the ECHO model. To take advantage of this funding opportunity, providers and
researchers from the University of Rochester teamed up with a large commercial insurer in the
local market (Excellus), and sent several attendees from the University of Rochester and
Excellus to visit Project ECHO in New Mexico to learn how to run an ECHO model (Hasselberg
interview, 2018).
Brief History of the Program
With widespread interest from PCPs, Rochester launched the first ECHO-based program in
New York State in September 2014, on the subject of geriatric mental health (see Figure E.4 for
a map of participating sites). Generalist mentees indicated that only a small subset of their
patients fit into this category, however. Therefore, they requested a program focusing on mental
health conditions across the lifespan, which was founded in January 2017. To date, Rochester
has expanded into 13 content areas, including LTC, palliative care, and hospital medicine.
Each rollout of a new subject was planned to enable a rigorous evaluation, such as by
ensuring the availability of patient-level data and by building in a control group. Some
evaluations used mixed methods; others used special project design considerations. For example,
one project limited provider eligibility to the ACO to which the University of Rochester belongs,
both to allow better access to data and to help ensure that the program benefits the ACO’s
bottom line. Numerous entities have contributed to evaluations in other ways, including Excellus
(which shared data) and the New York Academy of Medicine (which shared data and ran
analyses).
The Rochester ECHO model was proactive about soliciting and incorporating end user
feedback. Generalist mentees stated that weekly sessions lasting 90 minutes were too frequent
and too long. The sessions were quickly reduced to 60 minutes every other week for most
conditions.
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Figure E.4. Project ECHO Geriatric Mental Health for Primary Care

SOURCE: Hasselberg, 2018.

Unique Features of the Program
Rochester’s ECHO model has secured funding from different sources, such as private
foundations, HRSA, the New York State Department of Health, and the New York State Office
of Mental Health. At times, the Rochester model benefited from fortuitous circumstances. For
example, as members were preparing to start an ECHO in LTC, there was a Medicaid reform
effort in New York State funded by a Delivery System Reform Incentive Payment (DSRIP)
waiver project entitled “Behavioral Interventions Paradigm in Nursing Homes.” With the
incentives provided by this DSRIP program, many LTC facilities in the Rochester region elected
to be part of a project to improve behavioral health in LTC. This encouraged many LTC facilities
to sign up as spoke sites for Rochester ECHO’s related offering. Later, through its adult
behavioral health offering, Rochester ECHO helped respond to a second DSRIP in New York
State, entitled “Behavioral Health Community Crisis Stabilization Services.”
This diversified funding has enabled rapid program growth and a statewide reach. The
Rochester ECHO now essentially leads all efforts at EELM on behalf of the state government,
which is becoming increasingly enthusiastic about supporting such efforts. Recently, the New
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York State Office of Mental Health issued a contract with Rochester to replicate its LTC model
throughout the state.
Program Challenges and How They Were Addressed
One key challenge has been a lack of sufficient interest around certain conditions, which has
led to ending sessions in some subject areas. Despite having strong content leadership, some
ECHO programs are too subspecialized in disease focus to be successful because many clinicians
have only a few such patients in their panel. These programs might have had constrained
enrollment and limited sustainability that necessitated ongoing financial support.
A second key challenge has been balancing different subject areas. The Rochester ECHO
staff have learned that it is important not to offer too many programs in the same region—even if
they are on different subjects—because the potential generalist mentees can become “saturated.”
For example, an established ECHO in geriatric mental health had a noticeable decline in
participation after a new ECHO program focusing on palliative care was offered within the same
region of the state. Several PCPs have said that blocking out time in their schedule to attend one
ECHO program is difficult and that blocking out time to attend multiple ECHOs is almost
impossible. Thus, the Rochester ECHO has had to be strategic in choosing what to offer,
balancing the goals of maximizing participation, meeting the needs of the communities that the
spoke sites serve, and being mindful of the demands on PCPs’ time.
Lessons Learned
•

•
•

•
•

When possible, it is important to plan for evaluation from the very beginning of a
program because this can help make a case with decisionmakers and funders to
continue supporting the program.
Sometimes it can be difficult to attract enough generalist mentees to sustain a
program on a less-common clinical condition.
Partnering with a state Department of Health can help increase funding—as well as
program reach and impact—but creates an imperative to justify one’s impact on an
ongoing basis. The Rochester ECHO has met this imperative in part by incorporating
sophisticated evaluations of many of its offerings.
There is a limit to the number of offerings from EELM that a market can bear before
generalist mentees’ capacity to engage becomes saturated.
Anticipating priorities for state-level or other funders can ease implementation of a
new program, as with Rochester’s foray into LTC. Relatedly, positioning EELM to
concord with new and existing delivery system reform initiatives can help secure
funding and support.
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VA SCAN-ECHO
Adapting EELM to a unique system of care
“We had a need to demonstrate the impact of our program to justify continued
support. . . . I had to engage site-level program leaders to work on measures that
would demonstrate value, such as return on investment, to enable continued
funding and resource support.”
—Susan Kirsh, former acting director,
VA Office of Specialty Care Transformation (interview, 2018)

Introduction
VA has historically placed high value on access to care. Although VA has made sure that the
great majority of veterans live within 30 miles of a VA health care facility, sometimes these
facilities are community-based outpatient clinics, which are similar in capability to a small
primary care practice. Patients visiting these clinics who need referrals to specialty care might
need to travel to the parent VA Medical Center (VAMC), which could be located tens or even
hundreds of miles away. Many VA patients are reimbursed for such travel, meaning that both
patients and the VA system bear this cost. Therefore, there is a clear imperative to find ways to
obviate the need for such travel whenever possible while maintaining high-quality care. In
addition, VA received negative attention in 2014 as a result of complaints about wait times for
care, which added urgency to efforts to increase access.
Brief History of the Program
In 2013, the Office of Specialty Care Transformation (OSCT) in the VA Office of Specialty
Care was embarking on a new effort to institute a range of different options for delivering
specialty care to distant patients. This featured a mix of strategies, such as e-consults,10 miniresidencies,11 and direct provision of care via telemedicine. After a meeting with UNM’s Arora,
key OSCT staff selected the ECHO model as part of this multimodal approach alongside other
telehealth strategies (Kirsh interview, 2018). OSCT developed a request for proposals, inviting
VAMCs to apply for grants that would support setting up an ECHO program called SCANECHO. Participating VAMCs submitted proposals for programs to address a variety of medical
conditions and subject areas, including women’s health, pain management, HCV, diabetes, and
many others. Twelve VAMCs from across the country were ultimately selected to be part of this
national program and to set up a local franchise of SCAN-ECHO. Each received a $1 million
grant in year 1, followed by progressively smaller grants in subsequent years ($500,000 in year
2; $250,000 in year 3; and then no funds).
10

An e-consult allows a specialist to consult on a patient through chart review and by answering a specific question
from the generalist, without the patient traveling or being seen by the specialist, either in person or otherwise.

11
A mini-residency is a series of webinars or in-person sessions that attempts to increase the ability of a generalist
clinician to handle a specific problem. The format is usually primarily didactic. While there might be case
presentations, the cases are usually developed by the instructor.
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Many of the local SCAN-ECHO programs performed their own evaluations, either out of
academic interest or a need to justify the continued existence of the program. Soon after SCANECHO began, OSCT also requested proposals for a national evaluation of all the SCAN-ECHO
programs, together with an evaluation of other telehealth strategies (especially e-consults).
A mixed-methods evaluation, co-led by two VA Health Services Research and Development
Centers, began soon after SCAN-ECHO’s inception; an interim report was released in 2015, and
the evaluation continues. Briefly, the interim report found that many PCPs were highly
enthusiastic about the program but that many had difficulty obtaining release time to attend the
sessions. Thus, attendance was sometimes limited, despite a high degree of enthusiasm. Support
from site-level and Veterans Integrated Service Networks (VISN)-level leaders was mentioned
as a key facilitator to effective implementation of SCAN-ECHO—and a key barrier when not
present.
Unique Features of the Program
Several features of SCAN-ECHO align with the structure of VA. Most of the SCAN-ECHO
networks were set up within VISNs, the then-21 geographic units that are used to organize VA
care delivery (see Figure E.5). Because patient care dollars, referral networks, and even video
links are specific to individual VISN units, there are few incentives to expand SCAN-ECHO
programs beyond a single VISN—and there are considerable hurdles to doing so. As a result,
efforts to address a particular condition with a SCAN-ECHO program might occur in parallel in
two or more VISNs, with the leaders of such programs being aware of the other programs and
sharing ideas, but in most cases maintaining separate programs.
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Figure E.5. Map of VA’s VISNs and SCAN-ECHO Hub Sites

Initial funding was intended to support such activities as program administration, outreach to
potential spoke sites, and coverage for the cost of the expert telementors (i.e., the specialists but
not the generalist mentees). In such a system of care as VA, clinicians are salaried, but they are
still subject to productivity targets; therefore, supervisors must grant what is called “release
time” for any time they spend in activities other than patient care—even worthy activities.
SCAN-ECHO programs typically contained specific funds to cover the cost of release time for
specialists who develop and deliver content but not for generalist attendees.
Grant funding was intentionally reduced after the first few years because the program was
expected to be self-supporting after year 3; i.e., funds to support buy-in from leaders at the VISN
and the VAMC level would no longer be needed. In anticipation of the funding drop-off, many
of the SCAN-ECHO programs used some of their grant funding to engage in evaluations to
quantify their contribution to care delivery at the VAMC and/or the VISN level. The results of
these evaluations were then used to help justify requests for continued funding from local
VAMC or VISN leaders. Other programs obtained matching funds from other VA entities, such
as VISN- or national-level offices of rural health.
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SCAN-ECHO is also noteworthy for being inspired by the original ECHO model but not
necessarily bound to each detail of it. SCAN-ECHO has been adapted to fit the needs of the VA
context, with variation in the number and frequency of mentoring sessions, the content of the
case-based learning, and even the use of video technology rather than conference calls. Where
these details have been changed, the adjustments represent tailoring of the model to meet local
circumstances.
Program Challenges and How They Were Addressed
One of the key challenges facing SCAN-ECHO, as for many EELM, is the issue of obtaining
release time for generalist mentees. Generalist mentees would need to secure support from
supervisors for release time, during which it is understood that the provider would not be seeing
patients. Supervisors must be cognizant of facility-level productivity targets, and therefore might
not be able to honor all generalists’ requests. The system’s use of release time leaves supervisors
to choose which programs are worthy of release time, with SCAN-ECHO programs being only
one “good cause” to which the limited resources of release time might be devoted.
SCAN-ECHO programs have addressed this challenge in various ways. Clinicians could
attend programs during their lunch hour, if they are highly motivated and if clinical care
demands allow. Requests for release time have also been incorporated into appeals to VA- or
VISN-level leaders to support the SCAN-ECHO program itself, along with justification in the
form of evaluation results. Nonetheless, the lack of available release time has been a barrier in
some cases that ultimately ended the SCAN-ECHO program in question.
A second key challenge is that, although SCAN-ECHO had some degree of central funding
and coordination in its early years, the funding might end in the near future. There is no national
clinical lead for the SCAN-ECHO program; some local programs have become self-supporting,
relying on local VISN or VA-level funding, but two have ceased to exist. Although ten of the
original 12 programs continue to exist and do coordinate activities to some degree, they do so
without the benefit of significant national-level direction or guidance.
Lessons Learned
•

•

•

Developing EELM as part of a multipronged approach to increase access to specialist
care can generate enthusiasm for implementation but also make it harder to isolate the
effects of the program from those of other interventions being implemented
simultaneously.
Balancing fidelity to the ECHO model and the need to tailor to local circumstances is
a key tension in our evaluation of EELM. Here, VA SCAN-ECHO epitomizes a
program that chose to emphasize tailoring to local circumstances, possibly at the
expense of fidelity in some cases.
A lack of compensation for PCP time spent attending sessions is a crucial barrier to
implementation—both in the VA setting, where compensation is measured in internal
funds, and in settings where providers directly reduce their own profit by spending
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•

•

time in activities other than patient care. Incorporating a model of compensation for
both specialists’ and generalists’ time might be crucial to participation in programs—
and, therefore, their sustainability.
Programs that are developed in a highly decentralized environment with limited seed
funding (a common situation for new EELM) will need to rely on a high degree of
entrepreneurship to continue.
It is important for programs to evaluate their own impacts to effectively make the
case to funders and stakeholders for the value they add—and, thus, for their continued
existence.
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Vermont Hub-and-Spoke
One State’s Response to the Opioid Crisis
“We didn’t hear about Project ECHO until we’d already been doing our thing for
several years. So it’s home grown.”
—John Brooklyn, one of several informal leaders of the
Vermont Hub-and-Spoke model (interview, 2018)

Introduction
When Dr. John Brooklyn, a family medicine doctor practicing in Vermont, first got the idea
for a “hub-and-spoke” treatment model for OUD in 2011, the escalating opioid crisis was just
beginning to attract widespread public attention nationwide (Brooklyn interview, 2018). Rates of
unintentional deaths in the United States due to prescription opioid overdose had quadrupled
between 1999 and 2011 (Chen, Hedegaard, and Warner, 2014), and the number of Vermonters
seeking treatment for OUD was increasing rapidly (Simpatico, 2015). As of 2002, there was no
MAT for OUD available in the state of Vermont, and residents were forced to travel to other
states to receive care. Although MAT programs began to form after 2002, wait lists for care were
long and the nearest methadone or buprenorphine clinics were often many miles away. At the
same time, many trained buprenorphine prescribers were not providing any OUD care in their
practices. Brooklyn and others were determined to lower the barriers to quality OUD care, and
the Vermont Hub-and-Spoke was their proposed solution (Brooklyn interview, 2018).
Brief History of the Program
The Vermont Hub-and-Spoke program was established in 2013 with the support of the
Governor, Vermont Medicaid, the Vermont Department of Health, commercial insurers, and the
Vermont Blueprint for Health. It was designed to increase access to MAT for OUD by increasing
the number of trained buprenorphine prescribers with the expertise and the confidence to take on
new patients throughout the state. This program established a referral and treatment network of
hubs and affiliated spoke sites throughout the state. As the program grew, more hubs were added
throughout the state (see Figure E.6).
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Figure E.6. Map of Vermont Program Hub Locations

SOURCE: Rawson, 2017; Vermont Department of Health, undated.

All of the three most-common medications used to treat OUD—methadone, buprenorphine,
and naltrexone—are used in the Hub-and-Spoke model. Methadone is a full opioid agonist that
must be administered under observation in licensed, accredited Opioid Treatment Programs
(OTPs) on a daily basis, according to federal regulations (42 C.F.R., Part 8). Naltrexone can be
given as an oral medication, or more often as a long-acting injection. Buprenorphine is a partial
opioid agonist that was approved for use in the United States in 2002; it can be administered in
office-based settings by certified providers who have Drug Addiction Treatment Act of 2000
(DATA 2000) waivers, or special approval to prescribe buprenorphine under the Drug Addiction
Treatment Act of 2000 (SAMHSA, 2016). The Vermont MAT program focused almost
exclusively on methadone and buprenorphine (rather than naltrexone). Each of the hubs was an
accredited OTP that had authority to administer both methadone and buprenorphine, and each of
the spoke sites were established buprenorphine prescribers in office-based opioid treatment
(OBOT) settings.
The hub-and-spoke model was built on the belief that better triage of patients according to
OUD illness severity was key to improving access to treatment for all Vermonters with OUD. In
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this model, individuals with severe or unstable OUD are directed toward more-structured
treatment with methadone or buprenorphine in the hubs (i.e., the fully resourced, centrally
located OBOT clinics). Conversely, individuals with less severe OUD are retained for treatment
in local OBOT clinics at the spokes (Brooklyn interview, 2018). As individuals receiving OUD
treatment cycle through the various stages of recovery, including periods of relapse and sobriety,
they can be triaged between treatment programs. The reasoning is that during periods of relapse
or instability, the more-structured treatment setting in the hubs might be better for patient care.
People who are more established in recovery might require less structure and therefore be better
suited to receiving buprenorphine in OBOT settings.
Health Home teams, composed of one registered nurse and one master’s-level behavioral
health clinician, were created early in the Vermont Hub-and-Spoke program through funding
from the Affordable Care Act. Specifically, funding came from the Act’s Section 2703, which
allows a monthly rate, subsidized by Medicaid or a state grant, to pay for the creation of such
teams, provided that they deliver one standard clinical service and one medical service per
month. The teams were deployed at no charge to the OBOT prescribers and formed the basis of
the spoke team. Separate specific trainings for hub-and-spoke prescribers and for the MAT teams
were created, with spoke training focused on the use of buprenorphine in OBOT settings. Spoke
physicians who completed MAT training also received continuing support from the addiction
specialists at the hub sites as questions arose related to patient care (Brooklyn and Sigmon,
2017). Buprenorphine training and prescriber support is an ongoing characteristic of the Huband-Spoke program.
Whether patients present at a spoke or a hub, they can enter a system that includes an
assessment of both OUD severity and any psychiatric comorbidity at the hub, where a
determination about triage can be made. Those who screen positive for needing methadone are
required to go to a hub to receive the medication. However, patients screened to receive
buprenorphine could receive that medication at either spoke sites or the hub site. Hospitals,
emergency rooms, residential programs, community mental health clinics, and Department of
Corrections facilities also act as entry points into the Hub-and-Spoke system by referring a
person with OUD to one of the hubs or spokes for entry into treatment (Brooklyn and Sigmon,
2017).
Unique Features of the Program
We were not certain that this program was an ECHO-like model at the outset, and we
eventually learned that it does not meet the formal definition. This program’s differences from
other EELM lie mainly in its use of in-person training, multidisciplinary teams, and referral
pathways. However, the model attempts to solve many of the same issues and uses many of the
same tools. We therefore felt it was worth including here, despite the key differences from other
EELM.
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In-Person Training
Vermont conceptualizes its Hub-and-Spoke program differently from other EELM, which
have operationalized hub and spoke to mean a network of spoke generalist clinicians who are
connected by technology-enabling mechanisms to specialist providers at hubs (UNM, undated-f).
In Vermont, however, the training is mainly conducted in person. Spokes are regional clinics
with generalist providers who administer buprenorphine treatment; hubs are centralized clinics
that have OTPs for methadone treatment and specialists who have expertise on both methadone
and buprenorphine. Most EELM are also designed so that the majority of patients can stay in
their spoke clinics with their local primary care clinicians to receive treatment. Vermont Huband-Spoke requires patients to leave their local clinics and travel to the hub site if the severity of
the OUD illness warrants supervised daily dosing with buprenorphine or conversion to
methadone.
Vermont Hub-and-Spoke uses a learning collaborative that includes in-person meetings and
occasional webinars to achieve its aim of increasing clinician and health system knowledge.
Similar to typical EELM, the in-person training of Vermont Hub-and-Spoke is provided by
specialists at the hub sites to generalists at the spoke sites. Unlike EELM, however, technology
such as videoconferencing is used only when needed, not as the primary enabling mechanism for
training sessions (Brooklyn interview, 2018).
Additional spoke MAT team clinician and nurse education takes place during monthly inperson meetings of regional learning collaboratives, conducted in groups of approximately
20 spoke providers to share lessons learned and best practices (Rudolph et al., 2014). Vermont
Hub-and-Spoke thus builds networks among local communities of spoke providers for peer
collaboration, as well as consultation networks between spoke buprenorphine prescribers and
hub addiction specialists.
Comprehensive State Program

Also unlike typical EELM, the Vermont Hub-and-Spoke features a system of statewide
supports and services that are specific to treatment of OUD. A key feature of the Vermont Huband-Spoke model is that it is focused at increasing capacity to treat OUD, but it also emphasizes
making improvements at the level of the health system rather than expanding the capacity of
individual generalist clinicians to treat OUD. A statewide set of evidence-based practices in
MAT were developed and established for the purposes of the program, and all providers
generally adhere to the same treatment recommendations and standards. The model also provides
each spoke clinic with a MAT team made up of one registered nurse and one behavioral health
clinician per 100 Medicaid patients receiving buprenorphine treatment. The MAT team handles
patient drug tests, buprenorphine prescription refill and insurance authorizations, oversight of the
Vermont Prescription Monitoring System, and the provision of brief counseling and case
management services to spoke patients. A centralized quality monitoring program of all sites—
hubs and spokes alike—is provided by the Vermont Blueprint for Health (Brooklyn and Sigmon,
2017). The program uses economies of scale to provide standardized services to Vermonters
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across the state. Both the hubs and spokes can provide six different health home services that
enhance the integration of care for the individual and also provide associated systems to ensure
payment whether the service is provided in the hub (using an enhanced payment system) or in
the spoke (nonbillable). These six services are comprehensive case management, care
coordination, health promotion, transition of care, individual or family support, and referral to
community services. This model allows for robust collaboration with community agencies and
the medical community to create linkages to all types of services.
Referral Pathways

The bidirectional flow of patient referrals according to illness severity distinguishes the
Vermont Hub-and-Spoke from other EELM. In an attempt to optimize the match between
provider and OUD patient, the Hub-and-Spoke triage process determines which patients are best
suited to treatment by hub sites and which patients can receive adequate treatment at spoke
locations. Although spoke providers receive buprenorphine training and ongoing support, the
goal is not to bring their competence to a level that allows them to deliver treatment to morecomplex cases that are treated at the hubs—a similar feature to other EELM. Instead, the goal is
to provide spoke physicians with training in a limited area within OUD treatment and to increase
the rate of referral of complex cases from the spokes to the hub sites.
Multidisciplinary Care Teams

Individuals with OUD frequently experience co-occurring substance use and mental health
conditions which can complicate treatment. These individuals typically require more support
from their primary care teams and might also have increased social needs. They might need help
with housing, or they could be experiencing food insecurity precipitated by periods of
unemployment, or they might have weakened supportive social networks resulting from opioid
use. This dimension of OUD is addressed in the Hub-and-Spoke model by using a
multidisciplinary team-based approach to care that treats OUD as a chronic condition (Jaffrey,
2018). It is a model that encourages triage according to illness severity, ensuring that the higherneed patients receive care in the treatment settings that are best equipped to provide
comprehensive care. By leaning on specialist providers at the hubs for teleconsultation as
required, the model also frees up provider time to focus on patients who are deemed the most
appropriate for OBOT in spoke settings.
Program Challenges and How They Were Addressed
An early challenge faced by the Vermont Hub-and-Spoke was the nature of its sparsely
populated geography. By the U.S. Census definition of rurality—in which any territory that is
not otherwise included in an urban area, or areas of fewer than 2,500 people, are considered rural
(U.S. Census Bureau, undated)—Vermont is the state with the second largest percentage of its
residents living in rural areas. Such a context made it difficult for the designers and implementers
of Vermont Hub-and-Spoke to provide both structured and less-structured treatment settings in
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all parts of the state to Vermont residents with OUD. Low population density can make it more
difficult to deliver appropriate health care services, particularly when such services require
treatment from specialized clinicians and in specialized settings. Program implementers had to
think strategically about the geographic distribution of need in determining where to locate the
more highly structured hub treatment sites. The development of new methadone treatment
facilities is also expensive, and Vermont Hub-and-Spoke implementers had to justify the need
for such programs in sparsely populated parts of the state. By creating a statewide program,
Vermont Hub-and-Spoke established regional centers that could provide access to specialist
providers and specialized methadone clinics to residents all over the state. It also committed
itself to being responsive to residents in all parts of the state regardless of population density.
When the program first started, there were wait lists at the hub sites, and patients were
required to schedule appointments for new patient assessments in advance. Since September
2017, all hub sites have featured open access treatment in which any prospective patient can
show up at a hub to be assessed for and receive treatment. Also since September 2017, there
have been no wait lists at any of the hub treatment sites (Brooklyn interview, 2018). One critical
change to the model was to create new hub sites to address the volume of patient demand. What
started out as five hub sites and corresponding treatment regions has since been expanded to
eight (Brooklyn and Sigmon, 2017). The system is more integrated now than it was at its
inception: All spoke physicians have access to MAT teams for care coordination, case
management, and health promotion services. These teams also create a connection between hubs
and spoke providers because they are based at the hub site and spend one day per week at each of
the spoke offices to manage care coordination activities. There are an equal number of people
(approximately 4,000 patients) in each treatment region, which ensures that there is adequate
treatment capacity at each of the hub sites throughout the state (Brooklyn interview, 2018).
Another ongoing challenge to the Hub-and-Spoke model is the need for appropriate and
timely triage of patients at hubs and spoke sites throughout the course of treatment. Despite
established procedures and a statewide assessment protocol for making such determinations,
ensuring that patients are receiving the most appropriate level of care can be difficult. OUD is a
cyclical and chronic disease for many people, often characterized by periods of relapse and
recovery that require differing levels of treatment and structure. There have been some reports of
patients in the Vermont Hub-and-Spoke program who are kept at the hub level for OUD
treatment longer than is clinically necessary. Other patients have reported that, rather than
referring them to the hub for more-structured treatment after they relapsed to opioid use, their
spoke doctors discontinued care (Lopez, 2017). The challenge of coordinating referrals and
treatment for patients with OUD throughout Vermont is ongoing, and generally such difficulties
are being addressed through the continued education and support of program physicians, MAT
nurses and behavioral health clinicians, and other program staff.
These efforts have resulted in meaningful improvements in the quality of care for OUD, as
documented by in a 2016 manuscript. Specifically, the investigators tracked seven process-ofcare measures, such as documentation of an OUD in the record, the percentage of patients seen
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weekly, and the percentage of patients whose state prescription monitoring system record was
checked at least quarterly. Performance at participating sites improved on six out of seven
measures; for four, the difference was statistically significant.
Lessons Learned
•
•

•

Programs that are coordinated at the state level might be well-positioned to address
the challenges associated with delivering treatment in sparsely populated areas.
Various options exist to meet the same demands that can be met by EELM. Here, a
program was developed around the concept of a learning collaborative, an approach
that shares many features with EELM (ongoing mentorship, creating community,
capacity-building) but also has important differences (run democratically without
experts; meetings are less frequent, face-to-face, and run all day; most work takes
place in between meetings). In the case of the Vermont Hub-and-Spoke system, the
program appears to be meeting the local needs. This implies that EELM are not the
only effective approach to addressing unmet needs for specialty care, even in rural
areas.
As is true with many EELM, this program works well because clinicians feel a clear
need to increase their capacity to address OUD in Vermont—as opposed to a model
driven primarily by an expert who wants to share his or her expertise.
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Oregon ECHO
Organizing as a Core Utility to Serve the Needs of a State
“Our goal was to develop a statewide infrastructure for ECHO in Oregon.”
—Ronald Stock, director, Oregon ECHO (interview, 2018)

Brief Program History
Oregon’s foray into the ECHO model began with the confluence of several entities and
funding sources. The state’s Medicaid program, known for pursuing innovations in care delivery,
received funding from the CMS Center for Medicare and Medicaid Innovation’s (Innovation
Center) State Innovation Models Initiative Model Test Awards Round One to establish a
Transformation Center in 2013. As part of this initiative to transform care delivery, Oregon
formed several large Medicaid Coordinated Care Organizations (CCOs) that manage care for the
majority of the state’s Medicaid recipients (CMS, 2018).
As these CCOs looked for ways to deliver better care and to control costs, the ECHO model
was one of the top considerations, especially given the success of VA SCAN-ECHO within the
state. In 2013, a large CCO began a three-year pilot ECHO program using state money from the
Innovation Center’s award grant on the subject of adult psychiatric medication management.12
The success of this pilot and a favorable return on investment led to great demand by other
CCOs to develop a similar program. Oregon then set out to develop a statewide ECHO program,
with Oregon Health and Science University (OHSU) as a partner and with the CCOs, the State
Health Agency, and others as stakeholders.
In July 2016, the Oregon Rural Practice-based Research Network (ORPRN), a division
within OHSU, began a nine-month needs assessment, exploring the requirements for a statewide
ECHO program. In April 2017, ORPRN reported to the state on what would be needed to build
and sustain an ECHO network. Later that year, a new group containing representatives from
ORPRN, several CCOs, and the Transformation Center was chartered as the Oregon ECHO
Network (OEN). The Oregon ECHO has added multiple subject areas, and OEN is planning for
its second year of operations with an advisory council that meets on a quarterly basis for
planning and steering meetings.
Unique Features of the Program
Oregon ECHO has four ongoing ECHO programs in 2018 with four more in development for
2018–2019. Each is funded separately, with infrastructure provided by the OEN. Sometimes the
specialist mentors are drawn from OHSU, but not always. Current offerings are SUD, liver
disease, behavioral health, and mental health in LTC settings. The LTC offering was initiated at
the urging of the Oregon Health Authority, which had learned about a similar program at the
12

Claims regarding favorable return on investment are based on information shared during the discussion; these
have not been published.
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Rochester ECHO and wished to replicate it in Oregon. This LTC model was based heavily on the
program run by the Rochester ECHO.
As an ECHO program that began relatively recently, Oregon ECHO has sought ideas and
best practices from other ECHO programs. In addition to consultations with Project ECHO of
UNM, the architects of Oregon ECHO estimate that they have had ongoing conversations with
approximately eight other hubs.
The Oregon ECHO has an internal evaluation group as part of the core services it provides.
All sessions are evaluated on user satisfaction and changes in self-efficacy. Currently, evaluation
results are used for internal quality control to improve program delivery (rather than for adding
to the evidence base for ECHO through peer-reviewed publications). Some subject areas have
begun to generate opportunities to do more-rigorous evaluations, such as their receipt of
Minimum Data Set (MDS) data from the state. MDS data are used to evaluate care in LTC
facilities; thus, they could be used to help evaluate the impact of the Oregon LTC ECHO.
Oregon ECHO staff have begun to consider applying for funding from such entities as NIH, but
they have not yet done so because it would require a more research-oriented focus than they have
had to date.
Program Challenges and How They Were Addressed
As with other ECHO programs, a key challenge has been how to ensure financial
sustainability. The OEN currently relies on three primary sources of funding:
1. grants, including money from the 21st Century Cures Act and from CMS
2. stakeholder fees (paid by CCOs as part of joining the OEN) and subscription fees
(usually by the parent institutions of ECHO generalist mentees rather than the mentees
themselves)
3. contract fees from entities that wish to start up an ECHO program and enlist the services
of the OEN (dubbed the “private pay” model—as an example, a CCO recently enlisted
OEN’s assistance in organizing an ECHO program aimed at community health workers).
The OEN steering committee continually considers the ideal balance of these three funding
sources. The current proportion funded by grants is 60 percent, a number the committee hopes to
reduce over time. The committee also expects the number of subscribing organizations to
increase over time because several organizations that “sat out” from participating in the first
OEN advisory council have expressed an interest in being included soon, given the continuing
success of the program. Some CCOs are also trying to find ways to build the cost of ECHO
subscription into their fee structure.
Another challenge facing many ECHO hubs is how to remain focused on clear and
achievable goals. To this end, the Oregon ECHO has a clear set of priorities that help guide its
decisions. OEN aims to be:
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•

•
•

an efficient and sustainable “utility,” or a center providing services to all qualified
users within the state, under a single centralized destination for ECHO services in
Oregon
a user-centric program rather than an academic-centered one, driven by the needs of
ECHO mentees, as opposed to the desire of content experts to deliver content
dedication to collecting and addressing participant feedback for internal quality
improvement purposes.

Given these priorities, leaders select subject areas for their programs with input from
generalist mentees and the OEN advisory council, being careful not to saturate the community
with too many offerings. Subjects tend to be on clinical conditions with a clear need (HCV, HIV,
frail elderly, SUD, management of psychiatric medications) or serving groups of clinicians who
might feel especially in need of support (clinicians in LTC settings, nurse practitioners). Oregon
ECHO plans to add more programs oriented toward facilitating quality improvement rather than
a specific clinical discipline or disease. This requires a different perspective than other ECHO
programs because patients are not discussed one at a time as part of the practice of quality
improvement. Rather, when discussing a case about quality improvement, mentees refer to it as a
“practice situation.”
Lessons Learned
•

•

•
•

•
•

The Oregon ECHO has made several conscious choices in terms of how it is
organized and what it chooses to emphasize. These choices can be considered as
possible options by other EELM looking to similarly organize.
The Oregon ECHO program can be considered a sustainable “utility” on behalf of a
state, with participation from an academic center, but not ownership by them or any
other entity.
A needs assessment, conducted prior to launching the program, helped ensure
alignment of topics covered with local needs and priorities.
Governance of EELM can be set among multiple entities if a clear statement of
priorities is developed to guide programming choices and a plan for financial
sustainability is articulated.
Diversified sources of funding can help ensure uninterrupted program funding.
Similar to many ECHO programs formed more recently, Oregon ECHO elected to
limit the amount of time, typically to one year, that cohorts of generalist mentees
spend in each ECHO program. These limits help the program secure a strong level of
commitment from generalist mentees during that period and also facilitate pre- and
post-program evaluations. The program has not yet formally compared the effect of
different program durations on participation.
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•

•
•

Close participation and financial support from large Medicaid CCOs in the state can
help support both EELM and alignment with transformation initiatives within the
state’s Medicaid program.
Oregon ECHO maintains close contact with other large and successful EELM and
shows evidence of actively borrowing some of their most successful ideas.
To date, Oregon ECHO has focused on strong implementation rather than the
generation of academic evidence, peer-reviewed publications, or research grants.
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University of Missouri
Show-Me ECHO
“A big barrier to expanding ECHO beyond one’s state is that advice that works in
one place may not work in another.”
—Rachel Mutrux, senior program director for the Missouri Telehealth Network,
parent organization of Show-Me ECHO (interview, 2018)

Introduction
Missouri is a very rural state: In 2016, it had just over 6 million residents, more than onequarter of whom lived in rural areas (see Figure E.7) (U.S. Department of Agriculture, 2018).
Show-ME ECHO is a state-based implementation, covering several different topics and has
spread across the state, funded through appropriation of state funds.
Figure E.7. Map of Missouri’s Urban, Rural, and Most Rural Counties

SOURCE: U.S. Department of Agriculture, 2018.
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Brief History of the Program
A group of staff working on telehealth issues in Missouri, in coordination with a retired state
representative and a current state representative, became interested in ECHO and traveled to
UNM to learn more about the project. Their visit in December 2013 prompted efforts that led to
the passage of 2014 legislation to establish Show-Me ECHO under the Missouri Telehealth
Network (undated-a). This network works in concert with the Heartland Telehealth Resource
Center, a federally funded network that covers Missouri, Kansas, and Oklahoma (Heartland
Telehealth Resource Center, undated). The legislation passed, but a veto on spending prevented
the appropriation of any immediate funding. Instead, separate funding from the Missouri Primary
Care Association and the Missouri Telehealth Network was secured for a pilot. In partnership
with the Missouri Primary Care Association, Show-Me ECHO opened a pilot ECHO program
that focused on chronic pain management. A second effort, focused on autism, was funded by a
Medicaid managed care organization looking to partner on telehealth (see Figure E.8).
Figure E.8. Time Line for Show-Me ECHO Program Start Dates

Child Psych
Chronic Pain Management

Dermatology

2014

HCV

2015

Opioid Use Disorder
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Asthma

2017
Community
Health Worker
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Healthcare Ethics

SOURCE: Missouri Telehealth Network, 2017.

With two pilots already under way, the $1.5 million bill to fund Show-Me ECHO was
reintroduced in the 2015 appropriations cycle and passed, and the program was extended to
cover HCV, autism, dermatology, and asthma. Since then, the program has been funded through
state appropriations, though funding for FY 2018 was limited to $1.3 million.
Current ECHO offerings include chronic pain, HCV, dermatology, autism, and asthma. In
2017, Show-Me ECHO started an OUD program, in alignment with a targeted focus on the issue
at the state level both within the executive (State Department of Mental Health) and the
legislature. They also have a child psychiatry ECHO, one focusing on community health
workers, and one on health care ethics, through a partnership with the Rural Emergency Trauma
Institute, a nonprofit organization in West Virginia whose mission is to support and improve
West Virginia’s rural trauma system through research, data, and analysis. Topics covered
included when to obtain a formal ethics consultation, medical futility and when to stop treatment,
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duty to inform patients, and the obligation not to abandon someone in need of assistance. Thus
far, Show-Me ECHO sessions overall have been attended by health care professionals from
217 different health organizations in 62 of Missouri’s 114 counties (Mutrux interview, 2018).
Unique Features of the Program
Missouri’s Show-Me ECHO receives considerable financial support, given its state funding
and its relationship with the telehealth resource center and the Missouri Telehealth Network. The
program is highly integrated into other telehealth efforts in Missouri, with a common staff
running all state-based telehealth-related efforts, such as EELM, direct-delivery telehealth, and
other initiatives. This is in contrast to the programs at UNM, where telemedicine and ECHO are
run as separate programs and staffed by different people.
In Missouri, not all the hubs are at the University of Missouri, as the relevant expertise might
not be located at academic centers. In the child psychiatry subject area, for example, many
sessions are led by people who might not have academic credentials but do have deep and longstanding knowledge of how resources can be accessed in local school districts, counties, or
towns. Relatedly, Show-Me ECHO has emphasized the importance of understanding local
cultural norms and tailoring medical and health service offerings to align with them (see
Figure E.9).
The direct funding of Show-Me ECHO by the Missouri state legislature is unusual. The
program has had unanimous bipartisan support since initiation. One result of the source of
funding is that the program leaders feel an obligation to the state because they are using taxpayer
dollars. As Rachel Mutrux, the Telehealth senior program director, said, “We want to be
responsible with those dollars, and legislators want to know what their return is on this” (Mutrux
interview, 2018).
One measure of program success has been a steady advance in the ability of spoke generalists
to accurately diagnose skin conditions. When program staff started the dermatology subject area,
the initial diagnosis submitted with cases matched the final expert diagnosis 37 percent of the
time; this rate has increased to 77 percent to date. Program staff also note that ten melanomas
have been found through the dermatology program, although it is unclear how many would have
been found in any event.
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Figure E.9. Map of Show-Me ECHO’s Hubs and Spokes

SOURCE: Missouri Telehealth Network, 2017. Used with permission.

The Show-Me ECHO program also makes an effort to use specialist mentors from multiple
sites throughout the state. In part, this is because of politics, as staff endeavor to maintain broad
support in the state legislature by ensuring that specialist mentors are drawn from as many
districts as possible; in part, this reflects a recognition that the University of Missouri is not the
sole repository of expertise in the state. In addition, there are other reasons to favor geographic
diversity, most notably that experts located in different communities might understand local
realities and local resource availability. This understanding of local needs and resources is also a
point of pride for the program. A Missouri provider could attend an HCV ECHO session run out
of New Mexico and could receive excellent clinical advice, but this would not help the provider
answer questions related to securing payment or finding local contacts, which is seen as another
benefit of the program.
Lastly, Show-Me ECHO is one of ten official Project ECHO–approved “superhubs,”
meaning the site is authorized to train others in how to set up their own ECHO clinics (Missouri
Telehealth Network, undated-b). This demonstrates that the ECHO Institute has confidence that
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the program can “train and support hubs within the ECHO model while maintaining fidelity to
the ECHO model” (UNM, undated-b).
Participation statistics from 2017 are shown in Table E.3.
Table E.3. Participation Statistics, Show-Me ECHO, January–December 2017
Overall numbers

•
•
•

169 sessions
549 CME hours
803 unique individuals

Missouri participation

•
•
•
•
•

652 unique individuals
130 unique physicians (doctors of medicine and osteopathic medicine)
26 FQHC organizations
217 health care organizations (including satellite sites and departments)
62 counties and the City of St. Louis

Out-of-state participation

•
•

151 unique individuals
86 organizations

Promotion

•
•

16 statewide conference exhibits
39 Telehealth and Show-Me

ECHO presentations

•
•

5 ECHO posters presented
24 media placements

SOURCE: Missouri Telehealth Network, 2017.

Program Challenges and How They Were Addressed
As with other implementers of EELM, the implementers of Show-Me ECHO cited funding,
evaluation, and spoke recruitment as their biggest challenges (Mutrux interview, 2018).
Funding

Although the program has secured a state appropriation, its funding is still subject to changes
in the political landscape over time, meaning it could be subject to cuts or might not be renewed
in future years. The current year’s decrease in funding shows the potential vulnerability of
depending on one source for the majority of funding, even for a program with apparently broad
support.
Evaluation

It is hard to determine the number of people touched by Show-Me ECHO, which in the view
of program staff is key to understanding impact. Missouri staff suggested that it is likely that
there is a multiplier—that for each trainee or case presented, some larger number of patients are
affected—but that multiplier is hard to determine and could differ by condition. It is not clear
how many patients will be similar enough to those presented for the training experience to
improve treatment of other patients. As one key informant asked, “What is the multiplier, 20 or
30? In child psych, it’s probably high, and in dermatology, too, but maybe in autism it’s just
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limited to those children with autism or the question of autism. Figuring out that multiplier of the
patient impact is really hard” (Mutrux interview, 2018).
As with other EELM, multiple efforts are under way at the same time. For example, there is
an active listserv of providers around OUD, and they consult each other for advice. This simple
activity serves the clinicians well, but it can complicate measuring the impact of ECHO alone.
Recruitment

Recruiting generalist mentees at spoke sites has been a continuing challenge, as it has been
for many of the other EELM profiled. Missouri might be the first site to hire a full-time outreach
person to help recruit and retain sites.
Lessons Learned
•

•

•
•

Partnership within a telehealth center can help place the ECHO strategy within the
broader context of all telehealth efforts for the state and make it easier and more
affordable to start new ECHOs by leveraging existing funding and infrastructure for
implementation.
There are advantages to centralization, especially with regard to funding, but there are
also advantages to having multiple local hubs for specific policy and resource
knowledge, and having more than one hub also helps ensure a diverse set of
experiences with local resources and how to access them.
It is difficult to identify a potential multiplier effect in terms of evaluation.
Direct funding by a state legislature creates a particular imperative for accountability
and to demonstrate results.
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ECHO Colorado
ECHO to Meet the Needs of a State
“We tried to avoid a top-down structure—our goal was to ensure that people’s
needs were being met.”
—Fred Thomas, director, ECHO Colorado (interview, 2018)

Brief History of the Program
In 2015, the state of Colorado decided to invest in a statewide ECHO program, run expressly
for the benefit of the state and its citizens. The team began with a one-year planning grant,
funded by the Colorado Health Foundation, which supported the time needed to assess the needs
of potential generalist-mentees in Colorado and to visit successful ECHO programs, including
the pioneering program in New Mexico. Before building any programs, the team traveled around
Colorado, soliciting feedback from end users and stakeholders about what needs the programs
would meet. In 2016, the team began building a program in earnest, incorporating the feedback it
had collected. In that first year, it rolled out 20 time-limited ECHO subject areas (see
Figure E.10), and in 2017, it set up an evaluation core to lead evaluations of all ECHO offerings
(ECHO Colorado, undated).
Unique Features of the Program
Colorado ECHO deliberately embraced a start-up model, which stands in contrast to the more
organic development of early ECHO programs. From the beginning, the program was
distinguished by its goal to serve the entirety of the state according to the state’s priorities.
The relationship between CU and the ECHO program is different than the relationships that
many other ECHO programs have with academia. CU provides certain in-kind resources, such as
hosting the Zoom network, but it has no “ownership” of ECHO Colorado. The program is a
chartered independent program with ties to both the university and the state. Thus, unlike some
other ECHO models, the university participates in the program, but does not dominate it.
ECHO Colorado has begun to attract a lot of interest from potential participants, both experts
to deliver content and generalist mentees to receive it. Program staff have chosen partners
selectively; for example, they partnered with the Kempe Center to deliver content regarding child
abuse and neglect to geographically isolated teams in some of the state’s most rural counties.
ECHO Colorado receives many requests in part because it is the only ECHO infrastructure in the
state. This lack of competition among different ECHO programs decreases confusion and
duplication of effort.
ECHO Colorado uses a basic evaluation core for its offerings. All ECHO offerings now
receive the standard basic evaluation, which includes tracking attendance and a satisfaction
survey. Some ECHO offerings have more-ambitious evaluations as well. To date, the purpose of
these evaluations has been internal quality improvement.
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Figure E.10. ECHO Colorado Spoke Locations, 2015–2017

SOURCE: Thomas interview, 2018.

A key difference from the original Project ECHO is that ECHO Colorado has an end date for
all of its subject areas and conceives of them as time bound (some other sites have adopted
cohort models as well, such as Oregon, but it is not the typical design). Program staff have found
that a time-limited commitment might facilitate more consistent attendance.
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Program Challenges and How They Were Addressed
Long-term financial sustainability is a major issue for all ECHO programs. Diversification of
funding sources is seen as key to long-term sustainability. ECHO Colorado has a five-pillar
approach for sustainability:
1. gaining grant support (which has included CDC, HRSA, CMS Innovation Center, and
AHRQ, as well as PCORI)
2. alignment with state goals, such as those of the state’s departments of public health,
health and human services, Medicaid, and education
3. obtaining funding from philanthropic foundations, which have included the Denver
Foundation and others
4. selling contracting and consulting services, such as advising on setting up ECHO
programs or evaluation support, to other states or programs
5. integrating with CU, including its clinical networks, which allows the program to use
existing resources rather than needing to create them.
It is also apparent that ECHO Colorado has successfully addressed one of the key limiting
factors for ECHO programs: the startup cost to begin an ECHO offering. Staff from other ECHO
programs generally reported costs of $100,000–$120,000 to set up each ECHO subject area.
ECHO Colorado generally requires approximately half as much, which program staff believe is
because of the investments they have already made in setting up key core infrastructure that
makes effective use of specialist mentors’ time, which is the biggest expense. By developing a
streamlined process to take care of administrative matters, such as setting up session times,
specialist mentors are free to focus on content development and delivery.
Lessons Learned
•

•

•
•

In contrast to other programs, which developed organically over time, the developers
of ECHO Colorado were deliberate in their effort to build key infrastructure first, by
obtaining a grant to support a full year of planning and information-gathering before
building a program.
An ECHO program can be conceived of as a common utility in service to the entire
state. Being the sole provider of ECHO in Colorado reduces confusion about who
provides these kinds of services.
A model of continuous solicitation of feedback can help an ECHO program ensure
that it is meeting the needs of generalist mentees.
Time-bound ECHOs, with clear end dates, could result in lower barriers to entry for
generalist mentees, in contrast with the classic ECHO model, which is indefinite in
duration.
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Weitzman Institute
ECHO in an FQHC
“Project ECHO is exactly what we needed.”
—Daren Anderson, director, Weitzman Institute (interview, 2018)

Introduction
The Weitzman Institute is a research and innovation center located within Community Health
Center, Inc. (CHC) of Middletown, Connecticut, one of the largest FQHCs in the country. CHC
provides comprehensive primary care at 13 sites across Connecticut for more than
145,000 patients (Community Health Center Inc., undated), most of whom have household
incomes below 200 percent of the federal poverty level (Anderson et al., 2017). Dr. Daren
Anderson, a clinician-researcher at Weitzman, reported that he was flipping through NEJM one
evening in 2011 and saw an article about Project ECHO’s efforts in New Mexico (Arora,
Thornton, et al., 2011), which seemed applicable to the challenges CHC had been facing in
training PCPs to appropriately manage pain in the midst of the opioid crisis. He thought, “This is
exactly what we need” (Anderson interview, 2018).
Brief History of the Program
The Weitzman Institute stood up its own ECHO program within six months of being
introduced to the concept. The program began at two sites in Connecticut in early 2012, focusing
on HCV, similar to the original program at UNM. In addition, Weitzman quickly established an
HIV/AIDS program, and, by 2013, began two more ECHO programs: one focusing on pain
management and the other on MAT for OUD. More recently, in 2017, Weitzman launched a new
subject area in complex pediatrics for nurse practitioners and PCPs in underserved schools and
communities. The reach of the Weitzman ECHO now extends well beyond Connecticut to
FQHCs and similar clinics across the United States.
Connecticut is a small state with many hospital systems and thus does not face some of the
challenges with great distances between providers that other programs have described. It is not
considered rural, and patients are not usually physically far from major medical centers.
However, despite the proximity to specialists, only a small percentage of CHC patients with
HCV—10 percent, per an internal audit—were being seen by specialists. This is likely related to
the well-known challenges that FQHC patients experience with accessing specialty care because
many specialists do not accept Medicaid insurance. As an FQHC with a focus on creating a
PCMH, CHC aimed both to deliver care within the medical home as much as possible and to
improve patients’ access to specialty care.
Unique Features of the Program
CHC is the only FQHC to organize and run its own Project ECHO programming (Weitzman
Institute, undated-a), unlike many other EELM, which are organized by experts (who wish to
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deliver content). Whereas other EELM are mostly run by specialist mentors, this program is run
by generalist mentees who drive the choice of topics. This seems likely to help the program be
more centered on the needs of the generalist mentees; indeed, we were told that Weitzman
ECHO programming is designed to meet the specific needs of safety-net PCPs and their
communities. Spokes are recruited from FQHCs and similar clinics across the United States (see
Figure E.11). Specialist mentors could be drawn from diverse locations.
Figure E.11. Locations of Weitzman Project ECHO Spokes

SOURCE: Weitzman Institute, undated-b. Used with permission.

Subject Area Selection

Weitzman offers a fairly small number of ECHO offerings at any particular time, selected to
address conditions that are commonly seen in primary care and can likely be managed by PCPs
with additional support. Some common primary care conditions, such as diabetes, were not
selected by Weitzman for its ECHO because these conditions are already perceived to be core
competencies for PCPs, though other programs do include them. Other conditions, such as
pediatric epilepsy, were felt to be too uncommon to succeed as subject areas. A time line of
Weitzman’s ECHO launches is shown in Figure E.12.
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Weitzman developed and led a novel LGBT ECHO in collaboration with CDC, the National
Association of Community Health Centers, and the Fenway Institute from 2015–2016. The focus
was on health issues particular to LGBT patients, such as HIV prevention regimens and
transgender hormone therapy. The Fenway Institute has many experts in these clinical areas and
provided many of the faculty. This project ended, but the Fenway Institute (which is located in
Boston) created its own LGBT ECHO, which continues to operate.
Figure E.12. Time Line for Establishment of ECHO Programs at the Weitzman Institute

SOURCE: Anderson, 2018; Anderson interview, 2018. Used with permission.
NOTE: The Pediatric and Adolescent Behavioral Health curriculum was expanded in scope and the name was
changed in October 2017 to Complex Integrated Pediatrics. A new chronic pain subject area was started in early
March 2018, funded by HRSA, also called ECHO Pain. LGBT Health ended in June 2017, and ECHO Colorado
Chronic Pain ended in June 2017.

Innovation

Although the HCV ECHO was closely modeled after the UNM template, Weitzman staff
began innovating early on with their pain programs. They did not have people with the subjectmatter expertise to serve as specialist mentors because their FQHC does not have a pain center.
But staff realized that both the spokes and the hub specialists could be remote—that is, they
sometimes engage remote experts. For ECHO Pain, specialists are drawn from a
multidisciplinary pain center in Tucson, Arizona. Weitzman also began making these programs
available to PCPs in other locations that did not have a local community of practice to “come
together in virtual community.” Weitzman’s ECHO Pain has become especially popular,
drawing PCPs from more than 30 states since its inception.
Some of the ECHO programs organized by Weitzman meet weekly; others are held biweekly
(or, in one case, monthly). The length of the sessions also varies. Generalist mentees are asked to
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make a commitment to attend at least 75 percent of sessions, and recordings are provided after
each session to help accommodate schedules.
Concurrent Interventions

In addition to the ECHO efforts, Weitzman supports e-consults and learning collaboratives to
support training and care, and many physicians take advantage of a combination of these services
(see Figure E.11 for a map of locations). Weitzman also created a separate parallel platform to
allow PCPs to send an e-consult question with content from the patient chart directly to a
specialist in their network. E-consults allow for fast answers to time-sensitive questions because
they do not require waiting for the next ECHO session to present one’s case.
Learning collaboratives, which have certain similarities with EELM, focus on building
community through recurrent meetings. Meetings are usually face to face, and the emphasis
tends to be on creating processes and structures to support quality improvement, as opposed to
telementoring in a specific clinical discipline through case studies in the ECHO model. Learning
collaboratives are usually led by a combination of content matter experts and quality
improvement coaches rather than clinical experts.
The combination of these options, particularly with regard to managing pain (Weitzman
Institute, undated-c), offers providers a wealth of resources and tools to advance their knowledge
and better care for their patients. However, having multiple ongoing programs also increases the
challenge of evaluating the impact of any specific program in isolation.
Program Challenges and How They Were Addressed
Funding

Program challenges include funding, particularly for specialist mentors, who generally must
be compensated for developing and delivering content. Sustainability is a related challenge. So
far, Weitzman has achieved an agreement with only one insurance company to make capitated
payments to the ECHO program, but there are hopes that this can be replicated. Funding has also
been secured from a range of sources, such as federal organizations (CDC, HRSA, SAMHSA),
state Medicaid agencies, private and philanthropic organizations, and others (Weitzman Institute,
undated-a).
Evaluation

Similar to other sites, Weitzman aims to measure the impact of ECHO but faces challenges in
doing so. Despite the challenges, this work is felt to be important because of a sense on the part
of its organizers that ECHO’s expansion has outpaced its evidence base.
Two papers have been published to date on Weitzman’s ECHO offerings, with another under
review. In a 2017 paper by Anderson et al., researchers conducted a quasi-experimental pre-post
intervention, with a comparison group to examine the impact of ECHO Pain on knowledge of
pain care and processes of care. Compared with controls, intervention clinicians (those who
participated in the ECHO Pain program) showed increased pain knowledge and self-efficacy to
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treat pain; improvement on such process measures as the use of formal assessment tools and
opioid agreements; and, most importantly, a measurable decrease in opioid prescribing
(Anderson et al., 2017). Unlike diabetes, which has an objective measure to follow over time
(HbA1c levels), pain is more difficult to quantify, and that is why they used this evaluation
method of assessing knowledge, processes, and outcomes. The research team is also working on
a manuscript describing the impact of LGBT ECHO on practices around documenting sexual
history, sexual orientation and gender identity data, and screening for sexually transmitted
diseases.
Lessons Learned
•

•

•

•

EELM can play a role in increasing access even in places that are not rural. Patients
have difficulty accessing specialty care, even when it might be located very close by,
as did the FQHC patients in Connecticut who experienced access barriers because of
wait times, lack of insurance coverage, or lack of information.
EELM do not necessarily require any geographic connections—spokes can be across
the country or the world, and hubs can also be teams of experts who are separated
geographically. Here, ECHO programs are organized around a common set of needs
(i.e., the needs of FQHCs and similar providers) rather than a geographic designation
(e.g., within a state).
ECHO programs could operate alongside other programs designed to improve access
to specialty care, such as e-consults, which is beneficial for providers and patients but
could lead to challenges with evaluating the impact of any one intervention.
Having a program organized by generalist mentees rather than specialist mentors
could result in a product that is more focused on meeting the needs of the learners.
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Appendix F. Inventory

Please see the separate related file, RR-2934z1, for an inventory of active EELM across
the United States and in select other countries, describing the program, topic areas, and
funding sources, where available.
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